text stringlengths 102 99.6k | url stringlengths 31 426 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:29:49 2022-09-19 04:34:15 |
|---|---|---|
GRAND RAPIDS, Mich., Sept. 13, 2022 /PRNewswire/ -- Service Express, a leader in global data center and infrastructure solutions, today announced the acquisition of third-party maintenance (TPM) provider Sherlock Services based in Ohio. The acquisition complements Service Express' current third-party maintenance offerings and brings expanded data center solutions to existing Sherlock Services customers.
Founded in 1991, Sherlock Services provides multivendor data center maintenance and hardware solutions for server, storage and network systems. In addition to over 30 years of industry experience, the company brings a talented team of US-based Level 2 and Level 3 Engineers to Service Express.
"We've offered similar solutions and worked alongside Service Express for many years and have been impressed with the level of service the company provides," said Ron Pollard, Co-Owner and President of Sherlock Services. "We look forward to offering our customers a widened portfolio of services and end-to-end data center support."
The acquisition of Sherlock Services strengthens Service Express' technical team, brings additional OEM expertise and builds upon the company's comprehensive third-party maintenance offerings.
"Our primary goal throughout the acquisition is to ensure our people have the resources they need to develop skills and explore potential career opportunities," said Greg Brumbaugh, Co-Owner & VP Operations of Sherlock Services. "We anticipate a seamless transition and look forward to what's next with Service Express."
Data center solutions delivered by Service Express offer Sherlock Services customers new options for their day-to-day needs beyond third-party support, including Hybrid Cloud and Managed Infrastructure solutions. Service Express continues to expand its offerings to provide customers with one source for end-to-end data center and infrastructure needs.
"Sherlock Services has great reputation, and they serve their customers and employees well – making them a great fit for Service Express," said Ron Alvesteffer, President and CEO of Service Express. "We're thrilled to welcome Sherlock Services' skilled team to Service Express and offer the company's existing customers more depth and expertise for their data center!"
For more information on Service Express, visit serviceexpress.com.
About Service Express
Service Express is an industry-leading data center solutions provider specializing in global multivendor maintenance, hybrid cloud, managed infrastructure services, hardware solutions and more. Companies around the globe trust Service Express to deliver reliable end-to-end support. Service Express' flagship technology, ExpressConnect®, helps IT teams automate support with monitoring, ticketing, integrations and account management. For more information, visit serviceexpress.com.
About Sherlock Services
Sherlock Services is a data center solutions provider specializing in multivendor third-party maintenance (TPM) and hardware for server, storage and network systems. Since 1991, Sherlock Services has delivered data center support for its global customers. The company resolves hardware failures quickly and cost-effectively with local technicians and onsite parts. For more information, visit sherlockservices.com.
View original content to download multimedia:
SOURCE Service Express | https://www.wibw.com/prnewswire/2022/09/13/service-express-acquires-third-party-data-center-maintenance-provider-sherlock-services/ | 2022-09-13T10:00:59Z |
ALBANY – Cox Landing just off Philema Road in Albany was closed Friday so that Georgia Power could use the site to launch a barge and equipment. Cox Landing is expected to be closed Monday and Tuesday as well.
Georgia Power has requested and received permission to use the landing while work is being performed at Flint River Hydro.
The public is asked to pay special attention in areas marked off with safety barrels. The barrels are being placed at strategic locations for the protection of the public and to prevent any potential injury while crews are working. Anyone in the area should be mindful of these locations and citizens are asked to be courteous to those working and to be careful of their equipment.
Depending on the weather and work progress, workers may need an extra day to complete their job. If so, Cox Landing may also be closed on Wednesday.
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/local/georgia-power-work-leads-to-temporary-closure-of-cox-landing/article_81b8a7d8-310c-11ed-adc7-3beaa235e392.html | 2022-09-10T15:14:21Z |
Trained disaster professionals prepare enhanced capabilities to serve millions
ALEXANDRIA, Va., Aug. 2, 2022 /PRNewswire/ -- As natural disasters become more frequent and destructive across the U.S., The Salvation Army is prepared to assist millions of survivors and first responders with critical services. Many communities are in increasing need of a helping hand as inflation rises and the impacts of past disaster events linger. 2022 is predicted to have:
- 14-21 named storms during the Atlantic hurricane season
- 2,083,238 acres burned in wildfires
- $3.7 billion in damage caused by tornadoes
- 14.5 million households or people at risk of being impacted
Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/8972954-the-salvation-army-disaster-season-rapid-response/
Salvation Army Emergency Disaster Services
As one of the largest disaster relief organizations in the country, The Salvation Army is already on the front lines of meeting needs and can quickly activate response efforts unique to each community affected. In 2021 alone, The Salvation Army responded to 8,441 disasters; assisted over 2.3 million people in the aftermath of hurricanes, wildfires, winter storms, heat waves, tornadoes, and other events; and provided more than $8.3 million in financial aid to survivors.
The Salvation Army is on the ground in Southeast Kentucky after historic flooding impacted the area and are coordinating their efforts with state and local officials, as well as other participating relief agencies. Salvation Army teams responding to the disaster plan to continue providing meals, drinks, snacks, cleanup kits, and emotional and spiritual care for as long as their services are needed. Visit https://disaster.salvationarmyusa.org to learn more about how The Salvation Army is serving Southeast Kentucky.
Emergency Preparedness
Trained Salvation Army staff and volunteers have served in the wake of every major disaster since 1900. In addition to offering disaster-preparedness training programs across the country to get individuals and communities ready for emergencies, The Salvation Army also has a disaster preparedness handbook available.
Immediate Emergency Response
When a disaster strikes, The Salvation Army works with organizations and federal authorities to:
- Identify and mobilize resources through our national network of disaster professionals and service locations positioned in all 50 states
- Support survivors and first responders through mobile units that provide food, hydration, hygiene products, and emotional and spiritual care
Emotional and Spiritual Care
Some effects of disasters are unseen — many survivors and first responders suffer emotional stress and trauma. The Salvation Army delivers the vital emotional and spiritual care they need. That may mean a shoulder for crying or an ear for listening. Other times, it calls for a hug and a prayer.
Long-Term Disaster Recovery
The Salvation Army leads recovery efforts for as long as needs in a given community persist. That often means we stay to help months, even years, after a disaster. The Salvation Army's disaster response professionals work with all levels of government to form a long-term, far-reaching disaster recovery plan that meets basic needs, addresses restoration and rebuilding projects, and includes the dispersal of financial help and donated goods.
Disaster Response Media Communications
As a relief organization within the National Volunteer Organizations Active in Disaster (VOAD), The Salvation Army helped develop FEMA's National Response Network and is constantly improving the way it responds to — and communicates during — emergency situations. This year, the organization has led relief groups in evolving the way in which information is disseminated during disasters.
Starlink Connectivity: In the South, rapid response teams have been equipped with Starlink connectivity to help broadcast information and images from the ground immediately after a disaster hits, aiding other relief organizations and providing an immediate look at impacted areas, even before the press arrives on-site.
SMS Alert System: The Salvation Army has also implemented a national SMS alert system to provide immediate and useful information to members of the media who have opted in and are planning to cover each disaster. Information includes service locations, images, spokesperson information, insights from the impacted area, and service statistics.
- If you are a reporter, editor, producer or other member of the media, you can sign up for The Salvation Army's SMS alerts, by clicking here. All who sign up will only receive alerts when disasters hit.
How You Can Help
The best way to support survivors is by making a financial contribution, which allows The Salvation Army to meet immediate and long-term needs. During emergency disasters, 100% of designated gifts are used to support specific relief efforts. Those who are able to donate can do so through a variety of convenient and safe methods:
- Visit SalvationArmyUSA.org
- Call 1-800-SAL-ARMY
- Make a contribution through Amazon Alexa by saying, "Alexa, make a donation to The Salvation Army"
- Or text "STORM" to 51555
- Share this asset via your social media channels
For more information about The Salvation Army's Emergency Disaster Services and how we serve in times of need, visit disaster.salvationarmyusa.org.
About The Salvation Army
The Salvation Army annually helps more than 25 million Americans overcome poverty, addiction, and economic hardships through a range of social services. By providing food for the hungry, emergency relief for disaster survivors, rehabilitation for those suffering from drug and alcohol addiction, and clothing and shelter for people in need, The Salvation Army is doing the most good at 7,200 centers of operation around the country. During times of disaster, 100% of designated donations to The Salvation Army are used for immediate response and long-term efforts. In 2021, The Salvation Army was ranked No. 2 on the list of "America's Favorite Charities" by The Chronicle of Philanthropy. For more information, visit SalvationArmyUSA.org. Follow us on Twitter @SalvationArmyUS and #DoingTheMostGood.
Media Contact:
mediarelations@salvationarmyusa.org
(703) 302-8640
View original content:
SOURCE The Salvation Army | https://www.mysuncoast.com/prnewswire/2022/08/02/salvation-army-continues-respond-disasters-become-increasingly-destructive/ | 2022-08-02T14:27:15Z |
ATLANTA — The State Board of Pardons and Paroles is celebrating and supporting crime victims during National Crime Victims’ Rights Week through Saturday. The Georgia Office of Victim Services is participating in several events during the week.
“Our victim services division is second to no other in its support of Georgia crime victims,” Parole Board Chairman Terry Barnard said in a news release. “Registered crime victims can receive assistance through many programs.”
Barnard urged all crime victims to get registered so they can receive services and be provided notifications and parole status information regarding offenders.
The Georgia Office of Victim Services is a division of the State Board of Pardons and Paroles. The office also represents the Georgia Department of Corrections and the Georgia Department of Community Supervision.
Gov. Brian Kemp issued a proclamation recognizing April 26-30 as Crime Victims’ Rights Week in Georgia.
In addition to programs already participated in this week, the Georgia Office of Victim Services is taking part in a Blood Drive sponsored by Mothers Against Drunk Driving, and on Wednesday the office is coordinating its first Victim Impact Session with the Northeastern Judicial Circuit at the Hall County Courthouse.
The 2022 NCVRW theme is “Rights, access, equity, for all victims.”
Contact the Parole Board’s office of communications at (404) 657-9450 or steve.hayes@pap.ga.gov.
Multiple emergency response agencies responded on Wednesday to a simulated airplane crash at Southwest Georgia Regional Airport. Airport firefighters put out a small fire before paramedics hit the scene to assist patients made up to display a variety of mock injuries. The exercise was part o… Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/news/state-parole-board-recognizes-crime-victims-rights-week/article_866fef52-c654-11ec-9c10-b30ea1f83d65.html | 2022-04-27T22:20:27Z |
Letter to the editor: Show mercy to the homeless
In response to the Aug. 21 story in the Repository, "Number of homeless households increasing," I have been a minster to the homeless the past two years since the pandemic began. I drive around Canton looking for homeless people. When I see them I give them a sandwich and a water along with a rosary and Sacred Heart of Jesus badge as well as other religious articles and literature because I want them to have something of God with them and on them.
It is a very rough life for them. Not knowing where to go at times and not knowing where your next meal will come from can be a scary situation. I like to think with my homeless ministry I help ease that situation just a little bit.
Although times are tough with inflation and the cost of living getting higher, we must not forget the lives of those less fortunate. As stated in the article, many have mental health issues and some are drug-addicted or have just made bad decisions in life. Regardless of that, their lives are sacred and they are loved by God and not forgotten by him.
It is my hope that the housing market and the city of Canton will get better at helping the homeless and that those who I have been blessed to minster to will find housing and employment and completely turn their lives around.
However, it takes all of us. I encourage everyone to help a homeless person or family in need. I encourage lawmakers to find a way to meet the needs of the homeless so that they may have the resources they need to turn their lives around.
Remember that Jesus always said we will always have the poor. Let us show mercy to them.
Paul Crowley, Waynesburg | https://www.cantonrep.com/story/opinion/letters/2022/08/23/letter-to-the-editor-show-mercy-to-the-homeless/65414024007/ | 2022-08-23T12:33:21Z |
CHICAGO, April 11, 2022 /PRNewswire/ -- JBT Corporation (NYSE: JBT), a leading global technology solutions provider to high-value segments of the food & beverage industry, today published its 2021 ESG Report, "Make it BETTER," outlining key achievements in four focus areas: Sustainable Solutions, Operations, People, and Governance. JBT's purpose is to help our customers succeed in the marketplace by providing them with solutions to make better use of the world's precious resources.
Throughout our history, JBT has focused on continuous improvements that make smart use of precious resources. This work has never been more important to our customers, our industry, and the world at large.
"Many of our customers are making commitments to achieve net zero greenhouse gas (GHG) emissions, conserve water, and use natural resources more efficiently. JBT's advanced process and application knowledge allows us to engineer innovative products and solutions to help our customers in their sustainability journeys," said Brian Deck, President and Chief Executive Officer. "Our products, such as zero-emissions ground support equipment, packaging solutions that reduce food waste and plastic usage, and state-of-the-art bioreactors that make sustainable meat, are helping some of the largest companies in the world take meaningful steps toward achieving their environmental goals."
ESG Report Highlights
This report details how JBT is providing solutions for our customers to reduce their environmental footprint, how we strive to operate our own facilities efficiently and safely, and how we offer a workplace of choice that welcomes everyone and seeks to maximize their potential. Key highlights include:
Sustainable Solutions
- Our portfolio of equipment and services includes a significant number of products and technical support programs that enable our customers to make a positive environmental impact, including increasing yields, conserving water, ensuring food safety, facilitating use of alternative fuels, and automating processes. We estimate that 48% of our product revenue is from equipment that has an environmental benefit for our customers.
- In our AeroTech Division, we set a goal to increase electric-powered airport ground support equipment sales from less than 5% of total vehicle sales in 2020 to 30% by 2023. Additionally, we launched three new electric vehicles in 2021: JBT Commander® 30i E, JBT All-Electric B650 E tow tractor, and JBT LEKTRO® tow vehicle.
Operations
- We conducted an evaluation of our climate-related risks and opportunities and shared our findings consistent with the Task Force on Climate Related Financial Disclosures (TCFD) framework.
- We purchased an enhanced utility billing management platform that will expand our ability to manage and report on utility consumption and emissions broadly across our global operations.
- For the first time, we reported our water footprint in this year's report as we continue to expand our transparency about our environmental footprint.
People
- We launched our first global employee engagement survey, obtaining responses from approximately 65% of our employees. We distributed the resulting data to our managers to develop actions to address opportunities identified through the survey to strengthen our engagement with JBT employees.
- We partnered with an industry leader in DEI to develop and continue the JBT Inclusive Leadership Series (ILS). The ILS is a quarterly training for the top leaders in the company that focuses on providing structured and interactive leadership training sessions, with the primary objective to help JBT leaders incorporate inclusive practices into the way they manage their teams.
- We awarded our initial twelve Tom Giacomini Engineering Scholarships to diverse students pursuing degrees in mechanical engineering, electrical engineering, computer science, mechatronics, or industrial engineering.
- In conjunction with executive leadership sponsors, employees developed two pilot Employee Networking Communities (ENCs), Blacks/African-American in the U.S. and Women globally. The aim of these groups is to create safe spaces for employees to start building community with others that share specific demographics.
- Our Recordable Incident Rate (RIR), which is a measure of the total number of injuries and illness per 100 employees working a full year, was 0.79, a reduction of 20% from 2020.
Governance
- We appointed our first Chief Ethics and Compliance Officer, who reports to our Executive Vice President and General Counsel.
- We established a cross functional Ethics and Compliance Committee in 2021 to better ensure that ethics is embedded in everything that we do on a day-to-day basis. In addition, this committee will act as our "ethics champions" to raise awareness throughout the company.
- We spent over $29 million with 55 diverse suppliers, which provided products and services to our North American manufacturing sites.
"We continue to be impressed with the resilience of our employees who often take extraordinary steps to deliver results for our customers, especially in light of the challenging operating environment that we experienced in recent years," stated Deck. "As an integral part of the supply chains of many critical industries, JBT is proud to provide the solutions that ultimately enable our customers to Make It Better and, in the process, make our world better. We look forward to updating you on our progress in the years to come."
Please visit https://www.jbtc.com/about-us/esg/ to learn more about JBT's ESG efforts.
###
JBT Corporation (NYSE: JBT) is a leading global technology solutions provider to high-value segments of the food & beverage industry with focus on proteins, liquid foods and automated system solutions. JBT designs, produces and services sophisticated products and systems for multi-national and regional customers through its FoodTech segment. JBT also sells critical equipment and services to domestic and international air transportation customers through its AeroTech segment. JBT Corporation employs approximately 6,600 people worldwide and operates sales, service, manufacturing, and sourcing operations in more than 25 countries. For more information, please visit www.jbtc.com.
Investors & Media:
Kedric Meredith
(312) 861-6034
View original content:
SOURCE JBT Corporation | https://www.kxii.com/prnewswire/2022/04/11/jbt-corporation-issues-its-first-comprehensive-environmental-social-governance-esg-report/ | 2022-04-11T11:43:13Z |
COLUMBIA, Mo., May 3, 2022 /PRNewswire/ -- Valet Health, the leading ROI-driven digital platform for new patient acquisition, and OBERD, the leading practice intelligence software company for optimizing evidence-based patient engagement and practice performance, announced a collaboration to deliver a one-of-a-kind engagement and analytics offering for health care organizations called Amplify Patient Voice.
Amplify Patient Voice combines the functionality of the Valet Health LaunchPad product with OBERD's Patient Satisfaction and Outcomes modules.
Now, data from patient questionnaires will drive awareness across multiple channels through online physician and location profiles, ratings, and social media. Analysis on ROI and service line evaluation tools are included.
This is further enhanced by a unique relationship between Valet Health and WebMD Care, driving additional visibility to physicians by providing specialized procedures with a focus on outcomes data.
More than ever, patients research healthcare providers online as Pew Research indicates that 4 out of every 5 adults in the U.S. use the Internet for gathering health information while 94% of health care patients use online reviews to evaluate providers (Software Advice).
In the online consumer journey, patients see ratings, but not metrics that signal quality of care based on patient outcomes. Now, patients can be informed about functional recovery and satisfaction as it relates to specific physicians and healthcare organizations. They'll understand how similar patients have progressed through their health care experience.
Creating public awareness on patient outcomes has never been more important. Additionally, new government payment mandates require outcomes collection.
"As the digital landscape continuously changes, the forces driving new patient flow and digital channels for patient engagement are key pieces of the puzzle in helping health systems and specialty practices execute on a best-in-class digital strategy. Valet Health is truly excited for what is now possible in close collaboration with OBERD - a systematic approach to measuring and optimizing the patient journey, backed by patient-reported outcomes combined with the capability to quantify ROI... this is a significant development," states Dave Bowen, CEO of Valet Health.
"We are very excited to announce this new collaboration. This offering will deliver a new way of attracting patients with performance data, measuring their experience and analyzing the service lines they engage with. More importantly, healthcare organizations can understand ROI on their efforts," said Ali Hussam, PhD, CEO and Co-Founder of OBERD.
About Valet Health
Valet Health's role in emerging healthcare marketing technology leverages the power of data mining and digital marketing analytics to standardize online information about physicians and clinics, intelligently capture new patient referrals, and engage existing patient population segments with behavior-based automation. Valet Health specializes in growth-focused digital programs utilizing its proprietary healthcare experience platform to quantify and deliver evidence of marketing ROI for its clients across North America. For more information visit www.valethealth.com or follow us on LinkedIn www.linkedin.com/company/valet-health
About OBERD
OBERD (a.k.a. Universal Research Solutions, LLC) owns, develops, implements and supports outcomes and clinical data collection software systems. OBERD optimizes the data collection necessary to empower evidence-based medical practice, improve the quality and efficacy of care, and advance clinical decision-making and patient understanding. OBERD has been collecting patient outcomes data in orthopedics for over 11 years, with over four million active patients and one billion+ data points. It includes QCDR, with CMS-approved measures specific to orthopedics. For more information, visit www.oberd.com or follow the company on Twitter @oberdnews and LinkedIn www.linkedin.com/company/oberd.
CONTACTS: For further information, please contact Steve Garner, Chief Commercial Officer, OBERD, info@oberd.com or Matty Crescenzo, President and Founder, Valet Health info@valethealth.com
View original content to download multimedia:
SOURCE OBERD | https://www.mysuncoast.com/prnewswire/2022/05/03/valet-health-oberd-have-launched-partnership-focused-attracting-patients-based-evidence-based-patient-engagement-analyzing-their-experience/ | 2022-05-03T16:52:45Z |
DAVIE, Fla., Aug. 9, 2022 /PRNewswire/ -- BHG VC, the corporate venture capital arm of BHG Financial, is pleased to announce its investment in Effectiv, an industry leading fraud prevention and financial crime management company.
BHG VC's investment in the company comes after a successful partnership was established between Effectiv and BHG Financial. By implementing Effectiv's solutions, BHG Financial experienced cost savings in excess of $2 million and saw significant efficiency gains of 70%.
Effectiv is a fraud prevention and financial crime management platform that provides financial institutions with the technology and support they need to securely onboard customers and safeguard their assets in a digital and post-pandemic age. Created by experts in the fields of compliance, fraud, and technology, Effectiv's solutions are uniquely designed with a deep understanding of the global financial landscape. Powered by a combination of human-centered technology and AI, Effectiv's solutions quickly detect patterns and anomalies to protect account holders and facilitate a frictionless onboarding process.
Recognizing the increasing importance of staying ahead of evolving financial crime, BHG VC's investment demonstrates its ethos of supporting promising companies with more than just capital. "We're proud to partner with Effectiv and to further support financial institutions across the country," said Misha Polovneff, VP of Corporate Development. "Our parent company, BHG Financial, has been serving banks since 2001. We understand their needs and find that Effectiv provides a comprehensive platform for financial institutions to navigate fraud and minimize cost."
Built by a team who helped enterprises like USBank, Chime, Google, PayPal, and Walmart manage fraud and risk, Effectiv's solutions utilize hundreds of industry-leading data sources and enable financial institutions of all sizes to establish customized solutions based on their unique needs. With built-in machine learning capabilities and ML-model connectors, it makes it simple for financial institutions to leverage the power of ML in achieving their automation goals.
"Our relationship with BHG VC has been extremely positive," said Ravi Sandepudi, CEO of Effectiv. "The guidance of their leadership team and their expertise in the financial sector have been invaluable in helping us scale our operations. We're excited to continue working together to provide financial institutions with the support they need to manage fraud and risk in this constantly shifting environment."
Effectiv joins BHG VC's fintech-focused portfolio companies that operate in subsectors ranging from specialized loan origination and fraud prevention to digital banking and more. Through these partnerships, BHG VC aims to strengthen financial institutions and fintechs while empowering leaders across financial services.
About Effectiv
At Effectiv, we aim to empower financial institutions' genuine needs for effective fraud prevention and compliance management that are adaptable for the future and use human-centered technology with the perfect combination of AI. Backed by industry-leading investors, advisors, and experts, we're helping financial institutions stay ahead of fraud and compliant in today's dynamic and digital-first world. For more information about Effectiv, click here.
About BHG VC
BHG VC is unleashing rapid growth in the fintech space by investing capital and contributing strategic resources to exceptional entrepreneurs with revolutionary ideas. Powered by BHG Financial's superior data and experience, BHG VC utilizes a unique partnership investment methodology to elevate tomorrow's fintech leaders, today.
For more information about BHG VC, click here. Find out more about the company's financial solutions on https://bhgfinancial.com. Follow BHG on LinkedIn, Facebook, Instagram, and Twitter.
Media Contact:
Jasmine Heard
Jheard@bhg-inc.com
View original content to download multimedia:
SOURCE BHG Financial; BHG VC | https://www.wibw.com/prnewswire/2022/08/09/bhg-vc-announces-investment-fraud-prevention-financial-crime-management-company-effectiv/ | 2022-08-09T12:48:00Z |
FARMINGTON, Conn., June 12, 2022 /PRNewswire/ -- Otis Worldwide Corporation (NYSE: OTIS) Chair, CEO & President Judy Marks and CFO Rahul Ghai are meeting with international investors on Monday, June 13th and Tuesday, June 14th, respectively. A corresponding presentation can be found at www.otisinvestors.com.
About Otis
Otis is the world's leading elevator and escalator manufacturing, installation and service company. We move 2 billion people a day and maintain more than 2.1 million customer units worldwide, the industry's largest Service portfolio. Headquartered in Connecticut, USA, Otis is 70,000 people strong, include 41,000 field professionals, all committed to meeting the diverse needs of our customers and passengers in more than 200 countries and territories worldwide. To learn more, visit www.otis.com and follow us on LinkedIn, Instagram, Facebook and Twitter @OtisElevatorCo.
Media Contact
Katy Padgett
+1-860-674-3047
kathleen.padgett@otis.com
Investor Relations Contact
Michael Rednor
+1-860-676-6011
investorrelations@otis.com
View original content:
SOURCE Otis Worldwide Corporation | https://www.wibw.com/prnewswire/2022/06/12/otis-international-marketing-advisory/ | 2022-06-12T21:13:24Z |
AUSTIN, Texas, Sept. 12, 2022 /PRNewswire/ -- BeatBox Beverages, The World's Tastiest Party Punch, is now the official punch of the Alabama Crimson Tide. Fruit Punch, Blue Razzberry, Mango & Pink Lemonade are available at select locations at Bryant-Denny Stadium. BeatBox will have year-round brand visibility and availability for spectators at both womens & mens sporting events.
This three-year partnership kicked off the Alabama Crimson Tide football season at the home opener last Saturday, September 3rd.
In addition to in-stadium activations, BeatBox will utilize media and broadcast integrations across digital, print, and radio campaigns to amplify the partnership with the Alabama Crimson Tide Sports Network.
"As we continue to expand our partnerships beyond major national music festivals, we are constantly searching for new and exciting ways to integrate our product responsibly by connecting fans and bringing people together. And what brings people together more than cheering for their favorite team while enjoying BeatBox? Our partnership with the Alabama Crimson Tide gives consumers another fun place to drink the world's tastiest party punch," says Zech Francis, VP of Global Marketing.
BeatBox Beverages, one of the fastest growing RTD brands of 2022, is currently available in more than 40,000 retail locations. The brand is the fastest growing alcoholic beverage brand on social media and has reached over 6 million customers at festivals and events to date in 2022.
"We could not be more excited to partner with the Alabama Crimson Tide for the upcoming football and athletics seasons. BeatBox has deeply invested in its consumers through an all-inclusive customer experience so it was a natural fit to partner with the Alabama Crimson Tide as we continue to expand to new platforms and avenues to spread the BeatBox love" said Phil Jamison VP of Sales - North America.
United through a love of music and inspired by the entrepreneurial spirit of Austin, Texas, the founders of BeatBox Beverages set out to create something that could help everyone #PartyBetter. One year later, they made Shark Tank, walking away with the biggest investment the show had made at that time, $1million from Mark Cuban. Later adding on a team of industry veterans from InBev, MillerCoors, Deep Eddy, and Tito's Handmade Vodka, to name a few – who know how to develop, launch, and quickly grow authentic brands. Boasting a roster of investors including Mark Cuban, Rob Dyrdek as well as DJs Party Favor, Louis The Child, Good Times Ahead, and many others. BeatBox Beverages' reputation is secured as a company that creates products that drive incremental profit in high-growth categories with specific expertise in the Millennial and Gen Z target.
CONTACT: Taylor Foxman, +1-609-432-2237, taylor@theindustrycollective.org
View original content to download multimedia:
SOURCE Future Proof | https://www.wibw.com/prnewswire/2022/09/12/beatbox-beverages-worlds-tastiest-party-punch-is-now-official-punch-alabama-crimson-tide/ | 2022-09-12T15:43:43Z |
Shawnee Heights parents surprise seniors on final day
TECUMSEH, Kan. (WIBW) - Thousands of seniors across northeast Kansas will walk the stage over the next couple weeks, collecting their high school and college diplomas.
Parents at one area high school marked the milestone with a trip to the parking lot.
The Shawnee Heights parents came with posters, paint pens, balloons and other items to decorate their seniors’ vehicles. The parents formed a Facebook group this year, finding various ways to celebrate their students and let them know they’re loved.
Amy Simpson said even though it seems the big day arrived suddenly, she’s not necessarily sad.
“I have been saying all year I’m more excited and happy for what he has to come than I am sad for what he’s moving away from,” she said. “He has a lot of great things ahead of him and I’m super excited to see what happens with that.”
Shawnee Heights also had a special sign outside the high school, congratulating the class of 2022.
The Thunderbirds have 240 students graduating in Sunday’s ceremony at the Stormont Vail Events Center.
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/05/13/shawnee-heights-parents-surprise-seniors-final-day/ | 2022-05-13T22:41:56Z |
First national brand advertising campaign in nearly a decade highlights recent actions dedicated to customer service, diversity and sustainability and captures the optimism fueling United's future ambitions
Employees play a starring role, with more than 60 featured in the 150 pieces of advertising creative
Launch coincides with new era of commercial travel and historic uptick in demand leading into summer travel season
CHICAGO, May 16, 2022 /PRNewswire/ -- United Airlines today launched a new, national campaign – "Good Leads The Way" – that tells the story of United's leadership in areas like customer service, diversity and sustainability, and captures the optimism fueling the airline's large ambitions at a time of unprecedented demand in air travel.
"In the past few years, United has emerged as a force for good and an industry leader," said United CEO Scott Kirby. "We're taking actions that inspire pride among our employees and customers – everything from historic investments to fight climate change and training more women and people of color to become pilots to getting rid of change fees and upgrading our fleet with 500 new planes. This campaign serves not only as an exclamation point on our recent actions, but also as a commitment to how United Airlines intends to show up in the future."
The national campaign is United's first, fully integrated, national brand advertising campaign in nearly a decade and was developed in partnership with creative agency of record 72andSunny. It includes more than 150 different pieces of video, digital, social and out-of-home content and features more than 60 real-life employees, the most ever featured in a single United content series.
Starting this week, people can see Good Leads The Way content onboard United aircraft and in airport terminals as well as in television spots, streaming platforms, billboards, across social media and through unique, contextually relevant and unexpected spaces. This launch coincides with the kickoff of the summer travel season and a historic increase in demand – United's April seat fill in was the highest ever for a non-summer month, with 88 percent of seats occupied.
The Campaign
Each distinct piece across the integrated creative campaign represents a page in United's brand identity story, and aims to deliver inspiring ads with engaging storytelling around customer, employee and community benefits. No two pieces are the same, from anthemic film to dynamic live billboards counting the number of connections saved on United.
"At the heart of everything we do and say at United – every decision – is doing the right thing. That's why, even at the depths of the pandemic, we didn't dodge the tough questions facing our business. We confronted them head-on with optimism and a determination to be a force for good for our customers and the communities we serve," said United chief communications officer Josh Earnest. "As the industry emerges from the pandemic, we are entering a historic new era of commercial travel, which makes it the right time to unveil our ambitious 'Good Leads The Way' campaign."
Creative highlights include:
- Anthem Film: In its hero video, United puts an emotional stake in the ground around the intention and impact of Good Leads The Way. The film features a patchwork of employee and passenger-sourced photos and videos, as well inspirational scenes shot for the campaign, as a narrator tells the true story of an airline on a mission to be a force for good on their planes and in the world. It will be featured within a national broadcast campaign and on broadcast in local hub markets.
- Out of Home: While the anthem tells the full story, each piece of out of home represents a different chapter, from major milestone actions to small, impactful moments with passengers. The imagery includes a mix of inspirational moments to authentically document United employees and passengers. The out of home campaign includes large-format outdoor and in-airport placements within United hub markets.
- Digital/Social: Leveraging a social-first approach to truly engage audiences where they are, the storytelling continues via bite-size content, like social videos and a pithy Twitter thread. Additionally, employees get their own custom Instagram sticker to showcase their pride. The social campaign will live on owned and paid social and digital channels.
How Good Leads The Way at United
For Employees
- Careers, not just jobs: United offers competitive pay and benefits, the chance to grow, and flight privileges to see the world
- Only major U.S, airline with its own pilot training school: United Aviate Academy
- New, state-of-the-art inflight training center opening this year in Houston
- World's largest flight training center in Denver
- Surprised active employees with a special award of $1,000 each last fall
- First major U.S. airline to roll out an employee COVID-19 vaccination program
For Customers
- 500+ new aircraft - and hundreds of plane upgrades – by 2026, with features like larger overhead bins, screens in every seatback, Bluetooth connectivity and fast Wi-Fi
- First major global U.S. airline to eliminate change fees on most tickets
- Helped more than 288,000 customers and counting make their connecting flight this year via United's exclusive ConnectionSaver technology
- This summer, United will serve more transatlantic destinations than every other U.S. carrier combined and be the largest airline across the Atlantic
- The award-winning United app brings ease to customers, through features that allow you shop by map, get the latest trip details, plan trips with friends and makes travel easier for people with visual disabilities.
For Our Communities
- Hiring more than 50,000 people in the next five years, providing unionized, well-paying careers as pilots, flight attendants, agents, technicians, and dispatchers
- Will aim to train 5,000 new pilots by 2030 through the United Aviate Academy, with the goal that at least half will be women and people of color
- Invested more in sustainable aviation fuel production than any other airline in the world
- In 2021, United donated more than $10 million in cash and in-kind contributions to non-profits across the country and worked with its customers to donate another 100+ million miles to charities that depend on travel
- Industry-leading investments in electric aircraft designed to help us reduce our greenhouse gas emissions
- Committing to reduce our greenhouse gas emissions by 100% by 2050, without relying on traditional carbon offsets
For more information, visit united.com/goodleadstheway and download media assets here.
About United
United's shared purpose is "Connecting People. Uniting the World." From our U.S. hubs in Chicago, Denver, Houston, Los Angeles, New York/Newark, San Francisco and Washington, D.C., United operates the most comprehensive global route network among North American carriers. United is bringing back our customers' favorite destinations and adding new ones on its way to becoming the world's best airline. For more about how to join the United team, please visit www.united.com/careers and more information about the company is at www.united.com. United Airlines Holdings, Inc., the parent company of United Airlines, Inc., is traded on the Nasdaq under the symbol "UAL".
View original content to download multimedia:
SOURCE United Airlines | https://www.wibw.com/prnewswire/2022/05/16/good-leads-way-uniteds-new-campaign-celebrates-employees-doing-right-thing-customers-communities/ | 2022-05-16T14:45:35Z |
- Despite economic tailwinds, the U.S. labor market remains resilient with employers reporting a Net Employment Outlook of +33% for October through December.
- Positive outlooks are reported by employers across every industry – those in IT/Tech anticipate the most optimistic hiring pace (56%), followed by Banking/Finance/Insurance & Real Estate (42%).
- As the U.S heads towards the holiday season employers in Wholesale & Retail Trade and Restaurants & Hotels plan to boost their headcounts (+30% and +29%).
MILWAUKEE, Sept. 13, 2022 /PRNewswire/ -- The U.S. hiring sentiment remains relatively strong for the remainder of 2022, according to the Q4 ManpowerGroup Employment Outlook Survey (NYSE: MAN) of 6,050 employers published today.
Used internationally as a bellwether of economic and labor market trends, the Net Employment Outlook – calculated by subtracting the percentage of employers who anticipate reductions to staffing levels from those who plan to hire – now stands at +33%, down slightly (-5%) from Q3.
"Q4 is a critical bell-weather for the U.S labor market," said ManpowerGroup Chief Commercial Officer and North America President Becky Frankiewicz. "As we head into the holidays, employers are telling us skilled workers are the top of their wish-list and tailwinds like weaker growth and inflation haven't dampened their demands. The pandemic and subsequent talent shortages have taught companies that hiring and keeping the best talent is critical to success and just-in-time hiring is a challenge in this tight labor market. As the labor pool begins to look more like a labor puddle, we're counselling companies to do three things – look for potential versus simply past performance; reward and celebrate each and every person who dedicates their time and skills to work; and ensure flexibility and balance are an option for the many not the few. From factory floor to finance, every worker deserves the opportunity to work in a way that works for them."
KEY FINDINGS SUMMARY
- As tech for good gains momentum, digital roles continue to drive demand: IT, Technology, Telecoms, Communications & Media reported the strongest outlook (+56%), followed by Banking/Finance/Real Estate (+42%). The weakest hiring intentions were found in the Other Industry category (+20%).
- Employers in the Northeast and Midwest are least optimistic in hiring intentions compared to last quarter (-9%); yet Net Employment Outlooks are positive for both regions.
- Large organizations of 250+ employees report the strongest hiring intentions (+41%).
U.S. Hiring Plans by Industry Sectors
- Employers in all 11 U.S. industry sectors expect to grow their staff during the next three months: IT, Technology, Telecoms, Communications & Media (+56%); Banking, Finance, Insurance & Real Estate (+42%); Construction (+36%); Manufacturing (+35%); Other Services (+33%); Wholesale & Retail Trade (+30%); Restaurants & Hotels (+29%); Not-for-Profit (+26%); Education, Health, Social Work & Government (+25%); Primary Production (+24%); and Other Industries (+20%).
To view the complete results for the ManpowerGroup Employment Outlook Survey, visit: manpowergroupusa.com/meos.
The next survey will be released in January 2023 and will report hiring expectations for the first quarter. With MEOS beginning in 1962, this year's results mark the 60th consecutive year of the survey.
ABOUT THE SURVEY
The ManpowerGroup Employment Outlook Survey is the most comprehensive, forward-looking employment survey of its kind, used globally as a key economic indicator. The Net Employment Outlook is derived by taking the percentage of employers anticipating an increase in hiring activity and subtracting from this the percentage of employers expecting a decrease in hiring activity.
ABOUT MANPOWERGROUP
ManpowerGroup® (NYSE: MAN), the leading global workforce solutions company, helps organizations transform in a fast-changing world of work by sourcing, assessing, developing, and managing the talent that enables them to win. We develop innovative solutions for hundreds of thousands of organizations every year, providing them with skilled talent while finding meaningful, sustainable employment for millions of people across a wide range of industries and skills. Our expert family of brands – Manpower, Experis, and Talent Solutions – creates substantially more value for candidates and clients across more than 75 countries and territories and has done so for over 70 years. We are recognized consistently for our diversity – as a best place to work for Women, Inclusion, Equality, and Disability, and in 2022 ManpowerGroup was named one of the World's Most Ethical Companies for the 13th year – all confirming our position as the brand of choice for in-demand talent.
View original content to download multimedia:
SOURCE ManpowerGroup | https://www.kxii.com/prnewswire/2022/09/13/us-employment-outlook-remains-strong-employers-across-industries-plan-increase-headcounts-q4/ | 2022-09-13T14:16:40Z |
Bell County reported two new deaths due to COVID-19 on its dashboard Tuesday, raising the toll to 908 as cases rose slightly.
Bell County Public Health District Epidemiologist Costa Claver said the two new deaths were two women in their 70s and 90s, respectively.
Four new cases of the coronavirus were reported by the health district for a total of 110 active cases.
The county’s incidence rate went up to 30.31 cases per 100,000 residents in the county, more than double the 14.33 rate reported on May 11.
Of the 47,629 cases reported since the pandemic started, 46,611have recovered, and 908 people died.
The health district’s dashboard showed Trauma Service Area L had 16 of the 1,026 available hospital beds in the area taken up by COVID-19 patients. The service area covers about 512,799 residents in Bell, Coryell, Hamilton, Lampasas, Milam and Mills counties.
No confirmed cases were reported in the Temple or Belton independent school districts dash- boards.
Salado ISD reported one case Saturday.
Killeen ISD reported four student cases on its dashboard.
Several places in Temple offer vaccinations and testing, including CVS, Walgreens, Walmart, the Veterans Administration hospital, and the Baylor Scott & White Medical Center and clinics.
Free at-home test kits are available at covidtests.gov. Tests are limited to four per household and are shipped through the U.S. Postal Service. | https://www.tdtnews.com/news/central_texas_news/article_e6182082-d658-11ec-99ff-9743ed215965.html | 2022-05-18T03:54:17Z |
‘She was screaming’: Family says 89-year-old grandmother killed in pit bull attack
LAS VEGAS (KVVU/Gray News) - Police say a woman was killed in a dog attack Tuesday morning.
The Las Vegas Metropolitan Police Department reports that officers were called to a residential area at about 9:45 a.m. regarding a woman who was possibly mauled by a dog.
According to KVVU, medical personnel pronounced the woman dead when they arrived with the dog found nearby.
The animal was turned over to animal control, and the woman’s family identified her as 89-year-old Joan Caffiel.
The woman’s grandson, Peyton Faircloth, said she had severe dementia and was being watched by a caregiver when the attack happened.
“She called me and she was screaming,” he said.
Faircloth said the dog involved was Buc, a rescue pit bull, who had never been aggressive in the six years they’ve had him.
“There was not a mean bone in that dog’s body, that dog would sleep with us every night, and he loved grandma,” Faircloth said.
Copyright 2022 KVVU via Gray Media Group, Inc. All rights reserved. | https://www.mysuncoast.com/2022/08/10/she-was-screaming-family-says-89-year-old-grandmother-killed-pit-bull-attack/ | 2022-08-10T20:00:32Z |
NEW YORK, Aug. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SGFY, SMMT, PRTY, XRTX, and NHWK.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
- SGFY: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SGFY&prnumber=082220221
- SMMT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SMMT&prnumber=082220221
- PRTY: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=PRTY&prnumber=082220221
- XRTX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=XRTX&prnumber=082220221
- NHWK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NHWK&prnumber=082220221
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:
SOURCE InvestorsObserver | https://www.kxii.com/prnewswire/2022/08/22/thinking-about-buying-stock-signify-health-summit-therapeutics-party-city-xortx-therapeutics-or-nighthawk-biosciences/ | 2022-08-22T13:27:26Z |
Firm to support cost management of every phase of project lifecycle, as well as budget development for long-term Capital Planning projects
PITTSBURGH, June 2, 2022 /PRNewswire/ -- Michael Baker International, a global leader in engineering, planning and consulting services, announced today that the firm has been selected to provide cost consulting services for the Johns Hopkins Applied Physics Laboratory (APL). The Master Service Agreement Contract is a multi-year contract for future services, including cost engineering, cost estimating, value engineering and project management services across all phases of the project lifecycle, beginning in Spring 2022 through Spring 2027.
"Michael Baker has more than 30 years of experience developing independent cost and schedule estimates for all stages of project lifecycles, as well as extensive laboratory cost management support," said Kevin J. Owens, Vice President at Michael Baker International. "Our firm's proven cost management services will support every phase of the project lifecycle, as well as budget development for long-term Capital Planning projects and a variety of other cost management services that assist APL in its important mission."
With an expert team that brings a history of successfully completing similar projects for science and technology facilities, including laboratories, Michael Baker will address project challenges and areas of significant interest using innovation and industry best practices while maintaining APL's budget and schedule. The firm will provide the technical expertise in all aspects of cost management services during the design and construction project lifecycle, including:
- Cost Estimating
- Market Surveying
- Project Scheduling
- Life Cycle Cost Analysis
- Cashflow Forecasting
- Construction and Schedule Risk Analysis (CSRA)
- Project Scheduling/Analysis
- Value Engineering (VE) Studies
- Bid Evaluation and Analysis
- Construction Administration support
- Earned Value Management
- Request for Information (RFI)/Change Order Analysis and Management
About Michael Baker International
Michael Baker International is a leading provider of engineering and consulting services with Practices that encompass all facets of infrastructure, including design, civil engineering, planning, architecture, environmental, construction and program management. For more than 80 years, the company has been a trusted partner to commercial clients, all branches of the military and federal, state and municipal governments, providing comprehensive services and solutions. Embracing emerging technologies and the latest innovations – like intelligent transportation and design-build project delivery, Michael Baker is an industry leader that delivers expertise and quality. The firm's more than 3,000 employees across nearly 100 locations are committed to Making a Difference for clients and communities through a culture of innovation, collaboration and technological advancement while Reimagining Michael Baker to become a full-service engineering and consulting firm over the next five years. To learn more, visit https://mbakerintl.com/.
Contact: Julia Covelli
julia.covelli@mbakerintl.com
(866) 293-4609
View original content to download multimedia:
SOURCE Michael Baker International | https://www.mysuncoast.com/prnewswire/2022/06/02/michael-baker-international-selected-provide-cost-consulting-services-johns-hopkins-apl/ | 2022-06-02T14:26:31Z |
BOULDER CITY, Nev. (AP) — A transformer exploded Tuesday at Hoover Dam, one of the nation’s largest hydroelectric facilities, producing a thick cloud of black smoke and flames that were quickly extinguished.
No one was hurt in the explosion near the base of the dam, an engineering marvel on the Colorado River that straddles the border of Arizona and Nevada. Electricity produced at Hoover Dam continued flowing to the 8 million people in Arizona, Nevada and Southern California who rely on it, the Western Area Power Administration said.
The cause of the fire was under investigation and officials were working to determine the extent of damage to the transformer, one of 15 at the complex that control the voltages for power sent to customers.
“There is no risk to the power grid,” said Jacklynn Gould, a regional director for the U.S. Bureau of Reclamation.
The fire ignited around 10 a.m. and was out within a half-hour, Gould said in a statement. It captured the attention of tourists who said they heard an alarm sound and felt the ground rumble beneath them.
William Herro, 13, of San Francisco, was on a viewing bridge with his parents when he saw the explosion and then heard a “big boom.”
“A ton of black smoke just exploded in the air. It looked almost like a mushroom and then a fire followed,” Herro said. “I was really surprised and I started filming.”
The explosion occurred on the apron of a building housing turbines that is slightly downstream from the base of the dam, about 25 miles (40 kilometers) southeast of Las Vegas. Hoover Dam is one of the tallest concrete dams in the U.S. at 726 feet (221 meters). Each of its 17 generators can supply electricity to 100,000 households.
As many as 20,000 vehicles a day drive across the wide top of the dam, which is a National Historic Landmark and is seen in films including “Transformers” and “Fools Rush In.” Most motorists traveling between Arizona and Nevada use a bypass bridge high above the dam that opened in 2010.
The Bureau of Reclamation owns and operates the dam, powerhouses and turbines. The power produced at the site is transferred to a substation where it’s marketed through the Western Area Power Administration.
Hoover Dam is considered a baseload source of power, meaning it can respond quickly to the need for additional power on the grid or dial back supply.
The fire triggered an alert at the Western Area Power Administration’s control center in Phoenix. Spokesman Lisa Meiman said while the loss of a transformer or other equipment on hydropower facilities can put pressure on a grid, “no single source is integral to the health of the power grid.”
The administration markets power from 57 federal hydroelectric facilities. Hoover Dam and Glen Canyon Dam upstream on the Arizona-Utah border are among the largest, Meiman said.
Hydropower from those dams has threatened lately by the declining levels of Lake Mead and Lake Powell, the two largest human-made reservoirs in the U.S. that hold water from the Colorado River.
Federal officials have taken action in recent years to prop up the lakes to preserve the dams’ ability to generate power and keep water flowing to the Western states and Mexico that rely on it. Drought and climate change have sunk the lakes to their lowest levels in decades.
___
This story has been corrected to show 8 million people rely on hydropower from Hoover Dam, not 1.3 million.
___
Fonseca reported from Flagstaff, Arizona. Associated Press writer Terry Tang in Phoenix contributed to this report. | https://cw33.com/news/ap-top-headlines/fire-explosion-reported-at-hoover-dam/ | 2022-07-20T16:25:44Z |
Attend the SSE Showdown Vendor Demo Challenge and visit Lookout in Booth #325 to learn how to secure data within multi-cloud environments and receive a free Lookout SaaS Risk Assessment
SAN FRANCISCO, May 31, 2022 /PRNewswire/ -- Lookout, Inc., a leading provider of endpoint and cloud security solutions, today announced its full event schedule for the Gartner Security & Risk Management Summit 2022, to be held June 7 - 10 in National Harbor, MD. During the event, visit Booth #325 to learn how Lookout, a Visionary in the 2022 Gartner® Magic Quadrant™ for Security Service Edge (SSE)1, can secure cloud data along its entire data path.
While cloud connectivity has amplified security gaps, a cloud native, platform centric approach is the way organizations can keep pace with evolving, increasingly sophisticated threats. To prevent data leakage in this cloud-first era, organizations need a unified platform that protects users, devices, access and data across all applications and devices from any modern day cyber threats. The Lookout Security Platform safeguards an organization's data with security that goes everywhere the data goes — whether it's in a data center, public cloud or downloaded to an endpoint. With a unified platform, Lookout is integrating its endpoint security offering "Lookout Mobile Endpoint Security" with its Cloud Security or Secure Access Service Edge (SASE) technologies that includes Lookout Cloud Access Security Broker (CASB), Lookout Zero Trust Network Access (ZTNA) and Lookout Secure Web Gateway (SWG), Lookout enables organizations to make smart access decisions that mitigate threats, and protect sensitive data while enabling employees to access what they need.
Visit Lookout: During expo hours, please drop by Booth #325 to learn how Lookout can help you to protect your workforce and devices, secure access to private apps, and safeguard your data across various SaaS and cloud apps deployed in a multi-cloud environment.
Lookout Booth Presentations: Lookout will be offering in-booth sessions to learn how the Company solves your most critical data-centric cloud security challenges.
- Protect and Empower Your Hybrid Workforce: Stop by the Lookout demo station to walk through in-depth use cases that showcase Mobile Endpoint Detection and Response (mEDR) and Cloud Security (SSE) technologies.
- Watch a demo and win big: Watch a Lookout demo for a chance to enter a raffle to win a Meta Quest 2 virtual reality headset.
Expert Sessions: On Wednesday, June 8 at 12:45 p.m. ET in Theater II, Aaron Cockerill, Chief Strategy Officer at Lookout, will share how organizations can create a secure and productive work environment as apps and data move to the cloud to support a new hybrid work model at scale. On Thursday, June 9 at 11:50 a.m. ET in Theater I, Mahesh Rachakonda, vice president, SASE Products at Lookout, will present in the SSE Showdown, a Security Service Edge exhibition featuring six vendors, each showcasing their solutions, and hosted by Gartner analysts.
- View the full Lookout Gartner SRM Schedule
- Learn more about Lookout SASE.
- Sign up for a free 90-day trial.
- Follow Lookout on its blog, LinkedIn and Twitter.
- Listen and subscribe to Security Soapbox, Lookout's podcast covering privacy, security and everything in between.
Lookout is a leading provider of a leading provider of endpoint and cloud security solutions. Our mission is to secure and empower our digital future in a privacy-focused world where mobility and cloud are essential to all we do for work and play. We enable consumers and employees to protect their data, and to securely stay connected without violating their privacy and trust. Lookout is trusted by millions of consumers, the largest enterprises and government agencies, and partners such as AT&T, Verizon, VMware, Vodafone, Microsoft, Google, and Apple. Headquartered in San Francisco, Lookout has offices in Amsterdam, Boston, London, Sydney, Tokyo, Toronto and Washington, D.C. To learn more, visit www.lookout.com and follow Lookout on its blog, LinkedIn, and Twitter.
Contact Lookout PR: press@lookout.com
Gartner Disclaimer:
Gartner, "Magic Quadrant for Security Service Edge," John Watts, Craig Lawson, Charlie Winckless, Aaron McQuaid, February 15, 2022
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
© 2022 Lookout, Inc. LOOKOUT®, the Lookout Shield Design®, LOOKOUT with Shield Design®, SCREAM®, and SIGNAL FLARE® are registered trademarks of Lookout, Inc. in the United States and other countries. EVERYTHING IS OK®, LOOKOUT MOBILE SECURITY®, POWERED BY LOOKOUT®, and PROTECTED BY LOOKOUT®, are registered trademarks of Lookout, Inc. in the United States; and POST PERIMETER SECURITY ALLIANCE™ is a trademark of Lookout, Inc. All other brand and product names are trademarks or registered trademarks of their respective holders.
1 Gartner, "Magic Quadrant for Security Service Edge," John Watts, Craig Lawson, Charlie Winckless, Aaron McQuaid, February 15, 2022
View original content to download multimedia:
SOURCE Lookout | https://www.mysuncoast.com/prnewswire/2022/05/31/lookout-exhibit-data-centric-cloud-security-2022-gartner-security-amp-risk-management-summit/ | 2022-05-31T18:15:34Z |
Millions of young women dream of being honored on Mother’s Day. Millions of others know in their hearts that they don’t want to have children, or at least not on someone else’s timetable.
Many in both groups run the risk of someday facing an unplanned, unwanted pregnancy.
Society assures us these women always had only three choices: get an abortion, endure 18 years of servitude or go through an emotionally wrenching adoption.
There is another option for these women (and their “lovers”): be proactive and consider displaying a little common sense upfront. Rape, incest and those doggone substandard condoms are the usual scapegoats when an unintentional pregnancy develops, but those statistics are vastly overrated.
Let’s be honest: We see hundreds of thousands of “surprise” pregnancies year after year after year because (a) people are “dating” under the influence of alcohol, drugs or intense peer pressure, (b) women shack up with lowlife bums who molest their daughters and (c) couples take stupid, stupid shortcuts.
There. I said it.
Singers, movies, television, Madison Avenue, social media, teen magazines, college “sex weeks” and politicians are constantly telling impressionable, procreation-capable individuals that impetuous choices have no real consequences. (“Hey, let’s cross ‘Boys will be boys’ with ‘Girls just wanna have fun.’ What could possibly go wrong?”)
We recognize “buzzed driving” as drunk driving; but bedhopping while bombed? “Go ahead, you only live once. But be responsible. (Wink wink)”
Some feminist leaders treat self-control and delayed gratification like The Solution That Must Not Be Named. They want women to be empowered, but how much power do you wield when José Cuervo is calling the shots?
There is great power in providing the egg or sperm that could become a human being. But with great power comes great responsibility. If Hollywood, hormones and fair-weather friends are all urging you to do the same thing, there’s a 99 percent probability that it’s a bad idea.
I can’t think of a single civilization that wound up on “the right side of history” by promoting unbridled hedonism. Can you? The Sexual Revolution has produced immeasurably more bitter regrets, bad karma and carnage than the French Revolution. No one has ever died of spontaneous combustion simply because they decided not to be alone with a member of the opposite sex while stoned, depressed or on the rebound.
This column is not an attempt to shame anyone for misjudgments they have already made. It is not a critique of the pros and cons of recent abortion laws. It is not a declaration that we can/should become a nation of celibate monks and teetotalers.
It is a fervent prayer that at least one person will have the guts to block impaired judgment and sex from being allowed in the same ZIP Code.
Whether you are an influencer only under your own roof or your reach extends to the media, public office or service organizations, please think about what I’ve written. Every child deserves to be loved and wanted, but we’ll never achieve that if parents and civic leaders continue living vicariously through intoxicated daredevils in heat.
We can’t keep treating the symptoms of risky behavior without addressing the causes. We all want our children to grow up and get good jobs, but we need to put less emphasis on the vocation and more on the growing up part. | https://www.albanyherald.com/opinion/danny-tyree-mamas-dont-let-your-babies-grow-up-to-be-brainless/article_7ac4a74c-c7c6-11ec-98ad-13ef614141c6.html | 2022-04-30T23:46:12Z |
WASHINGTON, Aug. 4, 2022 /PRNewswire/ -- On behalf of the Council of the Great City Schools (CGCS), a coalition of 76 of the nation's largest urban public-school systems, Husch Blackwell submitted an amicus brief to the Supreme Court of the United States in connection with the cases Students for Fair Admissions v. President and Fellows of Harvard College and Students for Fair Admissions v. University of North Carolina, urging the Court to retain the race-conscious admissions procedures allowed under its prior decisions, including University of California v. Bakke (1978),Grutter v. Bollinger (2003), Fisher v. University of Texas (2013), and Fisher v. University of Texas (2016).
Oral arguments in Students for Fair Admissions v. President and Fellows of Harvard College have been scheduled to proceed on October 31, 2022.
The Council's brief details the persistent role segregation and educational inequality at the elementary and secondary level have played in creating and maintaining racial and ethnic achievement gaps among K-12 students. As the brief argues, "[b]ecause of unequal economic and educational opportunities, African American and Hispanic students suffer from educational outcomes at the elementary and secondary level that often do not fairly reflect their academic potential. As a result, race neutral efforts to promote diversity at select colleges and universities like Harvard and the University of North Carolina cannot effectively promote diverse enrollments and do not treat many minority students equitably."
"Our member school districts serve more than 7.6 million urban students, many of them from minority backgrounds, so we have a close-up perspective on the current and legacy challenges these students face on a daily basis," said CGCS Executive Director Ray Hart. "Eliminating race-conscious criteria for college admissions will do nothing to rectify these challenges; indeed, our data suggest the opposite. The Council strongly supports efforts to preserve the educational benefits of diverse public-school enrollments and believe our students will be harmed if race-conscious college admissions procedures are no longer allowed."
"I'm very proud of our team for putting together a compelling argument for why race-conscious admissions procedures unfortunately remain necessary to maintain diversity on college campuses," said John W. Borkowski, the Husch Blackwell partner leading the project.
The Husch Blackwell team led by Borkowski included Aleks Rushing, A.J. James, Mackenzie Conway, Graham Johnson, Marissa Hotujac, Naomie Kweyu, and Claire Hawley, among others. The CGCS team was led by Julie Wright Halbert, legislative counsel, Manish Naik, Akisha Osei Sarfo, Moses Palacios and Ray Hart.
Husch Blackwell is an industry-focused law firm with 20-plus offices across the United States, including its virtual office, The Link. The firm represents clients around the world in major industries including energy and natural resources; financial services and capital markets; food and agribusiness; healthcare, life sciences and education; real estate, development and construction; and technology, manufacturing and transportation. For more information, visit huschblackwell.com.
View original content:
SOURCE Council of the Great City Schools | https://www.wibw.com/prnewswire/2022/08/04/council-great-city-schools-files-amicus-brief-higher-education-admissions-cases/ | 2022-08-04T17:48:35Z |
WASHINGTON (AP) — The U.S. economy is caught in an awkward, painful place. A confusing one, too.
Growth appears to be sputtering, home sales are tumbling and economists warn of a potential recession ahead. But consumers are still spending, businesses keep posting profits and the economy keeps adding hundreds of thousands of jobs each month.
In the midst of it all, prices have accelerated to four-decade highs, and the Federal Reserve is desperately trying to douse the inflationary flames with higher interest rates. That’s making borrowing more expensive for households and businesses.
The Fed hopes to pull off the triple axel of central banking: Slow the economy just enough to curb inflation without causing a recession. Many economists doubt the Fed can manage that feat, a so-called soft landing.
Surging inflation is most often a side effect of a red-hot economy, not the current tepid pace of growth. Today’s economic moment conjures dark memories of the 1970s, when scorching inflation co-existed, in a kind of toxic brew, with slow growth. It hatched an ugly new term: stagflation.
The United States isn’t there yet. Though growth appears to be faltering, the job market still looks quite strong. And consumers, whose spending accounts for nearly 70% of economic output, are still spending, though at a slower pace.
So the Fed and economic forecasters are stuck in uncharted territory. They have no experience analyzing the economic damage from a global pandemic. The results so far have been humbling. They failed to anticipate the economy’s blazing recovery from the 2020 recession — or the raging inflation it unleashed.
Even after inflation accelerated in spring of last year, Fed Chair Jerome Powell and many other forecasters downplayed the price surge as merely a “transitory” consequence of supply bottlenecks that would fade soon.
It didn’t.
Now the central bank is playing catch-up. It’s raised its benchmark short-term interest rate three times since March. Last month, the Fed increased its rate by three-quarters of a percentage point, its biggest hike since 1994. The Fed’s policymaking committee is expected to announce another three-quarter-point hike Wednesday.
Economists now worry that the Fed, having underestimated inflation, will overreact and drive rates ever higher, imperiling the economy. They caution the Fed against tightening credit too aggressively.
“We don’t think a sledgehammer is necessary,’’ Ian Shepherdson, chief economist at Pantheon Macroeconomics, said this week.
Here’s a look at the economic vital signs that are sending frustratingly mixed signals to policymakers, businesses and forecasters:
___
THE OVERALL ECONOMY
As measured by the nation’s gross domestic product — the broadest gauge of output — the economy has looked positively sickly so far this year. And steadily higher borrowing rates, engineered by the Fed, threaten to make things worse.
“Recession is likely,’’ said Vincent Reinhart, a former Fed economist who is now chief economist at Dreyfus and Mellon.
After growing at a 37-year high 5.7% last year, the economy shrank at a 1.6% annual pace from January through March. For the April-June quarter, forecasters surveyed by the data firm FactSet estimate that growth equaled a scant 0.95% annual rate from April through June. (The government will issue its first estimate of April-June growth on Thursday.)
Some economists foresee another economic contraction for the second quarter. If that happened, it would further escalate recession fears. One informal definition of recession is two straight quarters of declining GDP. Yet that definition isn’t the one that counts.
The most widely accepted authority is the National Bureau of Economic Research, whose Business Cycle Dating Committee assesses a wide range of factors before declaring the death of an economic expansion and the birth of a recession. It defines a recession as “a significant decline in economic activity that is spread across the economy and that lasts more than a few months.”
In any case, the economic drop in the January-March quarter looked worse than it actually was. It was caused by factors that don’t mirror the economy’s underlying health: A widening trade deficit, reflecting consumers’ robust appetite for imports, shaved 3.2 percentage points off first-quarter growth. A post-holiday-season drop in company inventories subtracted an additional 0.4 percentage point.
Consumer spending, measured at a modest 1.8% annual rate from January through March, is still growing. Americans are losing confidence, though: Their assessment of economic conditions six months from now has reached its lowest point since 2013 in June, according to the Conference Board, a research group.
___
INFLATION
What’s agitating consumers is no secret: They’re reeling from painful prices at gasoline stations, grocery stores and auto dealerships.
The Labor Department’s consumer price index skyrocketed 9.1% in June from a year earlier, a pace not seen since 1981. The price of gasoline has jumped 61% over the past year, airfares 34%, eggs 33%.
And despite widespread pay raises, prices are surging faster than wages. In June, average hourly earnings slid 3.6% from a year earlier adjusting for inflation, the 15th straight monthly drop from a year earlier.
And on Monday, Walmart, the nation’s largest retailer, lowered its profit outlook, saying that higher gas and food prices were forcing shoppers to spend less on many discretionary items, like new clothing.
The price spikes have been ignited by a combination of brisk consumer demand and global shortages of factory parts, food, energy and labor. And so the Fed is now aggressively raising rates.
“There is a risk of overdoing it,’’ warned Ellen Gaske, an economist at PGIM Fixed Income. “Because inflation is so bad right now, they are focused on the here and now of each monthly CPI report. The latest one showed no letup.’’
___
JOBS
Despite inflation, rate hikes and declining consumer confidence, one thing has remained solid: The job market, the most crucial pillar of the economy. Employers added a record 6.7 million jobs last year. And so far this year, they’re adding an average of 457,000 more each month.
The unemployment rate, at 3.6% for four straight months, is near a half-century low. Employers have posted at least 11 million job openings for six consecutive months. The government says there are two job openings, on average, for every unemployed American, the highest such ratio on record.
Job security and the opportunity to advance to better positions are providing the confidence and financial wherewithal for Americans to spend and keep the job machine churning.
Still, it’s unclear how long a hiring boom will last. In keeping up their spending in the face of high inflation, Americans have been drawing down the heavy savings they built up during the pandemic. That won’t last indefinitely. And the Fed’s rate hikes mean it’s increasingly expensive to buy a house, a car or a major appliance on credit.
The weekly number of Americans applying for unemployment benefits, a proxy for layoffs and a bellwether for where the job market may be headed, reached 251,000 in the most recent reading. That’s still quite low by historic standards, but it’s the most since November.
___
MANUFACTURING
COVID-19 kept millions of Americans cooped up at home. But it didn’t stop them from spending. Unable to go out to restaurants, bars and movie theaters, people instead loaded up on factory-made goods — appliances, furniture, exercise equipment.
Factories have enjoyed 25 consecutive months of expansion, according to the Institute for Supply Management’s manufacturing index. Customer demand has been strong, though supply chain bottlenecks have made it hard for factories to fill orders.
Now, the factory boom is showing signs of strain. The ISM’s index dropped last month to its lowest level in two years. New orders declined. Factory hiring dropped for a second straight month.
A key factor is that the Fed’s rate hikes are heightening borrowing costs and the value of the U.S. dollar against other currencies, a move that makes American goods more expensive overseas.
“We doubt the outlook for manufacturing will improve any time soon,’’ Andrew Hunter, senior U.S. economist at Capital Economics, wrote this month. “Weakening global growth and the drag from the stronger dollar look set to keep U.S. manufacturers under pressure over the coming months.’’
___
HOUSING
No sector of the U.S. economy is more sensitive to interest rate increases than housing. And the Fed’s hikes and the prospect of steadily tighter credit are taking a toll.
Mortgage rates have risen along with the Fed’s benchmark rate. The average rate on a 30-year fixed-rate mortgage hit 5.54% last week, nearly double its level a year earlier.
The government reported Tuesday that sales of new single-family homes fell 8% last month from May and 17% from June 2021. And sales of previously occupied homes dropped in June for a fifth straight month. They’re down more than 14% from June 2021.
In response to the rapidly slowing home market, builders are cutting back. Construction of single-family homes dropped last month to its lowest level since March 2020, at the height of pandemic lockdowns.
____
AP Economics Writer Christopher Rugaber contributed to this report. | https://cw33.com/business/ap-business/us-economy-sending-mixed-signals-heres-what-it-all-means/ | 2022-07-26T17:56:47Z |
TORONTO, May 18, 2022 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (CSE: TGOD) (OTC: TGODF), a sustainable global cannabis company, will release its Q1 2022 financial results following the market close on the evening of Wednesday May 25, 2022. The Company will hold a conference call with analysts on Thursday May 26, 2022, beginning at 10:00 a.m. (ET). An audiocast of the conference call will be available on a listen-only basis at:
https://produceredition.webcasts.com/starthere.jsp?ei=1550743&tp_key=fff6b3ddd0
Scheduled speakers are Sean Bovingdon, Chief Executive Officer, Nichola Thompson, Chief Financial Officer, and Shane Dungey, Vice President, Investor Relations, followed by a question and answer period with analysts.
CONFERENCE CALL INFORMATION:
Date: May 26, 2022 | Time: 10:00 a.m. Eastern Time
Participant Dial-In:
Local – Toronto: 1-416-764-8688
Toll Free – North America: 1-888-390-0546
Conference ID – 81358956
A replay of the call will also be available through June 2, 2022, by dialing 1-416-764-8677 or 1-888-390-0541 (Passcode: 358956#).
The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (US–OTC: TGODF) is a sustainable cannabis company with a focus on innovation, quality, consistency, integrity, and transparency. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. In Canada, the Company serves the recreational market with a brand portfolio including The Green Organic Dutchman, Highly Dutch Organics, Ripple by TGOD and Cruuzy, and the medical markets in Canada, South Africa, Australia, and Germany. All cannabis utilized in products for The Green Organic Dutchman and Highly Dutch Organics brands is grown through a certified organic process, which includes living soil, filtered rainwater, sunlight, and natural inputs.
The Company's Common Shares and certain warrants issued under the indentures dated December 19, 2019, June 12, 2020, October 23, 2020, and December 10, 2020, trade on the CSE under the symbol "TGOD", "TGOD.WS", "TGOD.WR", "TGOD.WA", and "TGOD.WB" respectively. The Company's Common Shares trade in the U.S. on the OTCQX under the symbol "TGODF". For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
View original content to download multimedia:
SOURCE The Green Organic Dutchman Holdings Ltd. | https://www.wibw.com/prnewswire/2022/05/18/green-organic-dutchman-holdings-release-q1-2022-financial-results-may-25th/ | 2022-05-18T11:01:22Z |
- Reports Second-Quarter Diluted EPS of $0.51 on a GAAP Basis, an Increase of 21.4 Percent; Adjusted Diluted EPS of $3.37, an Increase of 11.2 Percent; These Results Include an Unfavorable Impact of $0.14 Per Share related to Acquired IPR&D and Milestones Expense 1
- Delivers Second-Quarter Net Revenues of $14.583 Billion, an Increase of 4.5 Percent on a Reported Basis and 6.1 Percent Operationally
- Second-Quarter Global Net Revenues from the Immunology Portfolio Were $7.207 Billion, an Increase of 17.8 Percent on a Reported Basis, or 19.2 Percent on an Operational Basis; U.S. Humira Net Revenues Were $4.664 Billion, an Increase of 9.6 Percent; Internationally, Humira Net Revenues Were $699 Million, a Decrease of 13.8 Percent on a Reported Basis, or 7.3 Percent on an Operational Basis, Due to Biosimilar Competition; Global Skyrizi Net Revenues Were $1.252 Billion; Global Rinvoq Net Revenues Were $592 Million; Combined Global Skyrizi and Rinvoq Net Revenues Were $1.844 Billion
- Second-Quarter Global Net Revenues from the Hematologic Oncology Portfolio Were $1.650 Billion, a Decrease of 9.1 Percent on a Reported Basis, or 7.9 Percent on an Operational Basis; Global Imbruvica Net Revenues Were $1.145 Billion, a Decrease of 17.1 Percent, with U.S. Net Revenues of $862 Million and International Profit Sharing of $283 Million; Global Venclexta Net Revenues Were $505 Million
- Second-Quarter Global Net Revenues from the Neuroscience Portfolio Were $1.658 Billion, an Increase of 13.7 Percent on a Reported Basis, or 15.2 Percent on an Operational Basis; Global Botox Therapeutic Net Revenues Were $678 Million; Vraylar Net Revenues Were $492 Million
- Second-Quarter Global Net Revenues from the Aesthetics Portfolio Were $1.371 Billion, a Decrease of 4.4 Percent on a Reported Basis, or 2.1 Percent on an Operational Basis; Global Botox Cosmetic Net Revenues Were $695 Million; Global Juvederm Net Revenues Were $344 Million, Unfavorably Impacted by COVID-19 Restrictions in China and Suspension of Aesthetics Operations in Russia
- Confirms 2022 Adjusted Diluted EPS Guidance Range of $13.78 - $13.98, which Includes an Unfavorable Impact of $0.23 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Through the Second Quarter 2022
NORTH CHICAGO, Ill., July 29, 2022 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2022.
"We delivered another strong quarter with substantial progress for our new products and indications. Importantly, Skyrizi and Rinvoq continued their impressive ramps and are on pace to deliver approximately $7.5 billion in combined annual sales, underscoring their significant potential," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "The momentum of our business, combined with advances across our pipeline continue to support AbbVie's promising long-term outlook."
Second-Quarter Results
- Worldwide net revenues were $14.583 billion, an increase of 4.5 percent on a GAAP basis, or 6.1 percent on an operational basis.
- Global net revenues from the immunology portfolio were $7.207 billion, an increase of 17.8 percent on a reported basis, or 19.2 percent on an operational basis.
- Global net revenues from the hematologic oncology portfolio were $1.650 billion, a decrease of 9.1 percent on a reported basis, or 7.9 percent on an operational basis.
- Global net revenues from the neuroscience portfolio were $1.658 billion, an increase of 13.7 percent on a reported basis, or 15.2 percent on an operational basis.
- Global net revenues from the aesthetics portfolio were $1.371 billion, a decrease of 4.4 percent on a reported basis, or 2.1 percent on an operational basis.
- On a GAAP basis, the gross margin ratio in the second quarter was 71.4 percent. The adjusted gross margin ratio was 84.7 percent.
- On a GAAP basis, selling, general and administrative expense was 37.1 percent of net revenues. The adjusted SG&A expense was 20.8 percent of net revenues.
- Research and development expense was 11.0 percent of net revenues on both a GAAP and Non-GAAP adjusted basis.
- Acquired IPR&D and milestones expense was 1.8 percent of net revenues.
- On a GAAP basis, the operating margin in the second quarter was 22.6 percent. The adjusted operating margin was 51.0 percent, which includes an unfavorable 180 basis point impact from acquired IPR&D and milestones expense.
- Net interest expense was $532 million.
- On a GAAP basis, the tax rate in the quarter was 21.6 percent. The adjusted tax rate was 13.4 percent.
- Diluted EPS in the second quarter was $0.51 on a GAAP basis. Adjusted diluted EPS, excluding specified items, was $3.37. These results include an unfavorable impact of $0.14 per share related to acquired IPR&D and milestones expense.
Recent Events
- AbbVie announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab) as the first and only specific interleukin-23 inhibitor for the treatment of adults with moderately to severely active Crohn's disease (CD). The approval is supported by three pivotal Phase 3 studies in which Skyrizi demonstrated significant improvements in clinical remission and endoscopic response, compared to placebo, as both induction and maintenance therapy. This marks Skyrizi's third FDA approved indication. Skyrizi is a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.
- AbbVie announced that the FDA approved Rinvoq (upadacitinib, 15 mg, once daily) for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers. The approval is supported by data from two pivotal clinical trials in which Rinvoq delivered rapid and meaningful disease control. This approval marks the fifth FDA approved indication for Rinvoq in chronic immune-mediated diseases.
- AbbVie announced the European Commission (EC) approved Rinvoq (45 mg (induction dose) and 15 mg and 30 mg (maintenance doses)) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC). The approval is based on results from two Phase 3 induction studies and one maintenance study in which significantly more patients treated with Rinvoq achieved the primary and all secondary endpoints compared to placebo.
- AbbVie announced the EC approved Rinvoq (15 mg, once daily) for the treatment of adult patients with active non-radiographic axial spondyloarthritis (nr-Axial SpA). The approval is based on results from the Phase 3 SELECT-AXIS 2 study in which Rinvoq met the primary endpoint and 12 of 14 ranked secondary endpoints.
- AbbVie announced that it submitted applications for a new indication to the FDA and European Medicines Agency (EMA) for Rinvoq (45 mg (induction dose) and 15 mg and 30 mg (maintenance doses)) for the treatment of adult patients with moderately to severely active CD. The submissions are supported by three Phase 3 clinical trials demonstrating Rinvoq achieved the co-primary endpoints of clinical remission and endoscopic response as induction and maintenance treatment.
- AbbVie announced positive top-line results from the Phase 3 maintenance study, U-ENDURE, evaluating Rinvoq in adult patients with moderate to severe CD. The results showed Rinvoq (15 mg or 30 mg, once daily) achieved the co-primary endpoints of endoscopic response and clinical remission, as well as the secondary endpoint of endoscopic remission, at one year (week 52) compared to placebo. The safety results in this study were generally consistent with the known profile of Rinvoq, with no new safety risks observed. Full results from the study will be presented at upcoming medical conferences and published in a peer-reviewed journal.
- At the Digestive Disease Week (DDW) Annual Meeting, AbbVie presented 27 abstracts that reinforced its leadership in advancing research and the standards of care across multiple gastroenterological conditions. Presentations included further analyses of Phase 3 clinical study programs for Rinvoq in moderately to severely active UC and investigational use of Skyrizi in moderately to severely active CD.
- At the European Alliance of Associations for Rheumatology (EULAR) 2022 Congress, AbbVie showcased its leadership in rheumatology research with new data across multiple inflammatory joint diseases. Key data presented included SELECT-AXIS 2 trial results evaluating the efficacy and safety of Rinvoq in patients with nr-Axial SpA, and in patients with AS; two-year data from the SELECT-PsA 1 and SELECT-PsA 2 studies of Rinvoq in patients with psoriatic arthritis (PsA); and results of the one-year data evaluating the efficacy and safety of Skyrizi in patients with active PsA in the KEEPsAKE 1 and KEEPsAKE 2 clinical trials.
- At the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress, AbbVie presented 46 abstracts for six investigational and approved medicines across eight cancer types. Highlights included new data that showed Venclexta (venetoclax) plus obinutuzumab demonstrated sustained progression-free survival (PFS) in chronic lymphocytic leukemia (CLL) patients after four years off treatment; results from a Phase 2 trial of epcoritamab which showed clinically meaningful efficacy in challenging-to-treat, highly refractory, large B-cell lymphoma (LBCL) patients; and new data from the Phase 2 REFINE study of investigational navitoclax in combination with ruxolitinib that is supportive of early intervention in myelofibrosis (MF) to achieve improved clinical outcomes in spleen volume reduction (SVR), symptom score and bone marrow fibrosis (BMF). Venetoclax is being developed by AbbVie and Roche and is jointly commercialized by AbbVie and Genentech, a member of the Roche Group, in the U.S. and by AbbVie outside of the U.S. Epcoritamab is being co-developed by AbbVie and Genmab.
- AbbVie announced that it submitted a New Drug Application (NDA) to the FDA for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD). The submission is based on results from a Phase 3, head-to-head, randomized and controlled clinical trial demonstrating statistically significant improvement in "On" time without troublesome dyskinesia compared to oral immediate-release carbidopa/levodopa (CD/LD). If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of CD/LD prodrugs.
- AbbVie announced that it submitted a supplemental NDA to the FDA for Qulipta (atogepant) to support label expansion for the preventive treatment of migraine in adult patients with chronic migraine. AbbVie also submitted a marketing authorization application for Qulipta with the EMA for the preventive treatment of migraine in adult patients who have at least four migraine days per month.
- At the American Headache Society (AHS) Annual Scientific Meeting, AbbVie presented 29 abstracts that covered a wide range of studies across AbbVie's migraine portfolio. Presentations highlighted positive results from the Phase 3 PROGRESS trial investigating Qulipta for the preventive treatment of migraine in patients with chronic migraine, clinical trial results evaluating Ubrelvy (ubrogepant) for acute treatment of migraine and data evaluating Botox (onabotulinumtoxinA) for the preventive treatment of migraine in patient with chronic migraine.
- At the American Psychiatric Association (APA) Annual Meeting, AbbVie presented positive data from a Phase 3 trial of Vraylar (cariprazine, 1.5 mg/day) for the adjunctive treatment of major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant therapy. The study met its primary endpoint of statistically significant improvement using the Montgomery-Åsberg Depression Rating Scale (MADRS) total score in patients compared with placebo. Vraylar's safety profile was consistent with that of previous studies across indications in the treatment of adults with depressive episodes associated with bipolar I disorder, the acute treatment of manic or mixed episodes associated with bipolar I disorder and schizophrenia. Vraylar is being co-developed by AbbVie and Gedeon Richter Plc.
- At the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, AbbVie presented new data from its leading portfolio of eye care treatments. Highlights included new data on Vuity (pilocarpine HCl ophthalmic solution) 1.25%, the first and only FDA-approved eye drop for the treatment of presbyopia (age-related blurry near vision) in adults, and Durysta (bimatoprost intracameral implant), a first-of-its-kind biodegradable implant to lower eye pressure for glaucoma patients.
- AbbVie and Cugene Inc., a clinical-stage biotechnology company focused on developing next-generation precision immunology and oncology medicines to treat autoimmune disease and cancer, announced an exclusive worldwide license option agreement for CUG252, a potential best-in-class Treg-selective IL-2 mutein, as well as other novel IL-2 muteins, for the potential treatment of autoimmune and inflammatory diseases.
- AbbVie and iSTAR Medical announced a strategic transaction to further develop and commercialize iSTAR Medical's MINIject device, a next-generation minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma. This alliance accelerates iSTAR Medical's goal to bring MINIject to more patients globally and provides an opportunity for AbbVie to further expand its diverse eye care portfolio.
Full-Year 2022 Outlook
AbbVie is confirming its adjusted diluted EPS guidance range for the full-year 2022 of $13.78 - $13.98 which includes an unfavorable impact of $0.23 per share related to acquired IPR&D and milestones expense incurred year-to-date through the second quarter 2022. The company's 2022 adjusted diluted EPS guidance excludes any impact from acquired IPR&D and milestones that may be incurred beyond the second quarter of 2022, as both cannot be reliably forecasted.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
Conference Call
AbbVie will host an investor conference call today at 8:00 a.m. Central time to discuss our second-quarter performance. The call will be webcast through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the call will be available after 11:00 a.m. Central time.
Non-GAAP Financial Results
Financial results for 2022 and 2021 are presented on both a reported and a non-GAAP basis. Reported results were prepared in accordance with GAAP and include all revenue and expenses recognized during the period. Non-GAAP results adjust for certain non-cash items and for factors that are unusual or unpredictable, and exclude those costs, expenses, and other specified items presented in the reconciliation tables later in this release. Beginning in the first quarter of 2022, the company includes the impact of upfront and milestone payments related to collaborations, licensing agreements, and other asset acquisitions in its reported non-GAAP financial measures. Prior periods have been revised to conform to the current period presentation. AbbVie's management believes non-GAAP financial measures provide useful information to investors regarding AbbVie's results of operations and assist management, analysts, and investors in evaluating the performance of the business. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, measures of financial performance prepared in accordance with GAAP.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "anticipate," "project" and similar expressions, among others, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the failure to realize the expected benefits of AbbVie's acquisition of Allergan or to promptly and effectively integrate Allergan's business, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, and changes to laws and regulations applicable to our industry. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, "Risk Factors," of AbbVie's 2021 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
View original content:
SOURCE AbbVie | https://www.kxii.com/prnewswire/2022/07/29/abbvie-reports-second-quarter-2022-financial-results/ | 2022-07-29T13:20:26Z |
SEOUL, South Korea, June 7, 2022 /PRNewswire/ -- One of Korea's fastest-growing fintech startups, Gowid, has partnered with QueryPie to integrate its secure data governance measures in order to protect user data and enhance the company's data governance while meeting global privacy regulation standards. QueryPie is also a member of the Born2Global Centre.
Gowid, one of Korea's most popular corporate credit card companies serving startups based on real-time data collection and analysis, issues corporate credit cards and provides SaaS discounts and usage management services to startups. The KPMG has already named it one of the top 100 firms globally. In response to the increasing volume of personal user data in the company's possession, resulting from its rapid growth and expanding user base, Gowid implemented improved safeguards to protect user privacy and security. As part of its user data protection policy, the company collaborated with QueryPie to implement a solid data governance architecture.
"We have witnessed remarkable expansion in recent years. Our objective is to help startups focus on boosting their growth while we handle budget optimization. We provide new ways to reduce IT expenses through corporate credit cards, cost management, and the SaaS Marketplace. QueryPie is assisting us in achieving our vision by strengthening and expanding our hybrid cloud architecture's data governance and protecting our most valuable asset: the user database," Gowid CEO Kim Hang-ki stated.
"QueryPie is excited to partner with Gowid; they are truly changing the fintech industry. With our flexible, non-evasive, and scalable cloud deployment, we make cloud integration simple, allowing our partners to focus more on their vision of streamlining startup expenses. We provide frictionless adoption through our many deployment environments, such as cloud-native, hybrid cloud, and on-premise data flow architectures," CHEQUER CEO Brant Hwang said.
QueryPie is an enterprise data governance platform that is trusted by industry leaders to modernize and strengthen their data security. Part of the data governance backbone, QueryPie is the preferred platform for cloud-native unicorns such as Yanolja, Hyperconnect, and Kakao Enterprise as well as enterprises seeking to increase the value and security of their data assets while complying with strict data privacy laws.
For more detailed information on QueryPie, visit https://www.querypie.com.
About QueryPie
QueryPie (www.querypie.com) is an advanced data governance solution developed by CHEQUER that simplifies data access and manages scattered data sources and data protection policies. It facilitates easier management and auditing of user or group-specific data access across the organization through a web-based solution, helping the organization ensure seamless data governance. QueryPie provides visibility and control of cloud applications, data, and users across multiple databases and cloud data platforms, including relational databases, NoSQL databases, data warehouses, and the Hadoop ecosystem. It has become an increasingly popular platform for enterprises implementing Personally Identifiable Information (PII) policies and complying with security standards such as PCI-DSS and data governance frameworks, including PIPA, GDPR, CCPA, and HIPAA.
About Gowid
Gowid, formerly known as Dayli Financial Group, is a startup that pivoted to fintech in 2019. The company raised USD 90 million in equity funding and focuses on providing corporate credit cards, installment loans, subscription management systems, and rewards programs to startups to help them reduce their IT expenses. Gowid's upcoming expense management service and SaaS marketplace aim to enhance spending optimizations further. Gowid offers customized IT subscription services that help startups manage their limited business expenses, freeing up their funds for other strategic activities. Between 2019 and 2020, Gowid's revenue grew by 39%.
About Born2Global Centre
The Born2Global Centre (www.born2global.com), operated by Born2Global, is a full-cycle service platform that supports the global expansion of promising companies. Established in 2013 under the Ministry of Science and ICT, Born2Global has been setting the standards for a successful startup ecosystem in Korea and continues to expand and transform startups so that they are engaged, well equipped, and connected with the global market.
View original content to download multimedia:
SOURCE Born2Global Centre | https://www.kxii.com/prnewswire/2022/06/07/credit-card-startup-gowid-partners-with-querypie-strengthen-data-governance-protect-user-information/ | 2022-06-07T13:15:15Z |
Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models
Context to initiate Phase 1b/2 clinical trial in Q4 2022
PHILADELPHIA and FLORENCE, Italy, Aug. 2, 2022 /PRNewswire/ -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a women's oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group ("Menarini") today announced a clinical trial collaboration and supply agreement for Menarini's oral selective estrogen receptor degrader (SERD), elacestrant.
This agreement will support the upcoming Phase 1b/2 ELONA clinical proof-of-concept trial evaluating onapristone extended release (ONA-XR), an oral progesterone receptor (PR) antagonist, in combination with elacestrant in estrogen receptor positive (ER+), PR+ HER2- metastatic breast cancer (mBC) patients who have previously been treated with a CDK4/6 inhibitor. Context will sponsor the clinical trial and Menarini will supply elacestrant at no cost.
According to the American Cancer Society, breast cancer is the second most common cancer among women occurring in 1 in 8 women (13%) over the course of a woman's lifetime, with ~280,000 new cases of invasive breast cancer and 51,400 cases of non-invasive breast cancer expected in 2022. Elacestrant is the first oral SERD to demonstrate a statistically significant and clinically meaningful improvement in progression-free survival (PFS) versus standard-of-care (SOC) endocrine therapy in a Phase 3 trial in patients with ER+, HER2- mBC, with 30% reduction in the risk of progression or death in all patients. Data also showed that 22% of patients were alive and progression-free at 12 months after elacestrant treatment initiation vs. 9% with SOC in the overall population. Therefore, elacestrant may become the new backbone endocrine therapy for ER+, HER2- mBC.
Preliminary data from preclinical studies suggest that a dual ER and PR blockade may be associated with enhanced tumor control. The ELONA clinical trial will be evaluating this important hypothesis.
"We are grateful to Menarini for their collaboration as we explore the therapeutic potential of adding ONA-XR, our oral PR antagonist, to elacestrant," said Tarek Sahmoud, MBBCh, Ph.D., Context's Chief Medical Officer. "We hope that this combination will further improve the clinical outcome in patients with ER+, PR+, HER2- mBC."
"ONA-XR's ability to restore hormone sensitivity and its tolerability profile positions it well for combination with elacestrant," said Nassir Habboubi, M.D., Menarini's Global Head of R&D.
Context anticipates initiating the Phase 1b/2 clinical trial in the fourth quarter of 2022. The two companies will form a joint committee to review results.
About Menarini Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for oncology, cardiology, pneumology, gastroenterology, infectious diseases, diabetology, inflammation, and analgesia. With 18 production sites and 9 Research and Development centers, Menarini's products are available in 140 countries worldwide. For further information, please visit www.menarini.com.
About ONA-XR
ONA-XR (onapristone extended release) is a potent and specific antagonist of the progesterone receptor (PR) that is orally administered. Currently, there are no approved therapies that selectively target PR+ cancers. Preliminary preclinical and clinical data suggest that ONA-XR has anticancer activity by inhibiting progesterone receptor binding to chromatin, downregulating cancer stem cell mobilization and blocking immune evasion. ONA-XR is currently being evaluated in three Phase 2 clinical trials and one Phase 1b/2 clinical trial in PR+ breast, ovarian and endometrial cancers. ONA-XR is an investigational drug that has not been approved for marketing by any regulatory authority.
About Context Therapeutics® Context Therapeutics Inc. (Nasdaq: CNTX), is a women's oncology company developing small molecule and immunotherapy treatments to transform care for breast and gynecological cancers. The Company's robust clinical program for lead candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian, and endometrial cancer. ONA-XR is a novel, first-in-class small molecule under development as a potent and specific antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women's cancers. Context is headquartered in Philadelphia, PA. For more information, visit www.contexttherapeutics.com.
Forward-looking Statements
This press release contains "forward-looking statements" that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding strategy, future operations, prospects, plans and objectives of management, including words such as "may," "will," "expect," "anticipate," "plan," "intend," and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are forward-looking statements. These include, without limitation, statements regarding (i) the timing to initiate, enroll, and obtain initial data for our clinical trials, (ii) the results of our clinical trials, (iii) the potential benefits of the product candidates, (iv) the likelihood data will support future development, and (v) the likelihood of obtaining regulatory approval of the product candidates. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we, therefore cannot assure you that our plans, intentions, expectations, or strategies will be attained or achieved. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the U.S. Securities and Exchange Commission, including the section titled "Risk Factors" contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.
Logo: https://mma.prnewswire.com/media/1846413/Menarini_Industrie_Farmaceutiche_Riunite_Logo.jpg
View original content:
SOURCE Menarini Industrie Farmaceutiche Riunite | https://www.mysuncoast.com/prnewswire/2022/08/02/context-therapeutics-menarini-group-announce-clinical-trial-collaboration-supply-agreement-evaluate-ona-xr-elacestrant-combination/ | 2022-08-02T14:20:52Z |
Russia’s war in Ukraine
By Rhea Mogul, Jessie Yeung, Amy Woodyatt, Matias Grez and Ed Upright, CNN
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
By Rhea Mogul, Jessie Yeung, Amy Woodyatt, Matias Grez and Ed Upright, CNN
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
You must be logged in to post a comment. | https://localnews8.com/news/national-world/cnn-europe-mideast-africa/2022/05/15/russias-war-in-ukraine-16/ | 2022-05-16T09:52:14Z |
Statement of Yolonda Richardson, Executive Vice President of the Campaign for Tobacco-Free Kids
WASHINGTON, June 1, 2022 /PRNewswire/ -- A new study published today in Tobacco Control details how the world's largest multinational tobacco companies are systematically advertising cigarettes to kids near playgrounds and schools in more than 40 countries. The study is the most expansive analysis to date of point of sale cigarette advertising in low- and middle-income countries and was authored by experts from the Institute for Global Tobacco Control at Johns Hopkins Bloomberg School of Public Health and the Campaign for Tobacco-Free Kids.
The new analysis includes data collected from 2015 to 2021 at points of sale within a short walking distance of schools and playgrounds in 42 mostly low- and middle-income countries. The analysis found nearly identical marketing tactics across the countries surveyed, suggesting that the tactics are part of a concerted effort by multinational companies to expose youth to their cigarette brands and products around the world.
Cigarette brands from British American Tobacco and Philip Morris International were found advertised near schools or playgrounds in nearly all of the countries surveyed. Both companies have emphatically claimed they do not market cigarettes to children – and have gone so far as to claim they want people to stop smoking cigarettes. Yet the overwhelming evidence from dozens of countries around the world suggests British American Tobacco and Philip Morris International target the world's most vulnerable populations to continue driving their cigarette business.
In addition to the advertising near schools and playgrounds, other common tactics identified in the analysis include displays of cigarettes near sweets and snacks, displays of cigarettes at a child's eye level and the sale of flavored and single-stick cigarettes. Tobacco companies work with and incentivize cigarette retailers to control the availability, placement, pricing and promotion of their products.
In 2021, British American Tobacco and Philip Morris International sold more than 1.3 trillion cigarettes combined. Cigarette sales have increased in many of the low-and middle-income countries identified in the analysis
Tobacco companies have known for decades that cigarette advertising at point of sale is associated with youth smoking initiation and leads many to become lifelong smokers. The evidence is clear that tobacco companies push their deadly products at points of sale frequented by kids because they know this strategy works to attract youth and their business depends on addicting new consumers.
The findings of this analysis underscore the urgent need for more countries to implement proven tobacco control solutions including comprehensive prohibitions on all tobacco advertising, promotion and sponsorship. Without urgent and comprehensive action to ban cigarette advertising, the world's largest tobacco companies will continue to capitalize on weak regulations to market cigarettes to children and youth.
For additional information on how tobacco companies target kids, please visit: https://www.takeapart.org/tiny-targets/
View original content to download multimedia:
SOURCE Campaign for Tobacco-Free Kids | https://www.wibw.com/prnewswire/2022/06/01/new-study-reveals-how-tobacco-companies-systematically-advertise-cigarettes-kids-near-schools-playgrounds-around-world/ | 2022-06-01T17:24:55Z |
3 more funerals for Buffalo victims in week of goodbyes
BUFFALO, N.Y. (AP) — A mother and sister known for baking decadent pastries. A restaurant worker buying his 3-year-old’s birthday cake. A father of six who worked as a school bus aide.
These three victims of the racist attack on a Buffalo supermarket will be laid to rest Friday, in a week filled with goodbyes for family and friends.
Funeral services are scheduled for Geraldine Talley, 62, of Buffalo, Andre Mackniel, 53, of Auburn, and Margus Morrison, 52, of Buffalo.
They’re among the 10 people killed and three wounded when a white gunman opened fire on afternoon shoppers and employees at a Tops Friendly Market on May 14. Authorities said he chose the grocery store because it’s in a predominantly Black neighborhood.
For many Black Americans, this latest example of targeted racial violence stirred the same feelings they faced after earlier attacks.
“It’s like Groundhog’s Day. We’ve seen this over and over again,” said Mark Talley, son of Geraldine Talley, at a news conference after the shooting. “I constantly think about what could have been done.”
Friends and family of Talley say she was an expert baker who treated them to apple crisps, cakes and pastries. She was with her fiancé at Tops when the shooting started. Her fiancé was in a different aisle and made it to safety.
“Gerri will be remembered for her beautiful spirit, her dimpled smile and immense love for her family,” her online obituary said. Veteran civil rights activist Rev. Al Sharpton is expected to memorialize Talley on Friday.
Mackniel was picking up a birthday cake for his young son when he was killed. He was a cook and stay-at-home father to his son, his obituary said.
“He loved basketball, playing the guitar, writing poems, listening to music, but most of all Andre was a very family-oriented man,” it said.
Morrison, a father of six, had worked as a security guard and was a bus aide with Buffalo Public Schools since 2019. He was buying snacks for a family movie night, his stepdaughter Cassandra Demps told WIVB.
Frederick Morrison said he’ll remember his brother who he often played basketball as comical and full of energy.
“All his jokes weren’t good,” Frederick told The Buffalo News, laughing, “but he was funny.”
Funerals for store security guard Aaron Salter, 55, of Lockport and Pearl Young, 77, of Buffalo were held Wednesday. In previous days, 32-year-old Roberta Drury, 72-year-old Katherine Massey, 67-year-old Heyward Patterson, and 65-year-old Celestine Chaney, were also laid to rest.
A funeral for the oldest victim, 86-year-old Ruth Whitfield, will be held Saturday.
The country was still mourning the violence in Buffalo when yet another mass shooting left 19 students and two teachers dead inside an elementary school in Uvalde, Texas, on May 24. Authorities say the shooters in both attacks were 18-year-old men with semi-automatic rifles.
The suspect in the Buffalo shooting was charged with first-degree murder and is being held without bail. His lawyer, at his initial court appearance, entered a plea of not guilty. In Texas, the suspected gunman was killed by law enforcement.
This story has been corrected to show that a funeral for Ruth Whitfield will be held Saturday, not Sunday.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/05/27/3-more-funerals-buffalo-victims-week-goodbyes/ | 2022-05-27T19:45:56Z |
Revolutionary Apyx Medical Device Used by Top Physicians in the US Now Available to Patients for Nonsurgical Facial Renewal
CLEARWATER, Fla., June 28, 2022 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX), the manufacturer of Renuvion®, a proprietary helium plasma and radiofrequency technology, previously announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the use of the Renuvion Dermal handpiece for specific dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II or III.
Branded as Facial Renewal, this treatment for wrinkle-reduction provides patients with an effective and nonsurgical option for smoothing and contracting the skin in one procedure. Facial Renewal enables dermatologists, plastic surgeons and cosmetic physicians to achieve transformative results, without the patient needing invasive surgery or risking looking unnatural. Facial Renewal with Renuvion is the first major advancement in decades of skin treatments for the face, providing patients with dramatic and natural-looking results.
"Renuvion for facial procedures is groundbreaking. It's a treatment that fulfills a big unmet need in cosmetic procedures," said New York oculoplastic surgeon Tabasum Mir, MD. "I have been using the Renuvion technology on patients in my practice and I've seen the transformative results firsthand. With the new clearance for Facial Renewal, this opens a whole new treatment option for patients to achieve the youthful appearance they're seeking."
"We are very pleased to receive FDA clearance with a specific clinical indication that enables Apyx Medical to market and sell our Renuvion Technology to physicians and patients for use in dermal resurfacing procedures," said Charlie Goodwin, President and Chief Executive Officer. "Facial Renewal with Renuvion offers patients a refreshed and more youthful look without having the unnatural 'pulled' appearance often associated with a facelift."
For more information visit Renuvion.com.
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision while minimizing unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to, any statements regarding the potential impact of the COVID-19 pandemic and the actions by governments, businesses and individuals in response to the situation; projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality including but not limited to the U.S. Food and Drug Administration, supply chain disruptions, component shortages, manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company's financial performance.
Forward-looking statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause the Company's actual results to differ materially and that could impact the Company and the statements contained in this release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company is subject to, including the Company's ability to gain requisite approvals for its products from the U.S. Food and Drug Administration and other governmental and regulatory bodies, both domestically and internationally; the impact of the recent FDA Safety Communication on our business and operations; factors relating to the effects of the COVID-19 pandemic; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and the Company's other filings with the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
Media Contact:
Jane Sparango
Coterie Media (for Renuvion)
jane@coteriemedia.com
310-339-1214
Investor Relations Contact:
ICR Westwicke on behalf of Apyx Medical Corporation
Mike Piccinino, CFA
investor.relations@apyxmedical.com
View original content to download multimedia:
SOURCE Renuvion | https://www.wibw.com/prnewswire/2022/06/28/renuvion-dermal-handpiece-wrinkle-reduction-procedures-cleared-by-fda/ | 2022-06-28T13:01:33Z |
HOUSTON, July 20, 2022 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK), a leader in technology-driven specialty green chemistry solutions, today announced that it expects second quarter 2022 revenue to be in excess of $28MM compared to first quarter 2022 revenue of $12.9MM and second quarter 2021 revenue of $9.2MM. In addition, the Company provided commentary on progress made ramping up volumes related to the ProFrac Holdings (ProFrac) contract.
"The revenue growth we expect to achieve in the second quarter is strong evidence that we are successfully ramping up the transformational ProFrac contract, and I am very proud of our team. During the second quarter, we serviced an average of 8 ProFrac hydraulic fracturing fleets with no service quality issues, and expect to service an average of 16 or greater fleets in the third quarter. Since the April 1, 2022 effective date of the contract, we have delivered over 31 million pounds of chemistry to ProFrac. Combined with the 9 million pounds of chemistry delivered to our transactional (non-ProFrac) customers, total delivered volume in the second quarter was approximately double what we delivered for the entire year in 2021. We are delighted with how far we have come over a short period of time, and are very excited about the future. While we still have additional work to do in order to achieve the full scope of the contract, we are up to the task," said CEO John W. Gibson, Jr.
"We are proud of the work that the collective teams at Profrac and Flotek have accomplished. We are well on pace to reach full fleet adoption per the Profrac/Flotek contract by the beginning of 2023. Flotek's chemistry is the highest quality and continues to enable the smooth transition of each of our fleets. With the continued expansion of volumes, our belief is that Flotek will see continued efficiencies in logistics and purchasing power that reduces over-all costs and improves margins," said Profrac Executive Chairman Matt Wilks.
While delivered volume and revenue are expected to show strong growth over the first quarter 2022, the ramp up required the Company to incur some one-time expenses, including costs related to the mobilization of additional field deployment tanks (ISO), which increased from 20 to 101. In addition, freight and logistics costs are expected to be significantly above expectations, consistent with inflation being experienced by peers. However, these issues are not expected to interrupt consistent improvement in Adjusted EBITDA margin through the second half of 2022, and the Company still expects to generate positive Adjusted EBITDA excluding convertible notes amortization before the end of the fourth quarter 2022.
Flotek Industries, Inc. creates solutions to reduce the environmental impact of energy on air, water, land and people. A technology-driven, specialty green chemistry and data company, Flotek helps customers across industrial, commercial, and consumer markets improve their Environmental, Social, and Governance performance. Flotek's Chemistry Technologies segment develops, manufactures, packages, distributes, delivers, and markets high-quality cleaning, disinfecting and sanitizing products for commercial, governmental and personal consumer use. Additionally, Flotek empowers the energy industry to maximize the value of their hydrocarbon streams and improve return on invested capital through its real-time data platforms and green chemistry technologies. Flotek serves downstream, midstream, and upstream customers, both domestic and international. Flotek is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.
Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect, any event or circumstance that may arise after the date of this press release.
View original content to download multimedia:
SOURCE Flotek Industries, Inc. | https://www.kxii.com/prnewswire/2022/07/20/flotek-announces-preliminary-second-quarter-2022-revenue/ | 2022-07-20T12:32:06Z |
RIVERSIDE, California (KTLA) — A man suspected of carjacking an Amazon delivery van after breaking into two homes in Riverside, California, is in custody following a wild pursuit earlier this week.
Authorities were alerted to the events around 5:15 p.m. Monday when they received calls about two home-invasion robberies occurring at a mobile home park, the Riverside Police Department stated in a news release.
Responding officers were told the suspect had just carjacked the Amazon van and fled the scene before they arrived. Police were able to locate the stolen delivery van after tracking it by GPS.
The driver didn’t stop and led police on a pursuit through city streets and toward the 60 Freeway, according to the news release.
The driver entered the freeway shortly after striking a vehicle near an intersection, video posted on the Police Department’s Facebook page showed.
The driver then collided with three other vehicles during a pursuit that lasted several minutes on the freeway.
The van eventually became disabled, prompting the suspect to run on foot across the westbound lanes of the freeway. He was caught after failing to climb over a tall barrier wall.
The suspect was identified as 32-year-old Quintin Jamall Larks, of Las Vegas.
Larks has been booked on suspicion of attempted murder, home invasion robbery, carjacking, assault with a deadly weapon, reckless evading of police, and suspicion of driving under the influence of drugs causing injury, according to the Police Department.
He is being held on $1 million bail. | https://cw33.com/news/nexstar-media-wire/video-california-home-invasion-suspect-flees-in-stolen-amazon-van/ | 2022-07-29T04:55:47Z |
16-year-old boy fatally shot near Chicago tourist attraction
CHICAGO (AP) - A 16-year-old boy was fatally shot near “The Bean” in Millennium Park in Chicago on Saturday, authorities said.
The Chicago Police Department said the boy was shot in the chest at about 7:30 p.m. near the popular tourist attraction. Police have not yet identified the boy.
He was taken to Lurie Children’s Hospital where he was pronounced dead, police said.
At least two suspects were taken in for questioning and at least two weapons were recovered, authorities said.
An investigation is ongoing. Police did not provide any additional information.
Hundreds of people were at the park Saturday as part of demonstrations across the U.S. protesting a recently leaked draft opinion that suggests the Supreme Court is prepared to overturn the constitutional right to abortion. It is unclear if the teen who was shot was part of the demonstrations.
Police cleared and closed the park following the shooting. It is unclear when it will reopen.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/05/15/16-year-old-boy-fatally-shot-near-chicago-tourist-attraction/ | 2022-05-15T10:22:49Z |
Investment to expand the company's cloud-native networking portfolio and global operations, changing the way networks are built, operated, and consumed
RA'ANANA, Israel, Aug. 17, 2022 /PRNewswire/ -- DriveNets, a leader in cloud-native networking solutions, today announced it has secured $262 million in a Series C venture capital funding round, considerably increasing the company's valuation over its January 2021 Series B round. The funding from this latest round of investment will be used to develop future technology solutions, pursue new business opportunities, and expand the company's global operations and support teams to support growing customer demand.
The round was led by D2 Investments with the participation of DriveNets' current investors, including Bessemer Venture Partners, Pitango, D1 Capital, Atreides Management, and Harel Insurance Investments & Financial Services.
"DriveNets' approach of building networks like cloud allows telecom providers to take advantage of technological efficiencies available to cloud hyperscalers, such as cloud-native software design and optimal utilization of shared resources across multiple services," said Ido Susan, DriveNets founder and CEO. "This latest round of investment demonstrates our investors' and customers' confidence in us and will enable us to expand the value and global operational support we offer them."
"DriveNets has demonstrated its ability to move the networking industry forward and has gained the trust of tier-1 operators," said Adam Fisher, Partner at Bessemer Venture Partners. "While other solution providers are facing challenging headwinds, DriveNets continues to innovate and execute on its vision to change the future of the networking market."
"DriveNets has already made a big impact in the high-scale networking industry, and its routing solutions are adopted by tier-1 operators for their quality and the innovation they enable," said Aaron Mankovski, Managing Partner at Pitango. "This investment will allow DriveNets to expand its footprint in the market and develop additional offerings."
Strong company performance supports investor confidence
Since its last funding round in 2021, DriveNets has gained significant market traction.
- Growing network traffic running on the DriveNets' Network Cloud solution by 1,000 percent
- Engaging with nearly 100 customers and doubled bookings year over year
- Establishing key strategic partnerships to speed up the deployment of next-generation networks worldwide, including agreements with Itochu Techno-Solutions Corporation (CTC), EPS Global, Wipro Limited, and KGPCo.
- Growing its overall employee base by 30 percent, significantly expanding its operations and deployment teams, and its global reach.
DriveNets also recently announced the addition of three cloud and networking industry veterans to its leadership team.
Learn more about DriveNets here.
About DriveNets
DriveNets is a leader in cloud-native networking software and network disaggregation solutions. Founded in 2015 and based in Israel, DriveNets offers communications service providers (CSPs) and cloud providers a radical new way to build networks, substantially growing their profitability by changing their technological and economic models. DriveNets' solution – Network Cloud – adapts the architectural model of cloud to telco-grade networking. Network Cloud is a cloud-native software that runs over a shared physical infrastructure of standard white-boxes, radically simplifying the network's operations, offering telco-scale performance and elasticity at a much lower cost. Learn more at www.drivenets.com
Media contact:
Crystal Monahan
+1-617-290-2882
drivenets@guyergroup.com
Martin Perlin
+972-54-921-3547
press@drivenets.com
Logo - https://mma.prnewswire.com/media/1657406/DriveNets_Logo.jpg
View original content to download multimedia:
SOURCE Drivenets Ltd. | https://www.wibw.com/prnewswire/2022/08/17/drivenets-secures-262-million-series-c-funding-continue-disrupting-telecommunications-cloud-infrastructure-industry/ | 2022-08-17T12:08:29Z |
MAJURO, Marshall Islands, July 5, 2022 /PRNewswire/ -- Gate.io – one of the world's leading cryptocurrency exchanges – announced the appointment of Tom Yang as Executive Vice President (EVP).
Tom Yang has driven global brand operation and management for many years in companies like Google and WeWork. Although the crypto market has been relatively turbulent recently, Gate.io believes that with its capital and technological advantages accumulated over the years, the current market conditions are an ideal time for them to deploy global marketing strategies and employ outstanding talents.
"Gate.io is one of the most trusted cryptocurrency exchanges in the world." Tom Yang said, "It is an honor to join a company with such great potential. Moving forward, my focus will be enhancing Gate.io's market share in key and emerging markets around the world, increasing its brand presence and strengthening the exchange's relationships with users and partners around the world, and exploring new business growth possibilities."
Lin Han, the Founder and CEO of Gate.io, said: "We have introduced a new brand identity during Gate.io's 9th-anniversary celebrations. Gate.io is a trading platform that insists on long-term vision and operations. We believe that cryptocurrencies are the future of finance. Although the market is currently very volatile, we will continue to innovate and adhere to our globalization strategy."
"We are delighted to welcome Tom Yang, who has extensive global operation experience, to our management team. We believe that his addition will give Gate.io a stable and long-term development path."
With the addition of Tom Yang, Gate.io will gradually carry out its global brand building and market development. As of now, Gate.io has kicked off its local brand sponsorship and strategic cooperation activities in southern Europe, Latin America, and East Asia, including brand partnership negotiations with top-tier sports teams, athletes, etc. More details will be announced later.
About Gate.io
Gate.io is one of the world's leading cryptocurrency exchanges, offering users access to most of the leading digital assets. The platform has over 10 million users from different parts of the world and boasts a comprehensive ecosystem of products and services. Gate.io exchange offers trading on spot markets and some innovative products in certain markets.
Besides standard crypto trading, Gate.io also offers users the opportunity to trade in NFTs through the company's dedicated Gate NFT platform. The wider Gate.io ecosystem includes its dedicated GateChain ecosystem and access to DeFi products through Hipo DeFi, custodial services through Wallet.io, and investments through Gate Labs and Gate Ventures.
Contact Details:
Summi Di
summidi@mail.gate.io
View original content to download multimedia:
SOURCE Gate.io | https://www.wibw.com/prnewswire/2022/07/05/gateio-hires-former-google-executive-evp-accelerate-global-expansion/ | 2022-07-05T13:09:24Z |
NEW YORK, May 31, 2022 /PRNewswire/ -- Shareholder rights law firm Julie & Holleman has launched an investigation into the proposed acquisition of Covetrus, Inc. (NASDAQ: CVET) by funds affiliated with private equity firms Clayton, Dubilier & Rice (CD&R) and TPG Capital.
To learn more about the investigation, click here.
CD&R and its affiliates already own 24% of Covetrus' outstanding shares of common stock. Under the companies' merger agreement, announced on May 25, 2022, CD&R and TPG will acquire the remaining outstanding shares of Covetrus for $21 per share in cash, which represents an enterprise value for the company of approximately $4 billion.
Julie & Holleman is investigating potential legal claims available to Covetrus shareholders regarding the proposed acquisition, including claims relating to CD&R's and management's conflicts of interest and the adequacy of the $21 per share acquisition price. Covetrus stock has traded at nearly 40% higher than the deal price within the last year, and Wall Street analysts' price targets also exceed the $21 per share price.
If you would like more information about Julie & Holleman's investigation, or about the acquisition in general, please contact W. Scott Holleman by email at scott@julieholleman.com or by telephone at (929) 415-1020. You may also visit the firm's website by clicking here.
Julie & Holleman is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. The firm's attorneys litigate in state and federal courts across the nation. For more information about the firm, please visit www.julieholleman.com. This notice may constitute attorney advertising.
View original content to download multimedia:
SOURCE Julie & Holleman LLP | https://www.kxii.com/prnewswire/2022/05/31/cvet-alert-julie-amp-holleman-investigates-potential-legal-claims-related-proposed-acquisition-covetrus-inc/ | 2022-05-31T14:08:58Z |
ROME (AP) — Italian police say the body of a 21-year-old American man was pulled from the Tiber River on Thursday, and an investigation was underway to determine the cause of death.
The family of Elija Oliphant of Dallas, Texas, reported him missing on Tuesday, after he left the hotel and never returned. They had arrived on holiday a day earlier.
The body was found in a section of the river near the Trastevere neighborhood, famous for its nightlife and popularity with foreign students.
The family had published an appeal on social media on Wednesday, including posting pictures of the smiling young man after voting in the November 2022 U.S. election. The appeal put his age at 22. | https://cw33.com/news/international/ap-international/body-of-american-man-pulled-from-romes-tiber-river/ | 2022-05-27T16:33:25Z |
Extends Core Intellectual Property coverage for treatment of lung cancer as well as esophageal cancer.
HOLLISTON, Mass., April 11, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted at the Mayo Clinic and published last August) and FDA approval to commence a clinical trial of the Biostage Esophageal Implant for severe esophageal disease including cancer, today announced that the U.S. Patent and Trademark Office (USPTO) has granted a new patent (US 11,266,763 B2) that extends its key intellectual property to cover regeneration and repair of the bronchus due to cancer, injury or birth defects.
Using a cell-seeded scaffold, which we call the Biostage Bronchial Implant, or BBI, we have performed the regeneration and repair of a bronchus (the airway that connects the trachea to the lungs) that was surgically removed from a pig. The bronchus regenerated, much as in the esophagus, first forming a tube and later developing into a bronchus with a functional lining known as the respiratory epithelium. The respiratory epithelium was seen in about two months in the pig. This respiratory epithelium is essential to the avoidance of infections such as pneumonia. This pig lived almost two years until scheduled euthanasia. This indication is protected by the newly-issued U.S. patent. Biostage's existing patents on the bioreactor and scaffold also protect this bronchial indication. This new patent now gives Biostage the protection needed to develop a business in treating lung cancer via the regeneration and repair of the bronchus. This is in addition to the existing business opportunity in the repair and regeneration of the esophagus.
The Biostage Bronchial Implant is a temporary delivery device that administers a large dose of the patient's own wound-healing cells to the site where the diseased or damaged bronchus was removed. The cells stimulate the body's natural wound-healing process and the scaffold guides the growth into a tube. The scaffold is temporary and, after a few months, is removed using a bronchoscope (a minimally invasive procedure, there is no second surgery in the chest), leaving behind a regenerated bronchus derived from the patient's own cells.
Treating bronchus cancer is a major new business opportunity for Biostage. Bronchus cancer is a subset of lung cancer. Lung cancer is the most common form of cancer and the most common cause of death from cancer worldwide. There are more than 700,000 new lung cancer diagnoses annually in the U.S. and Europe. In approximately 25% of all lung cancer cases, the cancerous tumor resides only in a bronchus and not in the lobes of the lungs and is known as central lung cancer. Approximately 33,000 central lung cancer cases diagnosed in the U.S. and Europe are Stage I and II and are considered eligible for surgical resection, often with adjuvant chemotherapy and radiation. Approximately 5,000 of those patients are treated via pneumonectomy, a surgical procedure involving the resection of the cancer tumor, the whole bronchus below the tumor and the entire lung to which it is connected. It is a complex surgery and, due to the removal of a lung, results in a 50% reduction in the patient's respiratory capacity. The procedure has reported rates of post-surgical, or in hospital, mortality of 8% to 15%. Complication rates associated with pneumonectomy are reported as high as 50%, and include post-operative pneumonia, supraventricular arrhythmias, and anastomotic leakage, placing patients at significant mortality risk post-discharge.
We intend to develop the Biostage Bronchial Implant to treat central lung cancer patients who would currently be treated with surgical removal of the lung and bronchus. Based on discussions with surgeons in the field, we estimate that approximately 7,000 patients with these conditions in the U.S. and Europe, and approximately 22,000 worldwide, would potentially be treatable with our technology. We estimate that revenue from treating these patients could be over $1bn a year.
Once developed and approved for marketing, the Biostage Bronchial Implant has the potential to provide physicians a treatment alternative superior to the pneumonectomy (lung removal) procedure currently used to treat central lung cancer. We expect that repair with a BBI could restore the function of the bronchus without sacrificing one of the patient's lungs. We believe this may result in fewer post-surgery complications, reduced mortality rates and improved quality of life for the patient.
In addition to developing the BBI for treating central lung cancer, we also intend to develop the BBI for the treatment of bronchial fistulas (holes) and birth defects in the bronchus.
Dr. Bill Fodor, Chief Scientific Officer of Biostage stated, "The pig study, although only in a single animal, demonstrates that the Biostage implant technology can stimulate the regeneration of an epithelialized tubular organ, similar to our esophageal implant".
David Green, founder, Chairman and interim Chief Executive Officer of Biostage stated, "The proof of concept in the pig combined with this new patent gives us the ability to develop a major new business for Biostage. We believe that Biostage's technology can now be used to regenerate and repair two major organs in the human body – the esophagus and the bronchus. Both organs can suffer life-threatening damage from cancer, injury and birth defects."
The patent issued by the U.S. Patent and Trademark Office (USPTO) is US 11,266,763 B2 "Method and Device for In Vivo Bronchus Regeneration", Fodor et al, granted on March 8th 2022.
About Biostage.
Biostage is a clinical-stage biotech company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects in the esophagus and bronchus. We have performed the world's first regeneration of an esophagus in a human cancer patient. This surgery was performed at Mayo Clinic and was published in August 2021. We have performed the regeneration of the bronchus in a pig.
Biostage has 8 issued U.S. patents, 2 orphan-drug designations (which provide 7 years of market exclusivity in addition to any patents), and the possibility of 2 Priority Review Vouchers from the FDA.
Biostage's current goals include raising capital, uplisting from the OTC bulletin board to NASDAQ and beginning its clinical trial for regeneration and repair of the esophagus.
For more information, please visit www.biostage.com and connect with the Company on Twitter and LinkedIn.
Forward-Looking Statements
Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements in this press release include, but are not limited to, statements relating to the capabilities and performance of our products and product candidates; our capital raising plans and expectations, including uplifting to NASDAQ; development expectations and regulatory approval of any of the Company's products, including those utilizing its Biostage Esophageal Implant technology, by the U.S. Food and Drug Administration, the European Medicines Agency or otherwise, which expectations or approvals may not be achieved or obtained on a timely basis or at all; and success with respect to any collaborations, clinical trials and other development and commercialization efforts of the Company's products, which such success may not be achieved or obtained on a timely basis or at all. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this press release, including, among other things, the Company's inability to obtain needed funds in the immediate future; the Company's ability to obtain and maintain regulatory approval for its products; plus other factors described under the heading "Item 1A. Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 or described in the Company's other public filings. The Company's results may also be affected by factors of which the Company is not currently aware. The forward-looking statements in this press release speak only as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such statements to reflect any change in its expectations with regard thereto or any changes in the events, conditions or circumstances on which any such statement is based.
Investor Relations Contact
Shunfu Hu
Vice President of Business Development
and Operations
774-233-7300
shu@biostage.com
View original content to download multimedia:
SOURCE Biostage, Inc. | https://www.kxii.com/prnewswire/2022/04/11/biostage-further-strengthens-ip-portfolio-with-additional-patent-regeneration-repair-bronchus/ | 2022-04-11T13:12:53Z |
Judge delays Alex Jones trial as Infowars seeks bankruptcy
Published: Apr. 20, 2022 at 11:27 AM CDT|Updated: 14 minutes ago
AUSTIN, Texas (AP) — A Texas judge has pushed back the first jury trial over how much conspiracy theorist Alex Jones should pay the families of the 2012 Sandy Hook Elementary School massacre.
The Infowars host has already lost defamation cases over his comments that the shooting was a hoax. But a judge Wednesday delayed the trial after Infowars this week sought Chapter 11 bankruptcy protection in Texas.
Attorneys for Sandy Hook families have accused Jones of trying to hide millions of dollars in assets.
A new trial date was not set.
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/04/20/judge-delays-alex-jones-trial-infowars-seeks-bankruptcy/ | 2022-04-20T16:42:39Z |
RICE LAKE, Wis., Aug. 16, 2022 /PRNewswire/ -- Leading lever action firearms manufacturer Henry Repeating Arms is proud to announce that its latest Guns For Great Causes campaign raised $36,400 for the family of Danica Brianne Mulholland. After losing their 12-year-old daughter to a three-year battle with brain cancer, the Levittown, Pennsylvania family is receiving a check from the sale of 50 Henry Golden Boy lever action rifles to assist with any outstanding medical and funeral expenses.
Danica was undergoing treatment for a grade IV medulloblastoma when Henry Repeating Arms CEO and Founder Anthony Imperato jumped at the opportunity to assist the family through the company's charitable branch, Guns for Great Causes. Henry Repeating Arms donated all the rifles, and Baron Engraving of Trumbull, Connecticut, donated their services to create the engraved artwork in tribute to Danica's life. The "Danica Strong" edition rifles sold out within two hours of the initial release announcement, and auctions of the first and last serial numbers brought in an additional $4,000 total. Since 2020, the program has distributed over $325,000 to individual families of sick children.
"Danica's memory will live on in all of us at Henry," says Anthony Imperato. "Her tenacity, grace, and unending kindness for those around her is something everyone can learn from and keep with them. My sincerest thanks to all who choose to support our Guns for Great Causes mission."
On top of these individual campaigns for sick children and in celebration of its 25th anniversary this year, Henry Repeating Arms is highlighting its charitable endeavors with a $1,000,000 pledge to benefit several different categories from children's hospitals, organizations supporting military veterans, first responders, law enforcement, wildlife conservation, and hunting and shooting sports education. Recent beneficiaries include the Veterans of Foreign Wars and the Tunnel to Towers Foundation.
For more information about Henry Repeating Arms and its products, visit henryusa.com or call 866-200-2354.
Henry Repeating Arms is one of the leading rifle and shotgun manufacturers in the United States and a world leader in the lever action category. The company motto is "Made in America, or not made at all," and its firearms come with a lifetime guarantee backed by award-winning customer service. The company is also known for its Guns For Great Causes charitable program, which focuses on assisting the families of sick children, children's hospitals, military veteran organizations, Second Amendment advocacy groups, and wildlife conservation organizations. The company currently employs over 550 people and has over 330,000sf of manufacturing space in its Wisconsin and New Jersey facilities. The company is named in honor of Benjamin Tyler Henry, who invented and patented the Henry lever action rifle in 1860 – the first practical repeating rifle and America's unique contribution to the international stage of firearms design. Visit Henry Repeating Arms online at henryusa.com, on Facebook at facebook.com/HenryRepeating, and @henry_rifles on Instagram.
View original content to download multimedia:
SOURCE Henry Repeating Arms | https://www.mysuncoast.com/prnewswire/2022/08/16/henry-repeating-arms-donation-raises-over-35000-memory-childhood-cancer-victim/ | 2022-08-16T15:04:45Z |
Contract Includes Massive Wage and Benefit Increases
LOS ANGELES, June 23, 2022 /PRNewswire/ -- Drivers and fleet maintenance workers at Nabis Cannabis have voted overwhelmingly to ratify their first contract with Teamsters Local 630. It is the first collective bargaining agreement at the rapidly-growing cannabis distribution company.
"I'm incredibly proud of the tenacity and courage that was demonstrated by this group of workers," said Lou Villalvazo, Local 630 Secretary-Treasurer. "What they have done at this company can serve as a model for successful organizing and bargaining throughout the California cannabis industry moving forward."
"These workers are the most critical component of the company's success and they deserve a collective bargaining agreement that reflects that," said Peter Finn, Teamsters Food Processing Division Director. "A Teamster contract ensures that cannabis workers have prosperous, long-term careers in this exciting and burgeoning industry."
The three-year contract includes a number of significant improvements. These include wage increases of at least 28 percent throughout the lifetime of the agreement, four weeks of paid vacation, paid sick days, paid holidays, guaranteed minimum of 40 hours per week and more. The agreement also provides these young workers with the opportunity to retire with dignity by being part of the Western Conference of Teamsters Pension Trust.
"I can say that I'm thankful for all my co-workers' determination and unity, and to Local 630 for all their guidance and assistance," said Driver Jordan Davis. "They gave all of us the opportunity to achieve our union and our first contract, which will change our lives. Thanks to Teamsters, I now have a career instead of a job."
Established in 1937, Teamsters Local 630 represents workers in various industries, from clerical, warehouse, professional drivers, food service, liquor, food processing, dairy and more. For more information, go to http://www.teamsters630.org/.
Contact:
Matt McQuaid, (202) 624-6877
mmcquaid@teamster.org
View original content to download multimedia:
SOURCE Teamsters Local 630 | https://www.wibw.com/prnewswire/2022/06/23/nabis-cannabis-drivers-ratify-first-contract-with-teamsters-local-630/ | 2022-06-23T20:58:03Z |
SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented on the 8th of August, at the 2022 IASLC World Conference on Lung Cancer held in Vienna, Austria, during the official session entitled "Overcoming Resistance to EGFR Inhibitors".
Prof. Cho Byoung-chul, Director of the Lung Cancer Center at Yonsei Cancer Hospital, Korea, presented data which indicates that 'JIN-A02' targets NSCLC cancers harboring double or triple C797S mutations.
In-vitro and in-vivo data of 'JIN-A02' showed robust inhibitory activities against NSCLC cancer cell-lines harboring double and triple C797S mutations, with selectivity away from EGFR Wild Type, which is important for patient safety.
In addition, 'JIN-A02' also effectively reduced tumor volume in a dose-dependent manner, compared to Osimertinib, in mouse model harboring EGFR C797S triple mutation, showing high brain penetrance with efficacy. Prof. Cho ended his presentation by putting forth that JIN-A02 may be the Best-In-Class 4th generation EGFR-TKI against NSCLC.
About J INTS Bio
J INTS BIO is a bio company specialized in developing innovative anti-cancer and orphan drugs to realize the goal of changing lives and improving health for patients around the world. J INTS BIO's teams have prior multi-year experience in multinational pharmaceutical companies and CROs and track records in medical, regulatory affairs, drug discovery and development.
About JIN-A02
'JIN-A02' is a novel orally administered 4th Generation EGFR TKI targeting C797S mutations in NSCLC. Although 1st, 2nd, and 3rd Generation EGFR TKIs have been used with some success, recurrence occurs in most patients including 3rd Generation TKIs such as Osimertinib. Currently, there are no approved therapies for patients who developed EGFR C797S mutations due to the use of 3rd Generation EGFR TKIs and with the high propensity of these cancers to metastasize to the brain, there is an urgent need to develop an effective drug with high blood-brain barrier permeability. 'JIN-A02', a novel oral EGFR TKI, which is effective against C797S mutations and have a high brain penetrance, is therefore expected to become the most promising Best-in-Class 4th-generation EGFR TKI in NSCLC patients with limited or no viable treatment options.
View original content to download multimedia:
SOURCE J INTS BIO | https://www.mysuncoast.com/prnewswire/2022/08/16/j-ints-bio-oral-presentation-preclinical-results-its-novel-oral-4th-generation-egfr-tki-jin-a02-2022-world-conference-lung-cancer-vienna-austria-iaslc-2022-wclc/ | 2022-08-16T07:19:46Z |
Company Continues to Grow and Ignite Innovation Within the Insurance Industry Domestically and Globally
DES MOINES, Iowa, Aug. 24, 2022 /PRNewswire/ -- BrokerTech Ventures (BTV), the industry's first broker-led group and accelerator program celebrates its 3rd anniversary while continuing to make headlines in the insurance industry.
BTV was launched in 2019 at InsureTech Connect (ITC), the largest insurance technology (insurtech) conference and convening platform in the world. Since that time, the company has grown to include 15 of the most notable super-regional brokerage firms in the nation, 14 of the world's most highly respected insurance carriers and wholesalers, and 48 insurtech startups from around the world, inclusive of those in the U.S., Israeli, and Latin American accelerator programs. BTV also represents multi-billions of dollars in premiums and overall distribution.
Due to its influence in the insurance industry brokerage space, BTV fueled BrokerTech Connect — an insurtech series for the broker-centric community — during ITC in 2021 and was asked to do so again this coming September in Las Vegas, Nevada.
Most recently, BTV has been featured in all Alliance of Area Business Publishers (AABP) publications for its work to ignite and fuel the "tech-enabled broker."
"When we launched BrokerTech Ventures, we knew there was a need in the insurance industry, specifically dedicated to the broker side of the equation," said Dan Keough, Holmes Murphy Chairman & CEO and BTV Co-CEO. "Brokers are the primary distribution channel for insurance with a direct lens into the client experience. However, until BTV was formed, there wasn't an effort to bring together brokers, innovators, investors, and the industry to find, vet, and bring to market products and solutions specific to clients' needs. That's what BTV is doing today in an effort to help our clients identify risks sooner and drive down costs faster."
What may be most impressive is the perceived valuation increase from the BTV Accelerator program, as BTV believes the greatest metrics of its success lives within the data. Here are the numbers we've seen to date:
- 2020 & 2021 Cohort Activity:
As BTV has grown, the brand has also evolved. In fact, BTV has just launched a refreshed look to modernize and reflect the depth and breadth of the company.
"Through BTV, we believe we are bringing together the greatest minds around insurtech trends, technologies, and applications through our collective owners, partners, and startups," said Keough. "We can't wait to see what the next year for BTV brings to the industry and to our clients."
Based in the insurance nucleus of Des Moines, Iowa, BrokerTech Ventures (BTV) is the first broker-led convening platform and accelerator program focused on delivering innovation to the insurance broker industry. Founded in 2019, BTV provides a venue for the best minds in insurance and technology to collaborate and bring to market leading-edge ideas and solutions. BTV invests in the research and testing for each of the chosen startups, provides access to veteran industry mentors, and helps scale the technology to market through broker distribution channels. Learn more at www.brokertechventures.com, or follow us on Twitter (@BrokerTechVen), LinkedIn, or Facebook.
Contact: Adam Scheurenbrand
515-205-4080
ascheurenbrand@ls2group.com
View original content:
SOURCE BrokerTech Ventures | https://www.kxii.com/prnewswire/2022/08/24/brokertech-ventures-celebrates-3-years-continues-make-impact-globally/ | 2022-08-24T12:34:19Z |
HSINCHU, Aug. 5, 2022 /PRNewswire/ -- AP Memory, the global leading design company that provides customized memory solution, has announced today its PSRAM solution up to 512Mb density is supported by Renesas RZ/A3UL MPUs.
The Renesas RZ/A3UL is a new product in the RZ/A series with significant enhancements in performance and specifications including the highest operating frequency of up to 1 GHz. Despite its high operating frequency, the RZ/A3UL is also an entry-class 64-bit MPU that provides a cost-effective solution, while providing the performance customers need. The RZ/A3UL provides an Octal-SPI memory interface that facilitates simpler and more compact board designs for industrial equipment, home appliances and office automation equipment with liquid crystal displays or control panels, as well as audio equipment and POS terminals. More information about the RZ/A3UL MPUs and the evaluation board kit is available on the Renesas website. (https://www.renesas.com/rza3ul & https://www.renesas.com/rza3ul-evaluation-board-kit)
APM's Octal-SPI PSRAM (Octal Serial Interface Pseudo Static Rando Access Memory) product family, as an alternative solution to standard parallel interface PSRAM (ADMUX or Cellular RAM), or legacy Low-Power SDR/DDR DRAM and SDRAM, supports high bandwidth with low-pin-count solution. Take 256Mb PSRAM for instance, it offers data transfer rate up to 400MBps (3.2Gbps) utilizing only 11 signal pins, equipped with HalfsleepTM mode, the ultra-low power standby mode, which is suitable for battery base IOT application. The latest Octal-SPI PSRAM product up to 512Mb was validated by the Renesas RZ/A3UL MPU, and is available on the RZ/A3UL reference board (EVK). For more information on Octal-SPI PSRAM or other PSRAM products, please refer to the following product link or contact APM directly.
About AP Memory Technology Corporation
AP Memory is a fabless DRAM and IP product company. As a world leader in Pseudo-SRAM, AP Memory delivers reliable solutions of low-pin-count ultra-low-power IoT RAM and high-performance derivative products. AP Memory is also the world-leading company in AI memory solutions, particularly for 3D IC. The headquarters is based in Hsinchu, Taiwan, with R&D centers in the US, Mainland China, Taiwan, and sales offices worldwide. For more information, please visit www.apmemory.com
View original content:
SOURCE AP Memory Technology Corp. | https://www.wibw.com/prnewswire/2022/08/05/ap-memory-octal-spi-psram-validated-by-renesas-rza3ul-mpu/ | 2022-08-05T16:47:01Z |
Visitors will soon need reservations for one of Hawaii’s most popular sites
By Forrest Brown, CNN
It’s one of the most popular spots in Hawai’i, and soon anyone from out-of-state will need a reservation to visit.
The new system for iconic Diamond Head State Monument — or Lē’ahi, to natives — will become effective May 12, the state’s Department of Land and Natural Resources (DLNR) announced in a Monday news release.
On the island of O’ahu, Diamond Head is one of the state’s most visited sites, the DLNR said, and is renowned for the stunning views along its hiking trail.
The system is slated to activate on Thursday, April 28, and will allow for reservations beginning 14 days ahead.
Starting May 12, people without a Hawaii driver’s license or ID must have secured a reservation to enter the park, the news release said. State residents will have free access without reservations, but entry might depend on whether parking spaces are left.
Find out more about the reservation system here.
Why is this happening at Diamond Head?
Hawaii is simply facing the same problem some US national parks and Venice, Italy, are having: Too many people crowding into the same space at the same time.
Overcrowding can sour the travel experience and damage the very things people want to see.
“The new reservation system will mitigate environmental impacts sustained by foot traffic, reduce vehicle congestion in the park and surrounding neighborhoods, improve the experience of kamaʻāina and visitors enjoying the monument,” the news release said.
This is the third state park to require reservations, the release said. The other two are Hā’ena State Park on Kaua’i and Waiʻānapanapa State Park on Maui.
Reservations are also required at Hanauma Bay Nature Preserve on O’ahu.
“We commend DLNR for bringing this reservation system to fruition, to support the efforts to manage the flow of visitors and residents into Diamond Head State Monument, and make the experience more enjoyable for all,” said Noelani Schilling-Wheeler, executive director of the O’ahu Visitors Bureau.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
Top image: An aerial view shows Diamond Head crater on February 23, 2022. (Photo by Daniel Slim / AFP via Getty images) | https://localnews8.com/cnn-other/2022/04/25/visitors-will-soon-need-reservations-for-one-of-hawaiis-most-popular-sites/ | 2022-04-26T07:38:48Z |
VENICE, Italy (AP) — Andrew Dominik had been trying to make a movie about Marilyn Monroe for over a decade.
The film wouldn’t be a biopic, but an experiential portrait delving into the psyche of Marilyn Monroe and Norma Jeane. It kept falling apart, but the New Zealand native couldn’t let it go. Then he found Ana de Armas, and, he said, the movie came alive.
“It was like love at first sight,” Dominik said Thursday, before the world premiere of the film at the Venice International Film Festival. “When the right person walks through the door, you know it.”
The nearly three-hour epic is based on a work of biographical fiction by Joyce Carol Oates and examines the public and private life of the Hollywood icon from her troubled childhood as Norma Jeane to her global stardom as Marilyn Monroe and various relationships along the way, from her mother (Julianne Nicholson) to her marriages to Joe DiMaggio (Bobby Cannavale) and Arthur Miller (Adrien Brody).
“I wasn’t very aware of Marilyn. I was familiar with some of her movies, but for me it was a huge discovery and learning process,” de Armas said. “We wanted to honor her in the recreations where she was Marilyn, but I also had a lot of room to create the real woman underneath that character. It was about understanding and empathizing and connecting with her and her pain and her trauma.”
She added: “If you put aside the movie star she is, she’s just a woman, just like me. Same age. It was a project I knew I had to let myself open and go to places I knew were going to be uncomfortable and dark and vulnerable.”
Filming began on Aug. 4, the day Monroe died in 1962 at her home in Los Angeles at age 36. It was an accident and just the result of some delays. But it also was one of many times the filmmaker and his cast felt a somewhat mystical connection to the subject of their film. Though the story takes many liberties with the facts of her life with the intent of getting to the truth of her life, the production did use real locations like the apartment she and her mother lived in when she was a child and the house she died in.
“It took on elements of being like a séance,” Dominik said.
De Armas agreed that “there was something in the air” being in the same places Monroe had lived.
“I wasn’t in character all the time. But I felt that. I was living that. I felt that heaviness and that weight in my shoulders. And I felt that sadness,” de Armas said. “She was all I thought about. She was all I dreamed about. She was all I talked about… It was beautiful. “
“Blonde” has been hotly anticipated for some time: For taking on a figure like Monroe in an experimental way, for its rating, the first ever NC-17 movie that Netflix has made, a designation set by the Motion Picture Association that forbids those younger than 17 from watching the film in the theater. There’s also curiosity around de Armas’s performance. The Cuba-born actor worked with a dialect coach for a year to prepare.
“Storytelling that is as brave as this is essential,” her co-star Brody said.
And for him, de Armas did more than just play the role. She channeled the person.
“The first day of filming, I went home with this sense of awe that I had the privilege of actually working with Marilyn Monroe,” Brody said. “It’s very rare that I can say that someone transported me to another time and place.”
For de Armas, it was about the challenge.
“I did this movie to push myself… to make other people change their opinion about me,” she said, through some tears. “This movie changed my life.”
“Blonde” opens in select theaters starting Sept. 16 before becoming available on Netflix on Sept. 23. It’s one of many Oscar hopefuls launching in Venice, where it is also among the films up for the festival’s awards on Saturday.
___
Follow AP Film Writer Lindsey Bahr on Twitter: www.twitter.com/ldbahr
___
For more on the Venice Film Festival, visit: https://apnews.com/hub/venice-film-festival | https://cw33.com/entertainment-news/ap-entertainment/ap-marilyn-monroe-film-blonde-arrives-in-venice/ | 2022-09-09T00:53:22Z |
Zoning meeting to be held in Palmetto over Riviera Dunes construction
Residents are concerned over traffic and safety issues
PALMETTO, Fla. (WWSB) - The City of Palmetto will hold a discussion Wednesday evening to discuss controversial development plans within Riviera Dunes.
Residents of the area say they are concerned about traffic issues following construction of new apartments near U.S. 301 that will cause hazardous conditions and significant backups.
They say the work in waterfront residential community runs contrary to existing zoning codes, Palmetto’s Comprehensive Plan, and the Riviera Dunes Master Plan.
Steve Teeple, vice president of the board of Laguna Riviera Dunes Condo Association, tells ABC7 that the work is violating the rights of residents and could possibly cause catastrophic and dangerous traffic issues among others.
“What happens if someone has a heart attack at the wrong time of day?” Teeple asked, pointing out that over 30 units per acre is a density that far exceeds the limits of the Zoning Code and Comprehensive Plan.
“We are homeowners in this area and we want people to be able to own homes here.” Teeple added.
The meeting starts at 7 p.m. at the Bradenton Area Convention Center’s Longboat Key Room.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/06/01/zoning-meeting-be-held-palmetto-over-riviera-dunes-construction/ | 2022-06-01T17:42:58Z |
COMPANY ADDS TENURED ENGINEERING & FINANCE LEADERS
SAN FRANCISCO, Sept. 12, 2022 /PRNewswire/ -- Tesorio, an A/R Cash Flow Performance Platform, today announces two new executive hires. Yogesh Bhumralkar joins as the company's new VP of Engineering and Max Dame as its new VP of Finance & Operations.
"Since raising our Series B earlier this year we've been focused on building out an exec team with deep SaaS and CFO software expertise. I'm thrilled to welcome Yogesh and Max to Tesorio, who complete our executive team, bring seasoned industry perspective, and allow us to spring forward on our R&D and finance operations," said Tesorio's CEO & Co-Founder Carlos R. Vega.
Tesorio's platform helps the world's best finance teams at companies like Slack, Box, Veeva Systems, Twilio and Domo turn revenue into cash and reinvest capital tied up in balance sheets to grow more efficiently. These strategic new hires come on the heels of the company's recent addition of GTM execs and fundraise while it expands to focus on product development that drives the future of cash flow performance.
"I've spent most of my career building software products that improve customers' lives through technology and I look forward to applying that knowledge at Tesorio. I admire Tesorio's strong culture and I'm really excited to work with its incredible team," said Yogesh Bhumralkar, Tesorio's new VP of Engineering.
Yogesh is an engineering leader with 15+ years of experience developing and managing mission-critical SaaS applications and high-performing engineering businesses that deliver great products to customers. Prior to Tesorio, Yogesh served in engineering leadership roles at Bill.com, Intuit and Samsara. His responsibilities at Tesorio will include leading all engineering and product development activities.
"It was a natural fit for me to join Tesorio because our finance customers are also my peers, so I understand the challenges they face. Tesorio has a proven product market fit and I'm excited to help grow the company to the next level," said Max Dame, Tesorio's new VP of Finance and Operations.
Max is an experienced finance and accounting executive with a history of working in SaaS and marketing technology at startups and large corporations. He previously held managerial roles at Formation, Schneider Electric and Kenandy. At Tesorio, Max will focus on scaling the finance and operations functions, while also bringing his expertise to help advance the product and serve as a voice for finance leaders.
To learn more about Tesorio, visit https://www.tesorio.com/live-demo
Tesorio is revolutionizing the way mid-market businesses manage their Accounts Receivables. In a world where it's all about cash flow, Tesorio's A/R Cash Flow Performance Platform turns revenue into cash now. Improving cash flow performance is critical in a time of inflation and rising interest rates—Tesorio helps businesses accelerate their collections and put them at the front of the line to get paid first. Tesorio is trusted by the world's best finance teams at companies like Slack, Box, Veeva Systems, Twilio, Domo, and others. The company has raised a total of $37.6 million in funding to date from investors such as BAMCAP, First Round Capital, Floodgate, Madrona Venture Group, and Y Combinator.
For more information, visit https://www.tesorio.com.
Contact: pr@tesorio.com
View original content to download multimedia:
SOURCE Tesorio | https://www.mysuncoast.com/prnewswire/2022/09/12/ar-cash-flow-performance-platform-tesorio-rounds-out-exec-team/ | 2022-09-12T15:07:33Z |
5 things to know for May 3: Roe v. Wade, Ukraine, Covid, Capitol riot, India heatwave
By Alexandra Meeks, CNN
Work smarter, not harder. Some people assume that you need a six-figure income to retire decades early, but that’s not necessarily the case. Check out these valuable saving and investing strategies from a man who retired when he was only 33 — when his income topped out at around $70,000.
Here’s what you need to know to Get Up to Speed and On with Your Day.
(You can get “5 Things You Need to Know Today” delivered to your inbox daily. Sign up here.)
1. Roe v. Wade
In a stunning breach of Supreme Court confidentiality and secrecy, Politico has obtained what it calls a draft of a majority opinion written by Justice Samuel Alito that would strike down Roe v. Wade — the law that affirms a woman’s right to have an abortion. The draft was circulated in early February, according to Politico. The final opinion has not been released and votes and language can change before opinions are formally released. The opinion in this case is not expected to be published until late June. CNN has not independently confirmed the document’s authenticity. Politico says it has authenticated the draft. The opinion would be the most consequential abortion decision in decades and transform the landscape of women’s reproductive health in America.
2. Ukraine
US and Western officials believe Russian President Vladimir Putin could formally declare war on Ukraine as soon as May 9. The declaration would enable the full mobilization of Russia’s reserve forces. Western officials have long believed that Putin would leverage the symbolic significance and propaganda value of May 9 to announce either a military achievement in Ukraine, a major escalation of hostilities — or both — because it would coincide with “Victory Day” inside of Russia, which commemorates the country’s defeat of the Nazis in 1945. Meanwhile, tensions remain heightened at the besieged Azovstal steel plant, where a commander among the Ukrainian soldiers said yesterday that the complex is under “constant fire” as hundreds of civilians try to evacuate.
3. Coronavirus
The US is likely to record its 1 millionth reported Covid-19 death in the next few weeks, according to data from Johns Hopkins University. This comes as public health officials are urging people to get booster shots months after vaccination to slow the spread of the virus. While more than three-quarters of the country has received at least one dose of a Covid-19 vaccine, less than one-third has received a booster. A detailed look at the CDC’s latest data shows that 77.6% of Americans — or nearly 258 million people — have received at least one dose of the vaccine. However, only about 30% of the total population has received a booster. For this reason, officials have moved away from that term “fully vaccinated” and instead encourage people to stay “up to date,” which means getting a booster when eligible.
4. Capital riot
Ivanka Trump cooperated with the House select committee investigating the January 6, 2021, attack on the US Capitol, according to the committee’s chairman. In a recent exclusive interview with CNN, Rep. Bennie Thompson said Ivanka Trump provided the most extensive account yet of the state of play inside the White House, as well as then-President Donald Trump’s state of mind that day. A person close to the Trump family told CNN the former President’s children never saw a reason not to cooperate with the committee because none of them felt appearing before the panel put them at any risk. Some of Trump’s former advisers, however, have been less willing to testify. Yesterday, three additional GOP lawmakers received letters asking that they voluntarily cooperate with the ongoing probe. But two of them, Reps. Andy Biggs of Arizona and Ronny Jackson of Texas, made it clear they will not cooperate with the investigation.
5. India heatwave
Extreme heat in India is “testing the limits of human survivability,” according to a climate expert. Last month, New Delhi saw seven consecutive days over 40 degrees Celsius (104 Fahrenheit). In some states, the heat has damaged crops and put pressure on energy supplies as officials warned residents to remain indoors and keep hydrated. The heatwave has also been felt by India’s neighbor Pakistan, where the cities of Jacobabad and Sibi in the country’s southeastern Sindh province recorded highs of 47 degrees Celsius (116.6 Fahrenheit) on Friday. Experts say India is among the countries expected to be affected the hardest by the impacts of the climate crisis, and will likely endure more frequent and longer heatwaves in the future.
BREAKFAST BROWSE
Here’s what stars wore at the Met Gala
Some celebrities embraced the “Gilded Glamour” theme, but others marched to the beat of their own drum — because why not? Fashion has no limits!
Jackie Robinson All-Star Game bat sells for $1.08 million
Legendary! The seven-figure price tag places the bat among the most expensive pieces of sports memorabilia.
Inside the space hotel scheduled to open in 2025
Have you heard the buzz about the space hotel? Yes, it’s happening. And yes, the room rates will likely be astronomical.
Watch this adorable toddler steal the show at his parents’ wedding
If you’re a sucker for cute viral videos, here’s another one to make you smile!
A CNN story helped a former refugee find the mystery woman who gave her $100 on a plane decades ago
Some people enter your life at the right time and right place. This is one of those beautiful instances.
TODAY’S NUMBER
$3 billion
That’s how much the Biden administration is investing in lithium ion battery production. The bipartisan infrastructure package is an effort to fight climate change, but also to make the US more energy independent with electric vehicles, officials said, as Russia’s invasion of Ukraine has disrupted global oil markets.
TODAY’S QUOTE
“To know I have three living survivors that are here with me right now [to] feel this partial victory, it means everything.“
— Attorney Damario Solomon-Simmons, celebrating a judge’s ruling yesterday allowing a lawsuit seeking reparations for the 1921 Tulsa Race Massacre to move forward. The 2021 lawsuit, which names 11 plaintiffs, looks to not only set the record straight on what took place between May 31 and June 1, 1921, but also create a special fund for survivors and descendants of the massacre that left at least 300 Black people dead and the once-booming neighborhood of Greenwood destroyed.
TODAY’S WEATHER
Check your local forecast here>>>
AND FINALLY
It’s Teacher Appreciation Day!
Send a positive message to an educator you know to brighten their day! And if you have a few minutes, watch this impressive classroom prank. This teacher really went the extra mile to fool his students! (Click here to view)
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/news/national-world/cnn-national/2022/05/03/5-things-to-know-for-may-3-roe-v-wade-ukraine-covid-capitol-riot-india-heatwave-2/ | 2022-05-03T11:26:09Z |
GÖTEBORG, Sweden, June 20, 2022 /PRNewswire/ -- Imagine a truck that only emits water vapor, produces its own electricity onboard and has a range of up to 1 000 km. It's possible with fuel cells powered by hydrogen, and Volvo Trucks has started to test vehicles using this new technology.
To decarbonize transport, Volvo Trucks already today offers battery electric trucks and trucks that run on renewable fuels, such as biogas. In the second half of this decade, a third CO2-neutral option will be added to its product portfolio – fuel cell electric trucks powered by hydrogen.
"We have been developing this technology for some years now, and it feels great to see the first trucks successfully running on the test track. The combination of battery electric and fuel cell electric will enable our customers to completely eliminate CO2 exhaust emissions from their trucks, no matter transport assignments," says Roger Alm, President of Volvo Trucks.
The fuel cell electric trucks will have an operational range comparable to many diesel trucks – up to 1000 km – and a refueling time of less than 15 minutes. The total weight can be around 65 tons or even higher, and the two fuel cells have the capacity to generate 300 kW of electricity onboard.
Customer pilots will start in a few years from now and commercialization is planned for the latter part of this decade.
"Hydrogen-powered fuel cell electric trucks will be especially suitable for long distances and heavy, energy-demanding assignments. They could also be an option in countries where battery charging possibilities are limited," says Roger Alm.
Generates its own electricity
A fuel cell generates its own electricity from the hydrogen onboard instead of being charged from an external source. The only biproduct emitted is water vapor.
Fuel cells delivered by cellcentric
The fuel cells will be supplied by cellcentric – the joint venture between the Volvo Group and Daimler Truck AG. Cellcentric will build one of Europe's largest series production facilities for fuel-cells, specially developed for heavy vehicles.
More green hydrogen needed
Fuel cell technology is still in an early phase of development and there are many benefits with the new technology, but also some challenges ahead. One of them is large-scale supply of green hydrogen*. Another is the fact that refueling infrastructure for heavy vehicles is yet to be developed.
"We expect the supply of green hydrogen to increase significantly during the next couple of years, since many industries will depend on it to reduce CO2. However, we cannot wait to decarbonize transport, we are already running late. So, my clear message to all transport companies is to start the journey today with battery electric, biogas and the other options available. The fuel cell trucks will then be an important complement for longer and heavier transports in a few years from now", says Roger Alm.
* Green hydrogen is produced by using renewable energy sources, such as wind, water and sun.
June 20, 2022
LINK to high resolution images
LINK to film (1 min)
LINK to film with more details (2 min)
For further information, please contact:
Jan Strandhede
Media Relations Director, Volvo Trucks
jan.strandhede@volvo.com
+46 31 323 3715
Press images and films are available in the Volvo Trucks image and film gallery at http://images.volvotrucks.com
Volvo Trucks supplies complete transport solutions for discerning professional customers with its full range of medium- and heavy-duty trucks. Customer support is provided via a global network of dealers with 2,200 service points in about 130 countries. Volvo trucks are assembled in 13 countries across the globe. In 2021 approximately 123,000 Volvo trucks were delivered worldwide. Volvo Trucks is part of the Volvo Group, one of the world's leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The group also provides complete solutions for financing and service. Volvo Trucks' work is based on the core values of quality, safety and environmental care.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE AB Volvo | https://www.mysuncoast.com/prnewswire/2022/06/20/volvo-trucks-showcases-new-zero-emissions-truck/ | 2022-06-20T20:16:37Z |
BEIJING (AP) — Shanghai is moving to allow in-person dining and reopening its Disney Resort theme park as domestically transmitted cases of COVID-19 in China’s largest city remain at zero following a more than two-month lockdown.
Chinese officials hail their hardline “zero-COVID” policy for stemming the growth of cases and deaths from the virus, despite the enormous cost to the Chinese economy and international supply chains reliant on China’s manufacturing and shipping abilities that have been thrown askew.
China has repeatedly defended the policy and indications are it will maintain “zero-COVID” at least through the spring of 2023, when President Xi Jinping is expected to be installed for a third five-year term as head of the world’s second-largest economy and a rising competitor to the United States in the Indo-Pacific region.
In remarks carried by the official Xinhua News Agency, Xi on Wednesday said China’s policies against the virus have “protected people’s lives and health to the greatest extent.”
Xi was speaking during a visit to the central city of Wuhan, where the virus was first detected in late 2019 before the outbreak of the pandemic that has killed more than 6.3 million people worldwide, according to a tally by Johns Hopkins University in the United States.
“If China had adopted the ‘herd immunity’ policy or a hands-off approach, given its large population, the country would have faced catastrophic consequences,” Xinhua quoted Xi as saying.
“Even if there are some temporary impacts on the economy, we will not put people’s lives and health in harm’s way, and we must protect the elderly and the children in particular,” Xi said, according to Xinhua.
Having associated himself so closely with “zero-COVID,” any backdown by Xi would be seen as a political liability as he seeks to ensure his further control of domestic power and influence abroad.
China’s tough approach, which involves lockdowns on hundreds of millions of people, mass testing costing billions of dollars and quarantines upending thousands of lives “are the most economical and effective,” Xinhua reported Xi as saying.
Xi also warned against “any tendency to let down guard, grow weary of the fight, or slacken prevention and control efforts.”
Despite the loosened restrictions, a negative test result on your mobile phone is still required for access to most public spaces in Shanghai and other cities.
Shanghai resident Amber Liu said she had long been hoping to leave the city for Chinese holiday destinations, such as the tropical island beaches of Sanya or the mountains and deserts of Yunnan, Tibet, and Xinjiang. Quarantine restrictions still made that difficult, if not impossible, she said.
“It’s a tricky kind of normalcy,” Liu said. “I think life is surreal now. It feels like there’s still a long way to go before a full recovery. … Everyone is resigned to the situation.” | https://cw33.com/health/ap-health/covid-restrictions-ease-in-shanghai-as-case-numbers-drop/ | 2022-07-01T00:15:21Z |
Pfizer CEO tests positive for COVID-19
Published: Aug. 15, 2022 at 12:22 PM EDT|Updated: 20 minutes ago
(AP) - The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.
Chairman and CEO Albert Bourla said that he started taking Pfizer’s Paxlovid pill treatment, and he’s staying in isolation while he recovers.
Bourla said Monday in a brief statement from the drugmaker that he has received four shots of Comirnaty, the COVID-19 vaccine developed by both Pfizer and German drugmaker BioNTech, and he is confident that he will recover quickly.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/08/15/pfizer-ceo-tests-positive-covid-19/ | 2022-08-15T16:44:01Z |
Givex and Counter Solutions can be found at CD 737 at ExCel in London from September 14 to 15.
TORONTO, Sept. 13, 2022 /PRNewswire/ - Givex Information Technology Group Ltd. ("Givex") (TSX: GIVX) announced today it will exhibit at the definitive restaurant, pub and bar event Casual Dining at ExCeL in London September 14-15 with recently-acquired UK-based Counter Solutions.
Casual Dining marks the first trade show that Givex and Counter Solutions will present together after the acquisition was completed in August. At CD 737, Givex will be showcasing its leading point-of-sale system, GivexPOS along with its Kitchen Display System (KDS), Stock System and loyalty and gift card products, while Counter Solutions will demonstrate its kiosk and WAY2PAY unattended retail functionality.
"We are thrilled at how quickly and thoughtfully the Counter Solutions and Givex teams collaborated in a few short weeks to prepare to display our new collective capabilities," said Jurgen Ketel, Managing Director of Givex EMEA. "Our products perfectly complement each other, and we are able to show both new and existing clients how seamlessly our products work together to create efficiencies that are simply not found through other providers."
Counter Solutions' WAY2PAY platform offers micro market & smart-refrigeration technology which allows customers to purchase products from controlled access chillers using their payment card, Apple Pay and Google Pay.
"In addition to our products being aligned and allowing us to offer new and exciting products to our respective client bases, one of the primary reasons we chose to partner with Givex is because of the depth of its team," said Richard Bernans, Managing Director of Counter Solutions. "Both teams worked hard to ensure that we were ready to present together at Casual Dining, and we are excited to be able to showcase new and innovative solutions at the show for our clients across the globe."
Givex (TSX: GIVX) (OTCQX: GIVXF) is a global fintech company providing merchants with customer engagement, point of sale and payment solutions, all in a single platform. We are integrated with 1000+ technology partners, creating a fully end-to-end solution that delivers powerful customer insights. Our platform is used by some of the world's largest brands, comprising approximately 116,000 locations across more than 100 countries. Learn more at givex.com.
View original content to download multimedia:
SOURCE Givex | https://www.wibw.com/prnewswire/2022/09/13/global-fintech-company-givex-recently-acquired-counter-solutions-exhibit-together-londons-casual-dining-trade-show/ | 2022-09-13T11:34:14Z |
Denison prepares for road test against Reedy
Denison prepares for Reedy
DENISON, Texas (KXII) - After securing their tenth straight victory over Sherman in the historic Battle of the Axe game, the Denison Yellow Jackets now face another tough test to start the season as they travel down to Frisco to take on the Reedy Lions at the Star.
For head coach Brent Whitson and his squad, this week is all about moving forward and taking down a very strong Reedy team that was able to easily take down their week one opponent with a 42 point victory.
Coach Whitson said, “We have to be physical defensively, their front five offensively and their tight end are big. Then offensively we have to hold on to the football. We know that we have a challenge in front of us, and I like the fact that we do so that we’re focused on it.”
Copyright 2022 KXII. All rights reserved. | https://www.kxii.com/2022/08/31/denison-prepares-road-test-against-reedy/ | 2022-08-31T04:32:31Z |
From the Metaverse to Artificial Intelligence, Industry Experts Touch on Some of the Most Prominent Topics in Computer Graphics
CHICAGO, Aug. 8, 2022 /PRNewswire/ -- SIGGRAPH 2022 presents its lineup for its Featured Speakers program. Industry experts will discuss a variety of topics from artificial intelligence and the metaverse to accelerated computing and digital realities. Their talks will cover themes such as the advancements and evolution in technology, their personal and professional experiences, and how art, design, and technology can be blended to create amazing storytelling. The 49th annual conference will run 8–11 August in person, and virtually 25 July–31 October 2022.
"We're honored to have these distinguished and notable Featured Speakers at SIGGRAPH 2022," said Munkhtsetseg Nandigjav, SIGGRAPH 2022 Conference Chair. "Our community continues to create and merge art, design, and technology, developing and innovating for the future, and our celebrated speakers are a big part of this progression. Having Sougwen Chung, Ed Catmull, Pat Hanrahan, Sarah Bond, and Ime Archibong, among others, share their experiences with us is a unique distinction that only SIGGRAPH can provide. Their talks on how the various disciplines in the SIGGRAPH community can help the industry move forward and grow will be invaluable."
Featured Speaker: Sougwen 愫君 Chung
Monday, 8 August 2022
9–10:15 am PT
Sougwen Chung's performance lecture, 'Seeing Double—Bridging Dualities with Relational Intelligence' questions: Where does "AI" end and "we" begin? Chung's ever-evolving work in human and machine collaboration builds upon a decade-long international journey. Starting with a simple line, the process has led to interdisciplinary insights, philosophical inquiry, and technological invention through pioneering artistic practice. Intertwining perspectives in art and science, Chung's practice envisions alternative futures for the relationship of humans and machines.
Bio:
Sougwen 愫君 Chung is a Chinese-Canadian artist and researcher, and is the founder and artistic director of Scilicet, a London-based studio exploring human & non-human collaboration. Chung is a former research fellow at MIT's Media Lab and is considered a pioneer in the field of human-machine collaboration—exploring the mark-made-by-hand and the mark-made-by-machine as an approach to understanding the dynamics of humans and systems.
Turing Award Lectures
Featured Speakers: Ed Catmull and Pat Hanrahan
Monday, 8 August 2022
2:15–3:15 pm PT
Ed Catmull and Pat Hanrahan will discuss the history and advancements of the computer graphics industry in a combined session. In "Shading Languages and the Emergence of Programmable Graphics Systems," Hanrahan charts the path of shading languages; first pioneered by Ken Perlin and Rob Cook, then becoming widely available in Pixar's RenderMan. This talk will review their history and discuss the broader implications for computing and the future of computer graphics.
With "The Wild, Unexpected, Exponential Ride Through Computer Graphics," Catmull will address the early belief in the promise of computer graphics, the depiction of the research in graphics as impractical, the incorporation of graphics in workstations, the role of the SIGGRAPH community leading to advances enabling movies, the incorporation of algorithms in GPUs, and the exponential rise of computing power in those GPUs driven by the game industry leading to completely unexpected results.
Bio:
Pat Hanrahan is the Canon Professor of Computer Science and Electrical Engineering in the Computer Graphics Laboratory at Stanford University. His research focuses on rendering algorithms, graphics processing units, and visualization. As a founding employee at Pixar Animation Studios in the 1980s, Hanrahan was part of the design of the RenderMan Interface Specification and the RenderMan Shading Language.
Bio:
Dr. Ed Catmull is a co-founder of Pixar Animation Studios and served as president of Pixar for 33 years, while also serving as president of Walt Disney Animation Studios for 13 of those 33 years. Catmull founded three of the leading centers of computer graphics research—including the computer division of Lucasfilm Ltd. and Pixar Animation Studios. Catmull earned B.S. degrees in physics and computer science and a Ph.D. in computer science from the University of Utah.
Featured Speaker: Sarah Bond
Tuesday, 9 August 2022
9–10 am PT
In her fireside chat, Sarah Bond will discuss "How Digital Worlds Today Can Make the Real World Better Tomorrow." Bond will address how gaming inspires empathy by fostering collaboration and enabling players to experience different perspectives. With 3D interactive experiences evolving from gaming to non-gaming environments, there will be an explosion of incredible content from a wave of new creators. As people experience the world through their screens, now more than ever, these worlds need to be built inclusively to cultivate their unique ability to break barriers, spark imagination, and create empathy.
Bio:
Sarah Bond is the corporate vice president of the Game Creator Experience and Ecosystem at Xbox. She leads the company's engineering, business, and strategy to grow creator success, helping them create and publish more games, and reach more players on any device. Prior to Microsoft, Bond was a senior leader at T-Mobile and an Associate Partner at McKinsey. She holds a B.A. in Economics from Yale University and an MBA from Harvard Business School. Bond sits on the Board of Councilors at the USC School of Cinematic Arts, as well as the Board of Directors at the Entertainment Software Association (ESA), Zuora, and CHEGG.
Featured Speaker: Ime Archibong
Thursday, 11 August 2022
2:15–3:45 pm PT
Ime Archibong will speak to how contributors to the computer graphics and interactive techniques community can—and should—help design the future, including the metaverse. In this fireside chat, he will talk about experimentation as an approach to innovation, share some examples of innovative ways people with a design mindset from around the world are more empowered than ever to build, and why it's so important that designers of all expertise help make the next era a reality.
Bio:
Ime Archibong is Head of New Product Experimentation (NPE) at Meta, where he leads the unit testing new product experiences outside of Meta's main platforms. He was previously the company's Vice President of Product Partnerships, where he built the global team that worked with startups and developers to build new products with Meta's platform tools and technology. Archibong is a listed inventor on more than a dozen technical patents. He holds a B.S. in Electrical Engineering and Computer Science from Yale University and an MBA from the Stanford Graduate School of Business.
Presented by NVIDIA: NVIDIA Special Address at SIGGRAPH 2022
Featured Speakers: Jensen Huang, NVIDIA; Rev Lebaredian, NVIDIA; Sanja Fidler, NVIDIA/University of Toronto, Ontario; Simon Yuen, NVIDIA; and Steven Parker, NVIDIA
Tuesday, 9 August 2022
9–10 am PT
Computer graphics is one of the most challenging computer science problems of our time. With GPU accelerated computing, AI, and physically accurate virtual world simulation, NVIDIA continues to deliver generational leaps to advancing the field of graphics. 3D worlds are no longer just for fun and games but for solving the world's most challenging important problems. Join NVIDIA's CEO and senior leaders for a special address at SIGGRAPH 2022 to get a glimpse into the future of AI-infused virtual worlds that provide new frontiers for artistic expression and creativity, or perfectly replicate nature's systems — and the research and technology that power them.
Bio:
NVIDIA founder Jensen Huang has served as president, chief executive officer, and a member of the board of directors. Starting out in PC graphics, NVIDIA helped build the gaming market into the largest entertainment industry in the world today. The company's invention of the GPU made possible real-time programmable shading, which defines modern computer graphics, and later revolutionized parallel computing. He holds a B.S. in electrical engineering from Oregon State University and an M.S. in electrical engineering from Stanford University in California.
Bio:
Rev Lebaredian is vice president of Omniverse and simulation technology at NVIDIA. For the last five years at NVIDIA, he and his teams have been combining the rendering, physics simulation, and artificial intelligence technologies pioneered by NVIDIA into a single platform for creating and simulating physically accurate virtual worlds — NVIDIA Omniverse. Lebaredian continues to lead the Omniverse product, engineering, and research teams.
Bio:
Sanja Fidler is an associate professor at the Department of Computer Science, University of Toronto, Ontario. She is also the vice president of AI research at NVIDIA. Previously, she was a research assistant professor at TTI-Chicago, a philanthropically endowed academic institute located on the campus of the University of Chicago, Illinois.
Bio:
Simon Yuen is senior director of avatar technology at NVIDIA where he leads the digital human efforts with the goal of developing new character technology and deep learning-based solutions that allow new and more efficient ways of creating high-quality digital characters. Prior to NVIDIA, Yuen spent over 21 years in the visual effects industry, straddling both the art and technology sides of the problem at many studios including Method Studios, Digital Domain, Sony Pictures Imageworks, Dreamworks, Blizzard Entertainment, and others, building teams and technologies that push the envelope of photorealistic digital character creation.
Bio:
Dr. Steven Parker is vice president of professional graphics at NVIDIA Corporation, where he holds responsibility for several ray tracing technologies, including NVIDIA RTX™ drivers and APIs such as NVIDIA OptiX™, the RTX™ rendering systems in NVIDIA Omniverse™, the Material Definition Language, and the NVIDIA IndeX® scientific visualization system. Combining a history of ray tracing, rendering, and high-performance computing, Parker has been focused on bringing physically based rendering systems to interactive applications.
Presented by Hexagon AB: Even Better Than the Real Thing: Worldbuilding With Digital Twins and AI
Featured Speaker: Burkhard Boeckem
Wednesday, 10 August 2022
9–10 am PT
Burkhard Boeckem, chief technology officer at Hexagon AB, will unveil a new category of digital reality technologies that fundamentally change how we think about worldbuilding, design, and production. Burkhard's passion is the democratization of digital realities, which led to Hexagon's development of the Leica BLK line of laser scanners, the launch of HxDR, a powerful visualization and collaboration platform, and recently led to the acquisition of Immersal, an AR technology for spatial mapping and anchoring. Discover the massive potential digital realities hold for worldbuilding, visualization, and immersive storytelling — from VFX to AEC, from metaverse to virtual production — in a world where ideas know no constraints.
Bio:
Burkhard Boeckem is the CTO of Hexagon AB and has worked in the geospatial industry for over 20 years. As CTO, he is responsible for driving innovation and development of Hexagon's autonomous technology vision. Throughout his career, he has focused on R&D, delivering innovation in digital reality, and working with the latest advances in disruptive technologies, such as AI and 5D visualization. Boeckem holds an M.S. in geodesy from the University of Bonn in Germany, and a PhD from the Swiss Federal Institute of Technology (ETH Zurich).
Presented by Unity: Lion: A Glimpse of the Future With Unity Art Tools
Featured Speakers: James Jacobs, Unity Technologies; Sara Hansen, Unity Technologies; Anton Blake, Moving Picture Company/Monster Emporium; Julio Cesar Garcia, Rocket Science VFX
Wednesday, 10 August 2022
2:15–3:15 pm PT
Watch the premiere of Unity's latest demo, Lion. This production features innovations in real-time technology that shows content created with Ziva, Wētā Digital, SyncSketch, SpeedTree, and the Unity Editor artist tools. Lion showcases plans to help artists create boundary-pushing visuals, as well as foundations for richer creator workflows.
Bio:
James Jacobs is a Sci-Tech Academy Award-winning VFX artist with over 25 years of expertise. He has held leadership positions at Weta Digital, Digital Domain, DreamWorks, Mr. X, and Method Studios. In 2015, James cofounded Ziva Dynamics, a company dedicated to solving challenging and high-value character obstacles in media and entertainment. At Unity, he leads the continued development of Ziva tools and finds new ways to bring the realism and quality of film characters into the game/real-time industry.
Bio:
Sara Hansen is a CG generalist with 11 years of VFX industry experience. With more than 25 film and television projects, her experience spans multiple areas in CG including texturing, look development, layout, lighting, hair, simulation, and rendering. Her work led her to Wētā Digital as a groom artist, and she joined Ziva in 2020, where she now collaborates with Unity. She is passionate about creating assets from start to finish, using a mix of her technical and artistic skill sets.
Bio:
Anton Blake has been a professional animator for 13 years, having worked in film, TV, and game industries. After contributing to "The Lion King," he chose to explore teaching and mentorship, starting with a tutorial based on the cubs from the film. The popularity of this tutorial motivated Anton to create entire animation workshops, eventually leading to Monster Emporium. He now works at MPC during the day and runs the Monster Emporium school at night.
Bio:
Julio Cesar Garcia is a VFX pipeline developer who enjoys mixing technology and art. He is currently working at Rocket Science VFX in Toronto. Julio's strong passion for animal behavior led him to apply his knowledge to creature animation and simulation. In 2020, he joined Monster Emporium as pipeline developer and creature TD, where he develops new technologies and improves creature assets.
Presented by AMD: The Collision of Technology and Art
Featured Speakers: James Knight, AMD; Dylan Sisson, Pixar; Leif Pedersen, Pixar; and Francois Chardavoine, Lucasfilm
Thursday, 11 August 2022
9–10am PT
This address with James Knight, Dylan Sisson, Leif Pedersen, and Francois Chardavoine will discuss how technology and art push each other to benefit great storytelling. Using examples of how some of the world's best creatives leverage advanced computing, giving artists more time with their pixels, they will explore how the creative sandbox is bigger and deeper than ever before.
Bio:
Dylan Sisson, marketing manager, Pixar Animation Studios, is an accomplished artist with more than 20 years of experience in feature film visual effects, combining a deep knowledge of computer graphics with a traditional background of painting, illustration, and toy design. Sisson brings a unique artistic style and a record of creative leadership to a diverse portfolio of work.
Bio:
James Knight is the global director of media and entertainment at AMD (Advanced Micro Devices), where he supports video streaming, VFX, virtual production, and post-production computing applications for the largest media brands, studios, and content streaming platforms in the world. Knight's work spans two decades in production, post-production, real-time visual effects, and virtual production.
Bio:
Leif Pedersen has more than 15 years of production experience. He is a RenderMan specialist and CG generalist on Pixar's RenderMan team, where he loves to showcase some of the most artistic and technical aspects of the renderer.
Bio:
As the chief technology officer, Francois Chardavoine is responsible for all aspects of global studio technology for Lucasfilm, Industrial Light & Magic, and ILMxLAB. With more than 20 years of experience in the VFX and animation industry, he is also a member of the VES Technology Committee and co-chair of the Academy of Motion Picture's Science and Technology Awards subcommittee.
Access to the Featured Speakers program at SIGGRAPH 2022 is available in person and online. Learn more and register for the conference at s2022.SIGGRAPH.org/register.
About ACM, ACM SIGGRAPH, and SIGGRAPH 2022
ACM, the Association for Computing Machinery, is the world's largest educational and scientific computing society, uniting educators, researchers, and professionals to inspire dialogue, share resources, and address the field's challenges. ACM SIGGRAPH is a special interest group within ACM that serves as an interdisciplinary community for members in research, technology, and applications in computer graphics and interactive techniques. The SIGGRAPH conference is the world's leading annual interdisciplinary educational experience showcasing the latest in computer graphics and interactive techniques. SIGGRAPH 2022, the 49th annual conference hosted by ACM SIGGRAPH, will take place as a hybrid event, with live events 8–11 August at the Vancouver Contention Centre and virtual content available starting 25 July through 31 October. Click here for news from the conference and its partners.
View original content to download multimedia:
SOURCE SIGGRAPH | https://www.mysuncoast.com/prnewswire/2022/08/08/siggraph-2022-presents-its-lineup-featured-speakers/ | 2022-08-08T13:21:55Z |
COLOMBO, Sri Lanka (AP) — A Rajapaksa political ally was appointed Sri Lanka’s prime minister Friday, hours after army troops and police forcefully cleared the main protest site occupied for months by demonstrators angry at the Rajapaksas over the country’s economic collapse.
The overnight raid occurred even though protesters had announced they would vacate the site on Friday voluntarily, and the U.N., U.S. and others denounced the heavy-handed force that was used. A lawyer said several protesters were hospitalized for injuries and that journalists and a lawyer were among people arrested.
Sri Lankans have taken to the streets for months demanding their leaders resign over an economic crisis that has left the island nation’s 22 million people short of essentials like medicine, food and fuel. Last week, the protests forced out former President Gotabaya Rajapaksa, whose family has ruled Sri Lanka for most of the last two decades.
The prime minister he appointed in May to lead negotiations for a bailout of the bankrupt country succeeded him. Ranil Wickremesinghe was elected president by lawmakers, and he appointed as his own successor his school classmate Dinesh Gunawardena, who is 73 and from a prominent political family.
On Monday, when he was acting president, Wickremesinghe declared a state of emergency giving him the power to change or suspend laws and giving authorities broad power to search premises and detain people. On Friday, he issued a notice under the state of emergency calling out the armed forces to maintain law and order nationwide.
Before dawn, troops and police cleared the main protest camp near the presidential palace in the capital, Colombo, where demonstrators have gathered for the past 104 days. Army and police staff arrived in trucks and buses around midnight, removing tents and blocking roads leading to the site.
Security forces were seen beating up at least two journalists. At least two lawyers also were assaulted when they went to the protest site to offer their counsel, said the Bar Association of Sri Lanka, the main lawyers’ body in the country.
Some protesters were badly injured and some protesters and lawyers were arrested, said Harshani Siriwardana, a lawyer and a protester.
The Bar Association called for a halt to the “unjustified and disproportionate actions” of armed forces targeting civilians. It called on Wickremesinghe to ensure he and his government respected the rule of law and citizens’ rights.
“The use of the Armed Forces to suppress civilian protests on the very first day in office of the new President is despicable and will have serious consequences on our country’s social, economic and political stability,” the association said in its statement.
The leader of the political opposition, Sajith Premadasa, tweeted, “A cowardly assault against PEACEFUL protestors, who agreed to vacate the sites today; A useless display of ego and brute force putting innocent lives at risk & endangers Sri Lanka’s international image, at a critical juncture.”
Hanaa Singer-Hamdy, the U.N. resident coordinator to Sri Lanka, expressed grave concern over the use of force and said journalists and human rights defenders should not be impeded when they monitor demonstrations. “Actions that stifle protests and the right to peaceful assembly can worsen economic and political instability in Sri Lanka,” Singer-Hamdy said.
U.S. Ambassador Julie Chung also expressed concern. “We urge restraint by authorities and immediate access to medical attention for those injured,” she said in a tweet.
Heavy security was present outside the president’s office at midday.
Earlier this week, Wickremesinghe said bailout talks with the International Monetary Fund were near a conclusion and talks on help from other countries had also progressed. He also said the government has taken steps to resolve shortages of fuel and cooking gas.
Even after restoring order and installing a new government, the outlook for reaching agreement on a bailout remains unclear. The head of the IMF, Kristalina Georgieva, told the Japanese financial magazine Nikkei Asia this week that the fund hopes for a deal “as quickly as possible.”
But Wickremesinghe said earlier this month that the task was proving difficult because Sri Lanka is effectively bankrupt. | https://cw33.com/news/international/ap-international/sri-lankan-forces-make-arrests-clear-main-protest-site/ | 2022-07-22T14:26:29Z |
TAMPA, Fla., Sept. 6, 2022 /PRNewswire/ -- Today's Dental Network, LLC ("TDN"), a leading multi-specialty dental practice network and support organization to dental providers in Florida, has officially formed a partnership with Eastman Periodontics & Implants, a multi-location dental practice led by Lindsay Eastman, DDS, MS for over 42 years. With offices in Lakewood Ranch and Bradenton, Florida, the addition of Dr. Eastman further expands the depth and geographical coverage of TDN's periodontic specialty capabilities to seven locations and the first practice location in the Bradenton market.
"As we continue to expand our footprint across new geographic markets, relationships with top clinicians like Dr. Eastman solidify our position across the West Central Florida coast and bring new opportunities for us to serve patients with best-in-class care," says Ryan Taylor, DDS, MS, head of periodontics at TDN.
Established in 1980, Eastman Periodontics & Implants has two state-of-the-art periodontal dental practices in Bradenton and Manatee Counties. Both incorporate the latest techniques in reconstructive periodontics, tissue engineering, dental implant placement, and were among the first to provide computer guided implant surgery in the Unites States.
"We continue to seek partnerships with clinicians who share our same values and commitment to patient care and clinical excellence," says Kevin Krause, DMD, chief executive officer for TDN. "Dr. Eastman and his team are dedicated to our mission to create a multi-specialty dental network that puts people first in every act of care, service and partnership and we are excited to welcome them to TDN."
"For me, the decision to join TDN was based on the core values and principles we share. Our practice is family run in partnership with my wife Marny, our daughter Dr. Christie Craighead and son-in-law Dr. Justin Craighead. We value integrity and treat our patients with love and compassion." says Lindsay Eastman, DDS, MS. "Like us, TDN is a people-first organization, and it is a dream come true to join a group of like-minded people."
Today's Dental Network is a premier multi-specialty concierge dental practice network and support organization focused on providing complete turnkey practice management outsourcing solutions to a captive network of best-in-class, entrepreneurial, dentist specialists & surgeons across the Southwest Florida region. The company offers a full suite of solutions and services through its centralized business office including IT systems, infrastructure & security, finance and accounting, sales & marketing solutions, human resources, risk management, legal and compliance administration, as well as acquisition and de novo practice expansion support. Today's Dental Network offers a truly integrated community network model with the depth and breadth of services and local geographic coverage to provide a true "infant-to-senior" continuum-of-care service offering through a single patient experience. For more information, please visit www.tdn.care.
HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge's partners have more than 100 years of combined operating experience in healthcare as CEOs and investors. For more information on HealthEdge, please visit www.healthedgepartners.com.
Synergistic Capital Partners is a healthcare-focused private equity firm led by healthcare experts and physicians with over a century of combined healthcare expertise. SCP generally invests solely in the healthcare services sector, where their investment methodology is rooted in patient-centered care and provider-centric values which has led to superior investment performance across their investment portfolio. To learn more about SCP, please visit: www.synergisticcapitalpartners.com.
View original content to download multimedia:
SOURCE Today's Dental Network | https://www.kxii.com/prnewswire/2022/09/06/todays-dental-network-adds-eastman-periodontics-amp-implants-partner-network/ | 2022-09-06T17:37:23Z |
Ukrainian rescue teams hunt for survivors in Vinnytsia
VINNYTSIA, Ukraine (AP) — Rescue teams with sniffer dogs combed through debris in a central Ukrainian city on Friday looking for people still missing after a Russian missile strike a day earlier that killed at least 23 people.
Russian forces, meanwhile, pounded other sites in a painstaking push to wrest territory from Ukraine and try to soften unbending morale of its leaders, civilians and troops as the war nears the five-month mark.
The cruise missile strikes on Vinnytsia launched by a Russian submarine on Thursday were the latest incidents to take civilian lives and fan international outrage since President Vladimir Putin launched the invasion on Feb. 24. The campaign now has been focusing on Ukraine’s eastern Donbas region, but Russian forces regularly fire upon targets in many parts of the country too.
Ukraine’s Interior Ministry claimed Friday that Russian forces had conducted more than 17,000 strikes on civilian targets during the war, driving millions from their homes, killing thousands of fighters and civilians and rippling through the world economy by hiking prices and crimping exports of key Ukrainian and Russian products like foodstuffs, fuel and fertilizer.
More than 73 people — including four children — remained hospitalized and 18 people were missing after Thursday’s missile strike, said Oleksandr Kutovyi, spokesman for the emergency service in the Vinnytsia region. Search teams were poring over two sites on Friday — an office building with a medical center inside, and a concert hall near an outdoor recreation area and park, where mothers with children often stroll.
Vinnytsia Gov. Serhiy Borzov said only 10 people among the nearly two dozen killed had been identified so far.
WARNING: Videos used may contain graphic content.
“Russia deliberately hit civilians and all those responsible for the crime must be brought to account,” he said, denouncing the “barbaric behavior by Russia that tramples on international humanitarian law.”
Kyrylo Tymoshenko, a deputy head of the president’s office, said three missiles were used.
“There is no answer to the question why yesterday and why in Vinnytsia,” Tymoshenko said. “We expect every second and minute that this could happen in any corner of Ukraine.”
After initial silence after the strikes on Vinnytsia, the Russian military said Friday its forces had struck an officers’ club — which the concert hall has been known for back in Soviet times. Ukrainian authorities insisted the site had nothing to do with the military.
Overall, Ukraine’s presidential office said 26 civilians have been killed and another 190 were wounded by Russian shelling over the past 24 hours. That included three other victims in the Donetsk region, which along with neighboring Luhansk — nearly totally controlled by Russian forces — makes up the broader Donbas region.
“The situation in the Donetsk region is exacerbating every day, and civilians must leave because the Russian army is using scorched earth tactics,” Donetsk Gov. Pavlo Kyrylenko said. It appeared that the cities of Kramatorsk and Sloviansk were next in line for Russian forces, but it wasn’t at all clear how soon such a push could begin in earnest.
Elsewhere, authorities in Mykolayiv said there were at least 10 explosions in the southern city overnight, accusing Russian fire of hitting universities. Vitaliy Kim, the head of Mykolaiv’s military administration, posted on social media a video of smoke rising over the strikes.
Separately, the Russian news agency Tass reported Friday, citing Russian-backed separatists, that two civilians were killed and six others were injured after Ukrainian forces allegedly shelled a bus terminal in the Voroshilovsky district of the city of Donetsk.
Also Friday, Daria Morozova, the human rights ombudsperson for the Moscow-backed separatist leadership in Donetsk, said a British “mercenary” died in captivity on Sunday. She said the man, whom she identified as Paul Urey, had died of chronic illnesses and stress.
“From our side, he was given the necessary medical assistance despite the grave crimes he committed,” she said.
___
Follow the AP’s coverage of the war at https://apnews.com/hub/russia-ukraine
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/07/15/ukrainian-rescue-teams-hunt-survivors-vinnytsia/ | 2022-07-15T10:26:26Z |
CHARLOTTE, N.C., July 8, 2022 /PRNewswire/ -- The Barings Global Short Duration High Yield Fund (the "Fund") (NYSE: BGH) announced its monthly dividend for July 2022 of $0.1056 per share, payable on August 1, 2022. Based on the Fund's June 30, 2022 share price of $13.01 per share, the distribution represents an annualized yield of 9.74% per share. Based on current projections through the payable date, the Fund expects that this distribution will be comprised of net investment income.
In addition, the Fund announced estimated monthly distributions of $0.1056 per share for August and September 2022.
The distribution schedule appears below:
The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain or return of capital. The final determination of the source and tax characteristics of these distributions will depend upon the Fund's investment experience during its fiscal year and will be made after the Fund's year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes.
The Fund is a non-diversified, closed-end management investment company that is managed by Barings LLC. The Fund invests primarily in short-duration, global high yield bonds with the objective of seeking as high a level of current income as Barings determines is consistent with capital preservation, with a secondary objective of capital appreciation. The Fund expects to maintain a weighted average portfolio duration, including the effects of leverage, of 3 years or less.
Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date in which they are made and which reflect management's current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially. These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the fund's trading intent. References to specific securities are not recommendations of such securities, and may not be representative of the fund's current or future investments. We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise.
Past performance is not necessarily indicative of future results.
About Barings
Barings is a $371+ billion* global investment manager sourcing differentiated opportunities and building long-term portfolios across public and private fixed income, real estate, and specialist equity markets. With investment professionals based in North America, Europe and Asia Pacific, the firm, a subsidiary of MassMutual, aims to serve its clients, communities and employees, and is committed to sustainable practices and responsible investment. Learn more at www.barings.com.
*Assets under management as of March 31, 2022
Contact
View original content:
SOURCE Barings | https://www.kxii.com/prnewswire/2022/07/08/barings-global-short-duration-high-yield-fund-announces-july-2022-monthly-distribution-01056-per-share/ | 2022-07-08T17:16:31Z |
16 states that want to electrify USPS fleet file lawsuits
(AP) - California and 15 other states that want the U.S. Postal Service to buy more electric delivery vehicles are suing to halt purchases of thousands of gas-powered trucks as the agency modernizes its mail delivery fleet.
Three separate lawsuits, filed by 16 states and environmental groups Thursday in New York and California, ask judges to order a more thorough environmental review before the Postal Service moves forward with the next-generation delivery vehicle program.
Plaintiffs contend that purchases of fossil fuel-powered delivery vehicles will cause environmental harm for decades to come.
“Louis DeJoy’s gas-guzzling fleet guarantees decades of pollution with every postcard and package,” said Scott Hochberg, an attorney with the Center for Biological Diversity, referring to the postmaster general.
One lawsuit was filed by the Center for Biological Diversity, Earthjustice, CleanAirNow KC and Sierra Club in San Francisco. Attorneys general from 16 states and the District of Columbia filed another suit in the same venue. Another was filed by the Natural Resources Defense Council and United Auto Workers in New York.
All of three of them target the environmental review underpinning of the Postal Service’s planned purchase of up to 165,000 next-generation delivery vehicles over the next decade.
California Attorney General Rob Bonta said it’s key to stop the process before it’s too late.
“Once this purchase goes through, we’ll be stuck with more than 100,000 new gas-guzzling vehicles on neighborhood streets, serving homes across our state and across the country, for the next 30 years. There won’t be a reset button,” he said.
The Postal Service defended its actions.
“The Postal Service conducted a robust and thorough review and fully complied with all of our obligations under (the National Environmental Policy Act),” spokesperson Kim Frum said Thursday in an email.
The Postal Service contract calls for 10% of the new vehicles to be electric but the Postal Service contends more electric vehicles can be purchased based on financial outlook and strategic considerations.
The percentage of battery-electric vehicles was doubled — to 20% — in the initial $2.98 billion order for 50,000 vehicles.
Environmental advocates contend the Postal Service’s environmental review was inadequate and flawed, and that the contract represented a missed opportunity to electrify the fleet and reduce emissions.
The review process “was so rickety and riddled with error that it failed to meet the basic standards of the National Environmental Policy Act,” said Adrian Martinez, senior attorney on Earthjustice’s Right to Zero campaign.
The Postal Service is in the process of replacing the ubiquitous delivery trucks that went into service between 1987 and 1994.
The new gasoline-powered vehicles would get 14.7 miles per gallon (23.7 kilometers per gallon) without air conditioning, compared to 8.4 mpg (13.5 kpg) for the older vehicles, the Postal Service said.
All told, the Postal Service’s fleet includes 190,000 local delivery vehicles. More than 141,000 of those are the old models that lack safety features like air bags, anti-lock brakes and backup cameras.
The new vehicles are taller to make it easier for postal carriers to grab packages and parcels that make up a greater share of volume. They also have improved ergonomics and climate control.
The states that sued are California, Connecticut, Delaware, Illinois, Maine, Maryland, Michigan, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, Vermont and Washington.
The Bay Area Air Quality Management District in California, District of Columbia and city of New York joined that lawsuit, as well.
___
Sharp reported from Portland, Maine.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/04/28/groups-that-want-electrify-usps-fleet-file-lawsuits/ | 2022-04-30T03:19:58Z |
Expect more traditional playoff hockey in NHL’s 2nd round
By STEPHEN WHYNO
AP Hockey Writer
The start of the NHL playoffs included more penalties called than any other first round in almost a decade. Referees even whistled more per game than the regular season. The first week also featured more blowouts than one-goal games and a scarcity of comebacks. The second round should look more like old-school traditional playoff hockey after the end of the first began to show signs of change. Given a lack of upsets, the eight teams are left vying for the Stanley Cup with some of the league’s best. That also should ratchet up the quality of play. | https://localnews8.com/sports/ap-national-sports/2022/05/16/expect-more-traditional-playoff-hockey-in-nhls-2nd-round/ | 2022-05-17T01:51:47Z |
Potential homebuyers and agents are invited to an open house at Villa Bella!
PUEBLO, Colo., June 20, 2022 /PRNewswire/ -- Richmond American Homes of Colorado, Inc., a subsidiary of M.D.C. Holdings, Inc. (NYSE: MDC), is pleased to announce that the new North Vista Highlands community is now open for sales out of the Villa Bella Sales Center.
The homebuilder is hosting an open house for both communities at the Villa Bella location, and potential buyers and agents are encouraged to stop by for model home tours, a complimentary lunch and a special prize drawing. The event will be on Saturday, June 25, from 12 p.m. until 3 p.m. (RichmondAmerican.com/VillaBella).
VILLA BELLA AT A GLANCE:
- New ranch and two-story homes from the mid $300s
- 14 versatile floor plans
- 2 to 4 bedrooms, approx. 1,420 to 2,540 sq. ft.
- Minutes away from I-25 and the CSU Pueblo campus
- An abundance of parks, golf courses and outdoor recreation
NORTH VISTA HIGHLANDS AT A GLANCE:
- New ranch and two-story homes from the $300s
- Seven inspired floor plans, including some from the Seasons™ Collection
- 3 to 6 bedrooms, approx. 1,120 to 2,540 sq. ft.
- Easy access to shopping, golf courses, recreation and schools, including CSU Pueblo
- Close proximity to I-25
Those who choose to build a new home from the ground up at Villa Bella or North Vista Highlands will have the opportunity to work with professional design consultants to select colors, textures, finishes and fixtures for their new living spaces—a complimentary service!
The Villa Bella Sales Center is located at 2502 Torino Way in Pueblo.
Call 719.637.4751 to RSVP or visit RichmondAmerican.com for more information.
About M.D.C. Holdings, Inc.
Operating under the name Richmond American Homes, MDC's homebuilding subsidiaries have built more than 220,000 homes since 1977. Among the nation's largest homebuilders, MDC's subsidiary companies have operations in Arizona, California, Colorado, Florida, Idaho, Maryland, Nevada, New Mexico, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia and Washington. Mortgage lending, plus insurance and title services are offered by the following MDC subsidiaries, respectively: HomeAmerican Mortgage Corporation, American Home Insurance Agency, Inc. and American Home Title and Escrow Company. M.D.C. Holdings, Inc. is traded on the New York Stock Exchange under the symbol "MDC." For more information, visit MDCHoldings.com.
View original content to download multimedia:
SOURCE M.D.C. Holdings, Inc. | https://www.wibw.com/prnewswire/2022/06/20/richmond-american-debuts-new-community-homes-pueblo/ | 2022-06-20T22:17:56Z |
SHENZHEN, China, May 26, 2022 /PRNewswire/ -- On June 6, Huawei is hosting the 2022 Tech for a Better Planet summit with support from IUCN(International Union for Conservation of Nature).
With greenhouse gases choking the earth and up to 1 million of plant and animal species threatened with extinction, World Environment Day 2022 comes at a time when our planet is facing unprecedented challenges.
The world's growing population requires more power than ever before, with average energy consumption jumping by 1% to 2% every year. And increasing technology adoption is a contributing factor to humanity's growing carbon footprint. For example, in 2020, smartphones accounted for 1% of global carbon emissions, but this is forecast to rise to 3.5% within a decade. Equally, traffic on telecom networks is predicted to increase fivefold from 2018 to 2024, with each person in the world expected to generate the data equivalent of 6,700 photo uploads per day.
So, is technology helping or hurting the planet? Can we turn the tide against the environmental threats using technology?
A key step moving forward is to prioritize energy-efficiency and green development in the technology sector and to pass on the innovations we make to other industries. From green communications networks to green data centers, green innovations can make a pivotal difference to the global carbon footprint created by business. By adopting digital technologies, we predict that industries can reduce their energy consumption by 20% by 2030, a carbon offset that will be ten times greater than the energy used by the ICT sector itself.
However, increased energy consumption is not the only threat our planet faces. The ability of the world's rainforests to remove carbon from the atmosphere is declining as rapidly as forest cover is disappearing, reducing carbon sinks and creating a domino effect on habitat and biodiversity loss.
For nature conservation, we must develop solutions that can understand the world's ecosystems and form the basis of effective protective measures. With our partners, including the International Union for Conservation of Nature (IUCN) and Rainforest Connection, we have been developing solutions under our Tech4Nature and TECH4ALL initiatives to make this possible in ecosystems around the world, from rainforests, mountains, and plateaus to wetlands, rivers, and oceans.
Infrared camera technology analyzed by cloud AI, for example, is helping to track and monitor species that are close to extinction, including the Darwin's fox and Hainan gibbon.
Similar technologies are enabling the restoration of a coral reef system in the Indian Ocean and working to prevent an invasive species from decimating wild Atlantic salmon populations in Europe. AI-powered acoustics solutions deployed in tree canopies can detect the sounds of chainsaws and trucks associated with illegal logging in rainforests and send real-time alerts to rangers in the field. According to the UN, up to 90% of logging is illegal and, since pre-industrial times, 64% of all rainforest has been destroyed or degraded.
Collaborate for conservation
While technology underpins nature conservation and the net zero journey, partnerships deliver the results. On June 6 – the day after World Environment Day 2022 – Huawei is hosting the 2022 Tech for a Better Planet summit with support from IUCN. Our partners will be discussing the role of technology as an enabler of protecting and restoring our badly damaged planet, including many of the projects outlined in this article.
After all, we only have one earth.
Click the link to register for the webinar.
View original content to download multimedia:
SOURCE Huawei | https://www.wibw.com/prnewswire/2022/05/27/tech-better-planet-can-technology-protect-our-home/ | 2022-05-27T06:21:23Z |
GENEVA (AP) — The number of coronavirus deaths globally dropped by about 21% in the past week while cases rose in most parts of the world, according to the World Health Organization.
In its weekly report on the pandemic released Thursday, the U.N. health agency said the number of new COVID-19 cases appears to have stabilized after weeks of decline since late March, with about 3.5 million new cases last week, or a 1% rise. WHO said cases increased in the Americas, Middle East, Africa and the Western Pacific, while falling in Europe and Southeast Asia. Some 9,000 deaths were recorded.
Infections rose by more than 60% in the Middle East and 26% in the Americas, while deaths fell everywhere except Africa, where they jumped by nearly 50%.
The COVID-19 figures reported to WHO do not include the recent outbreak figures announced by North Korea, which has yet to officially share requested data with the agency.
On Thursday, the authoritarian country headed by Kim Jung Un reported more than 262,000 more suspected cases as its caseload approaches 2 million, a week after the country acknowledged the outbreak and scrambled to slow infections in its unvaccinated population.
Earlier this week, WHO chief Tedros Adhanom Ghebreyesus said he was “deeply concerned” about the spread of COVID-19 in North Korea, noting the population was unvaccinated and that there were significant numbers of people with underlying conditions that could put them at risk of more severe disease and death.
Tedros said the agency was working to persuade North Korea to share more information and to accept help including technical support, vaccines, tests and medicines, but so far had received no response.
In the Western Pacific, WHO said the biggest number of reported cases was in China, which saw a 94% increase, or more than 389,000 new cases. After weeks of a sometimes severe and chaotic lockdown, Chinese authorities say they will allow some supermarkets, malls and restaurants in its financial capital of Shanghai to reopen under limited conditions next week.
WHO’s Tedros has previously described China’s extreme “zero-COVID” approach as “ unsustainable,” but acknowledged that countries are free to choose their own control strategies.
__
Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic | https://cw33.com/health/ap-health/who-covid-deaths-dropped-by-21-last-week-but-cases-rising/ | 2022-05-20T02:29:45Z |
PITTSBURGH, Aug. 12, 2022 /PRNewswire/ -- "I wanted to create a way to proudly display a treasured photograph in the car," said an inventor, from Edgecliff Village, Texas, "so I invented the VISOR FRAME. My design could help to promote positive thoughts while driving."
The invention provides a neat way to display a photograph within a vehicle interior. In doing so, it eliminates the need to tape or prop the photo up. As a result, it helps to keep the photo safe and nice and it prevents the photo from falling. The invention features a simple and attractive design that is easy to apply and use so it is ideal for vehicle owners, professional drivers, truck drivers, etc. Additionally, it is producible in design variations.
The original design was submitted to the Dallas sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 20-DLL-3907, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
View original content to download multimedia:
SOURCE InventHelp | https://www.kxii.com/prnewswire/2022/08/12/inventhelp-inventor-develops-photo-display-vehicles-dll-3907/ | 2022-08-12T17:09:37Z |
Kemal El Moujahid Joins Chainlink Labs After Scaling the World's #1 Machine Learning Platform
SAN FRANCISCO, May 16, 2022 /PRNewswire/ -- Chainlink Labs, the organization developing the global decentralized oracle standard powering mainstream blockchain adoption, today announced that Kemal El Moujahid, former director of product management for TensorFlow at Google, has joined as chief product officer.
"Kemal has a track record of world changing success, he was most recently responsible for building TensorFlow into the world's leading machine learning platform and ecosystem," said Sergey Nazarov, co-founder of Chainlink. "His work there helped to define the machine learning industry and enable millions of developers to be successful using that technology. I am excited to have him join Chainlink Labs to replicate that success in the blockchain industry."
El Moujahid was the director of product management for TensorFlow at Google, the world's #1 open source machine learning platform, which he scaled to 300 million downloads and some of the largest enterprise use cases for AI. Prior to his work on TensorFlow, El Moujahid was at Meta (Facebook) where he launched the Messenger platform, connecting 20 million businesses with 1 billion people. While there he also launched M, Facebook's virtual assistant, ultimately reaching 200 million monthly active users.
"I couldn't be more excited to join Chainlink Labs at such a pivotal time in blockchain and oracle development," said El Moujahid. "I have seen the incredible things that developers have built when machine learning tools become more accessible to them. I believe that smart contracts are radically changing the world for the better and Chainlink is in a unique position to accelerate this by enabling millions of developers and builders to take this disruption to new heights."
In addition to El Moujahid, Chainlink Labs also recently hired Dr. Dahlia Malkhi, former Diem Association chief technology officer, as the company's chief research officer. Mike Derezin, former vice president at LinkedIn, joined Chainlink Labs late last year as the company's chief operating officer. Chainlink Labs has also seen the addition of notable advisors, including former Google CEO Eric Schmidt, Stanford cryptographer Dan Boneh, and Diem co-creator Christian Catalini.
Chainlink Labs is hiring globally across all departments and was recently featured as a top remote company. Learn more about open roles at chainlinklabs.com/careers.
Chainlink Labs is the leading provider of secure and reliable open-source blockchain oracle solutions, enhancing smart contracts by connecting them to a wide range of off-chain data sources and computations, such as asset prices, web APIs, IoT devices, payment systems, and more. We are dedicated to the development and integration of Chainlink as the standard decentralized oracle framework used by smart contracts across any blockchain.
Chainlink is the industry standard for building, accessing, and selling oracle services needed to power hybrid smart contracts on any blockchain. Learn more about Chainlink by visiting chain.link or reading the developer documentation at docs.chain.link. To discuss an integration, reach out to an expert.
View original content to download multimedia:
SOURCE Chainlink Labs | https://www.mysuncoast.com/prnewswire/2022/05/16/chainlink-labs-welcomes-new-chief-product-officer/ | 2022-05-16T15:45:59Z |
INDIANA, Pa., July 1, 2022 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank with operations in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York, announced today that a conference call detailing the company's second quarter 2022 earnings will be held live over the Internet at 1:00 p.m. ET on Thursday, July 21, 2022. Christopher J. McComish, chief executive officer, David G. Antolik, president, and Mark Kochvar, chief financial officer, will conduct the conference call. The public is invited to listen.
S&T Bancorp, Inc. intends to release its second quarter earnings before the market opens on Thursday, July 21, 2022.
PERTINENT USER INFORMATION:
To access the webcast, go to S&T Bancorp's webpage at the address listed above and click on "Events & Presentations." Select "2nd Quarter 2022 Conference Call" and follow the instructions. After the live presentation, the webcast will be archived on this website for at least 90 days. A replay of the call will also be available until July 28, 2022, by dialing 1.877.481.4010; the Conference ID is 45770.
Prior to the webcast, please email questions to investor.relations@stbank.com. Also, participants who log into the conference call will have an opportunity to email their questions directly from the webpage beginning at 12:55 p.m. ET until the conclusion of the presentation.
The S&T Bancorp, Inc. Second Quarter Earnings Press Release can be accessed on Thursday,
July 21, 2022 at www.stbancorp.com. Click on "Press Releases."
S&T Bancorp, Inc. is a $9.4 billion bank holding company that is headquartered in Indiana, Pennsylvania and trades on the NASDAQ Global Select Market under the symbol STBA. Its principal subsidiary, S&T Bank was established in 1902 and operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. S&T Bank recently received the highest ranking in customer satisfaction for retail banking in the Pennsylvania region by J.D. Power. For more information visit stbancorp.com or stbank.com. Follow us on Facebook, Instagram and LinkedIn.
View original content to download multimedia:
SOURCE S&T Bancorp, Inc. | https://www.kxii.com/prnewswire/2022/07/01/sampt-bancorp-webcast-second-quarter-earnings-conference-call/ | 2022-07-01T17:38:54Z |
Driver crashes into Camp Bow Wow doggie daycare center
Sarasota Police report Luis Vargas Romero, 24, has been taken into custody after allegedly driving into the building.
SARASOTA, Fla. (WWSB) -A daycare owner is picking up the pieces after a car plowed into the side of the building early Sunday morning.
Sarasota Police have taken Luis Vargas Romero, 24, into custody for allegedly driving into the Camp Bow Wow doggie daycare center on 17th Street. No one was hurt since the center has been closed for construction for the past several months, but the owner is looking at serious damages with shattered glass, broken gutters and severe wall damage.
Anita Saho, who owns Camp Bow Wow, flew in from out of town to check out the damages. Although it’s a mess, she said it could have been much worse.
“We were very lucky that there were no dogs and no employees here because we are under construction and I am so thankful for that,” she said.
Construction at the doggie daycare center will be pushed back another three months because of the wreck.
Sarasota Police are still investigating the incident.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/06/27/driver-crashes-into-camp-bow-wow-doggie-daycare-center/ | 2022-06-27T23:40:58Z |
EVANSTON, Ill., Aug. 19, 2022 /PRNewswire/ -- AMTA believes the current disciplinary action against Deshaun Watson for his predatory behavior in violation of the League's personal conduct policy doesn't go far enough. We strongly feel that any client- including professional athlete - who steps over the line to inappropriate touch should face serious legal consequences. This type of inaction by the NFL further perpetuates misconduct and abuse by athletes in the League.
Creating a safe workplace for all massage therapists and other professionals who are part of the athletes' care teams should be a priority for the NFL. Yet, the NFL continues to send the wrong message by not adhering to higher standards and professionalism. Inappropriate behavior without serious consequences creates real danger for professional massage therapists. Furthermore, 86% of licensed massage therapists are female and this level of inaction shows a profound lack of respect towards women and their safety.
Licensed massage therapists deserve more – they should feel respected and safe in their professional environment. AMTA had previously reached out to Roger Goodell asking for his support to help facilitate an environment where licensed massage therapists can practice massage therapy safely and professionally as part of the care team for NFL athletes across the League. We were greatly disappointed not to receive a direct response.
Massage therapy is an important recovery tool for NFL athletes, and science and research show that it can help with accelerating the healing and recovery process, preventing re-injury and long-term complications, along with reducing stress and pain. The blatant disregard for the trained licensed massage therapy professionals who are contributing to the success of athletes in the League is appalling.
Additionally, irresponsible remarks made by lawyers or in the media coverage put professional, licensed massage therapists at risk by condoning inappropriate conduct in a massage environment. It's dangerous to speak so cavalierly about massage therapy, and can give the wrong impression on what one should expect during a massage session.
AMTA strongly believes massage therapists deserve mutual respect, courtesy and professionalism at all times. And, massage therapists should never have to tolerate conduct outside the bounds of therapeutic massage therapy. We will continue to advocate for all massage therapists to receive a higher level of respect and support from the NFL to ensure that they can practice massage therapy in the safe, professional environment that they rightfully deserve.
"The NFL needs to take a more serious approach to protecting massage therapists who are an important part of athletes' care teams. Abuse and inappropriate conduct are never okay and we are very disappointed that the League has not made the safety of massage therapists who provide care for athletes a stronger priority." Michaele Colizza, National President of AMTA
The American Massage Therapy Association, the most trusted name in massage therapy, is the largest non-profit, professional association serving massage therapists, massage students and massage schools. The association is directed by volunteer leadership and fosters ongoing, direct member-involvement through its 51 chapters. AMTA works to advance the profession through ethics and standards, the promotion of fair and consistent licensing of massage therapists in all states, and public education on the benefits of massage. To find a qualified massage therapist in your area, please visit AMTA's Find a Massage Therapist Locator Service™.
Media Contact: communications@amtamassage.org
View original content to download multimedia:
SOURCE American Massage Therapy Association | https://www.kxii.com/prnewswire/2022/08/19/amta-dissatisfied-with-weak-response-nfl/ | 2022-08-19T18:16:21Z |
Grants Build on Company's Commitment to the Health and Well-Being of Local Communities and Supports Innovative Work at Schools and Nonprofit Organizations
LOS ANGELES, July 7, 2022 /PRNewswire/ -- The Wonderful Company is pleased to announce that its $1 million Wonderful Community Grants application process is now live, building on a long-standing commitment to help local organizations and schools in the Central Valley further their missions and programs. Over the last seven years, The Wonderful Company and its co-owners, Lynda and Stewart Resnick, have awarded over $5 million in Wonderful Community Grants to more than 71 area nonprofits and 165 schools in California's San Joaquin Valley.
Designed to help spark increased engagement with local and regional organizations, the Wonderful Community Grants program encourages initiatives that support health and wellness, recreation, art, social services, and community beautification. The funds will directly support game-changing programs that demonstrate community need and yield tangible and visible results. Every year, The Wonderful Company and its co-owners invest more than $30 million in community development, education, and health and wellness initiatives across the Central Valley and beyond. This program is at the center of the company's ongoing Wonderful Neighbor commitment to support the communities its employees call home.
"Giving back is an essential part of the way we operate every day," said Andy Anzaldo, chief operating officer, corporate social responsibility at The Wonderful Company. "The Central Valley is the heart of our business, and we have always been a company focused on making the communities we serve more equitable places to live, work, and play. Whether it's through the grants we provide or inspiring volunteer efforts of Wonderful employees, we believe in leading through action and we're passionate about helping our neighbors make a profound difference."
Organizations are encouraged to apply. To learn more about the application process and eligibility requirements, join the Wonderful Philanthropy team at one of the following upcoming virtual information sessions:
- Thursday, July 7: 10:00 a.m. to 11:00 a.m. PDT (RSVP here)
- Thursday, July 21: 2:00 p.m. to 3:00 p.m. PDT (RSVP here)
- Wednesday, August 10: 10:00 a.m. to 11:00 a.m. PDT (RSVP here)
All applications must be received by Wednesday, August 31, at midnight PDT for priority consideration and will be reviewed on an ongoing basis past the August deadline. The 2022–2023 class of Wonderful Community Grants recipients will be announced in October 2022.
For additional information and to submit an application, please visit www.wonderfulcommunitygrants.com or email communitygrants@wonderful.com.
The Wonderful Company and its co-owners, Lynda and Stewart Resnick, have a long-standing commitment to invest in the communities their employees call home, especially in California's Central Valley. In addition to the millions of dollars the Resnicks and The Wonderful Company invest in the Central Valley every year, the Wonderful Community Grants program provides critical funding to organizations impacting change throughout the area. Local governments, area nonprofits, schools, and faith-based organizations can apply for grants in the categories of health and wellness, recreation, art, social services, community beautification, and COVID-19 recovery efforts for amounts between $1,000 and $100,000. Funds are available for program development/expansion, innovation, small scale capital improvements, technology, and equipment. More information about Wonderful Community Grants can be found at www.wonderfulcommunitygrants.com.
The Wonderful Company is a privately held $5 billion global company dedicated to harvesting health and happiness around the world. Its iconic brands include FIJI® Water, POM Wonderful®, Wonderful® Pistachios, Wonderful® Halos®, Wonderful® Seedless Lemons, Teleflora®, JUSTIN®, JNSQ™, and Landmark® wines.
The Wonderful Company's connection to consumers has health at its heart and giving back in its DNA. To learn more about The Wonderful Company, its products, and its core values, visit www.wonderful.com, or follow us on Facebook, Twitter, and Instagram. To view the current Corporate Social Responsibility report, visit www.wonderful.com/csr.
View original content to download multimedia:
SOURCE The Wonderful Company | https://www.wibw.com/prnewswire/2022/07/07/wonderful-company-opens-application-window-1-million-central-valley-community-grants/ | 2022-07-07T17:12:47Z |
EAST LANSING, Mich., July 26, 2022 /PRNewswire/ -- Samuel M. Keim, M.D., M.S., has been elected President of the American Board of Emergency Medicine (ABEM).
Dr. Keim received his medical degree from the University of Arizona College of Medicine, completed residency training at the Los Angeles County, King/Drew Medical Center, and received a Master's degree in Clinical Epidemiology from the Mel and Enid Zuckerman College of Public Health at the University of Arizona. He is Professor and Chair of the Department of Emergency Medicine at the University of Arizona College of Medicine, and a professor in the Division of Epidemiology and Biostatistics at the Mel and Enid Zuckerman College of Public Health. He practices clinically at Banner University Medical Center in Tucson.
"I am extremely proud to work for and represent ABEM," said Dr. Keim. "This is an organization that works hard to improve the specialty by partnering with individual physicians and collaborating with other organizations. The board and staff are phenomenal and I'm really looking forward to the year."
Others elected to the Executive Committee are:
Ramon W. Johnson, M.D., M.B.A., President-Elect. Dr. Johnson is a community physician and full-time partner in Mission Viejo Emergency Medicine Associates at Mission Hospital Regional Medical Center in Mission Viejo, California, and Medical Director of the Doctor's Ambulance Company, Santa Ana, California.
Marianne Gausche-Hill, M.D., Immediate-Past-President. Dr. Gausche-Hill is Medical Director of the Los Angeles County EMS Agency, Professor of Clinical Emergency Medicine and Pediatrics at the David Geffen School of Medicine at UCLA, and clinical faculty at Harbor-UCLA Medical Center, Departments of Emergency Medicine and Pediatrics.
Diane L. Gorgas, M.D., Secretary-Treasurer. Dr. Gorgas is a Professor and Vice Chair of Academic Affairs in the Department of Emergency Medicine and Executive Director of the Office of Global Health at The Ohio State University in Columbus, Ohio.
James D. Thomas, M.D., Member-at-Large. Dr. Thomas is a community physician and practices Emergency Medicine at St. Anne's Hospital in Fall River, Massachusetts.
Wallace A. Carter, M.D., Member-at-Large. Dr. Carter is a Professor of Clinical Emergency Medicine at Weill Cornell Medical College and Vice Chair of Clinical and Faculty Affairs in the Department of Emergency Medicine. He practices Emergency Medicine at New York-Presbyterian/Weill Cornell Medical Center.
All ABEM physician directors are clinically active emergency physicians.
Learn more about ABEM.
Contact: A.J. Wolf
Email: awolf@abem.org
View original content to download multimedia:
SOURCE American Board of Emergency Medicine | https://www.wibw.com/prnewswire/2022/07/26/samuel-m-keim-md-ms-elected-president-american-board-emergency-medicine/ | 2022-07-27T00:19:27Z |
WASHINGTON (AP) — President Joe Biden continues to “improve significantly” despite a lingering sore throat from his coronavirus infection, according to an update Sunday from his doctor.
“The president is responding to therapy as expected,” wrote Dr. Kevin O’Connor in his latest note. Biden has been taking Paxlovid, an antiviral drug that helps reduce the chance of severe illness.
O’Connor wrote that Biden still has a sore throat, though other symptoms, including a cough, runny nose and body aches, “have diminished considerably.”
Biden tested positive for the coronavirus on Thursday morning. O’Connor said Saturday that the president likely became infected with a highly contagious variant, known as BA.5, that is spreading throughout the country, and Dr. Ashish Jha, the White House COVID-19 response coordinator, said Sunday, “It is the BA.5 variant.”
“Thank goodness our vaccines and therapeutics work well against it, which is why I think the president’s doing well,” Jha told CBS’ “Face the Nation.”
Jha also gave a positive update on the president’s health.
“I checked in with his team late last night. He was feeling well. He had a good day yesterday,” Jha said.
That variant is an offshoot of the omicron strain that emerged late last year. It is believed responsible for the vast majority of coronavirus cases in the country. He has been isolating in the White House residence since then.
Administration officials have emphasized that his symptoms are mild because he has received four vaccine doses, and he started taking the antiviral drug Paxlovid after becoming infected.
The White House has not released any photos or video of Biden since Friday, when the media watched him participate in a virtual meeting with economic advisers.
Jha pledged that the White House would keep giving updates on the president’s condition and whether he might have long-term symptoms.
“We think it’s really important for the American people to know how well their president is doing,” he said.
“Obviously if he has persistent symptoms, obviously if any of them interfere with his ability to carry out his duties, we will disclose that early and often with the American people. But I suspect that this is going to be a course of COVID that we’ve seen in many Americans who have ben fully vaccinated, double boosted, getting treated with those tools in hand,” Jha said. “The president’s been doing well and we’re going to expect that he’s going to continue to do so.’’
Biden’s press secretary has said 17 people, including members of the president’s senior staff and at least one member of Congress, were determined to have been in close contact with Biden when he might have been contagious. None has tested positive so far, Jha said on “Fox News Sunday.” | https://cw33.com/health/ap-health/biden-feeling-much-much-better-after-covid-diagnosis/ | 2022-07-24T19:31:03Z |
Ukrainian President Volodymyr Zelensky accused Russian troops of indiscriminately killing civilians "just for their pleasure" in an emotionally-charged address to the United Nations Security Council on Tuesday, before questioning the very mandate of the Security Council itself.
Zelensky's speech came a day after he visited the Kyiv suburb of Bucha, where shocking images of bodies in the streets emerged over the weekend.
On Tuesday, he related the aftermath of Russia's retreat from the town in horrifying detail, describing entire families killed, people with their throats slashed, and women raped and killed in front of their children. Zelensky said Russia's actions were no different from those of a terror group, except that Russia is a permanent member of the UNSC.
The Ukrainian leader then criticized the body, asking representatives point blank: "Where is the security that the Security Council needs to guarantee? It is not there, though there is a Security Council."
Zelensky added: "It is obvious that the key institution of the world designed to combat aggression and ensure peace cannot work effectively.
"Ladies and gentlemen, I would like to remind you of Article 1, Chapter 1 of the UN Charter. What is the purpose of our organization? Its purpose is to maintain and make sure that peace is adhered to. And now the UN charter is violated literally starting with Article 1. And so what is the point of all other Articles?" he asked.
At least 1,480 civilians have been killed and at least 2,195 have been injured in Ukraine between the start of the Russian invasion on February 24 and April 4, a UN official said at the meeting, citing updated numbers from the Office of the High Commissioner for Human Rights (OHCHR). The latest figures on the number of Ukrainian civilians in the conflict had "more than doubled" since the last briefing to the UNSC on March 17.
In Bucha, bodies strewn across the streets and in basements were found by human rights groups and documented by independent journalists. Satellite images suggest some bodies had been there since at least March 18.
In his damning speech, Zelensky said there was "not a single crime" that the Russians "would not commit," alleging that Russian troops had "searched for and purposefully killed anyone who served our country."
"They shot and killed women outside their houses when they just tried to call someone ... They killed entire families, adults and children and they tried to burn the bodies," Zelensky said.
"I am addressing you on behalf of the people who honor the memory of the deceased every single day and in the memory of the civilians who died, who were shot and killed in the back of their head after being tortured," he told the UNSC.
"Some of them were shot on the streets. Others were thrown into wells, so they died there suffering. They were killed in their apartments, houses, blown up by grenades. Civilians were crushed by tanks while sitting in their cars in the middle of the road, just for their pleasure," he continued. "Women were raped and killed in front of their children. Their tongues were pulled out only because the aggressor did not hear what they wanted to hear from them."
Zelensky also warned that the horrors found in Bucha would be replicated in other cities across Ukraine. Demanding accountability, he called for any Russians who have given "criminal orders" and "carried out them by killing our people" to be brought before a tribunal, similar to the Nuremberg trials that occurred after World War II when Nazis were put on trial.
UN: Civilians were targeted
Separately, the United Nations on Tuesday said that the shocking images from Bucha showed "all the signs" that civilians were "directly targeted and directly killed."
In a virtual press briefing, OHCHR spokesperson Liz Throssell said the reports emerging from Bucha and other areas were "very disturbing developments."
She specifically referenced the "disturbing" images of people with their hands tied behind their back and of partially naked women whose bodies have been burnt as further evidence suggesting the direct targeting of individuals.
"We have been talking about war crimes in the context of shelling, bombardment, and artillery attacks. Now they need to be investigated. But you could argue there was a military context, for example, to a building being hit. It's hard to see what was the military context of an individual lying in the street with a bullet to the head or having their bodies burned," Throssell continued.
As the OHCHR is trying to currently gain access to Bucha, she didn't have "exact information" to share regarding the situation on the ground.
Throssell also paid tribute to the "crucial role" that journalists are playing in documenting these scenes, mentioning the "multiple teams" involved in "reporting, analyzing, and sending video footage."
Russia's response
Russia has repeatedly denied the alleged atrocities, despite increasing evidence suggesting otherwise. Vassily Nebenzia, the Russian ambassador to the United Nations responded to Zelensky's remarks, calling the accusations against the Russian military "ungrounded."
"We place on your conscience the ungrounded accusations against the Russian military, which are not confirmed by any eyewitnesses," Nebenzia said in translated remarks.
The ambassador recalled Zelensky's election to the Ukrainian presidency in 2019, stating that hopes that Zelensky would end the fighting in the Donbas region of Ukraine "failed to materialize."
Nebenzia also repeated past claims that "a huge amount of lies about Russian soldiers and military" continue to proliferate.
Addressing Zelensky directly, Nebenzia concluded his remarks by claiming Russia "came to ... Ukraine" to bring peace, not to "conquer lands."
Nebenzia's words echoed those of Kremlin spokesman Dmitry Peskov earlier Tuesday, who called the allegations not only "groundless, but ... a well-staged tragic show" and "a forgery in order to try to denigrate the Russian army."
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/news/ukraines-zelensky-questions-un-security-councils-mandate-in-speech-on-alleged-russian-atrocities/article_f3844e22-1718-510c-9c5f-11b2ef6718ac.html | 2022-04-05T22:16:49Z |
UNITED NATIONS (AP) — Pakistan’s new foreign minister says the United States and his country must move beyond past tensions over Afghanistan and are entering a new engagement after years of strained relations under former Prime Minister Imran Khan.
Bilawal Bhutto Zardari, the 33-year-old son of assassinated Prime Minister Benazir Bhutto, spoke in an interview with The Associated Press in New York, where he was attending meetings this week on the global food crisis at U.N. headquarters. He has also held talks with top diplomats, including a one-hour discussion with U.S. Secretary of State Tony Blinken.
Bhutto Zardari called the meeting with Blinken “very encouraging and very positive and productive.”
“We believe that Pakistan must continue to engage with the United States at all levels,” he said. “This meeting was indeed an important first step.”
Bhutto Zardari co-chairs one of the two largest parties in Pakistan’s disparate governing coalition, which spans the political spectrum from the left to the radically religious. The coalition removed Khan in a no-confidence vote on April 10. Shahbaz Sharif, the leader of the other major party, replaced Khan as prime minister.
U.S.-Pakistani ties deteriorated under Khan, who as prime minister tapped into anti-American sentiment in Pakistan that has spread ever since the 9/11 terror attacks by al-Qaida, and the U.S. war on terror. The 2011 American raid that killed al-Qaida leader Osama bin Laden in Pakistan angered many hardliners in the country.
Khan accused the Biden administration of colluding with the opposition to oust him, a claim the administration denies.
Afghanistan also raised mistrust between the two countries. Washington felt Islamabad did too little to help ensure peace as the U.S. and NATO carried out their troop withdrawal from Afghanistan; Pakistan insists it did all it could to broker peace and blamed the abrupt U.S. pullout. After the American withdrawal, the Taliban overran Kabul in August and seized power.
Bhutto Zardari said the Pakistan-U.S. relationship in the past had been “too colored by the events in Afghanistan, of the geopolitical considerations, and it’s time for us to move beyond that to engage in a far broader, deeper and more meaningful relationship.”
Under Khan, Pakistan pushed hard for the world to engage with the Taliban after they took power in Afghanistan, and Bhutto Zardari said his country continues to do so.
“Regardless of what we feel about the regime in Afghanistan,” the world can’t abandon the Afghan people and must immediately address the country’s humanitarian crisis and crumbling economy, he said. A total collapse of the Afghan economy would be a disaster for Afghans, Pakistan and the international community, he said, expressing concern that many Afghans would flee the country.
Pakistan is also insisting the Taliban live up to their international commitments that the country not be used for terrorism, that girls and women be able to pursue education, and that they form an inclusive government, he said.
The Taliban, however, have taken a more hard-line turn in recent weeks, imposing new restrictions on women. At the same time, tensions have grown between the Taliban and Pakistan over militants based in Afghanistan carrying out attacks in Pakistan.
Bhutto Zardari said the more the humanitarian crisis is alleviated and the economy is saved from collapse, “the more likely we are to succeed in our pursuit for women’s rights and the more likely we are to succeed in our efforts against terrorism.”
He said his focus in talks with Blinken was on increasing trade, particularly in agriculture, information technology and energy. He said he is looking forward to working with the U.S. on an initiative to empower women and women entrepreneurs.
On economic, defense and military coordination, “if we continue to engage, then we can move forward in a more positive direction,” Bhutto Zardari said.
Asked about Khan’s anti-U.S. rhetoric, Bhutto Zardari dismissed his accusation of American collusion behind his ouster. He called it a “fanciful conspiracy theory based on a big lie” to explain away his removal.
“I am particularly anti the politics of hate, division and polarization,” the foreign minister said. “If we consistently pursue the politics of `you’re with us or against us,’ whether that’s on an international level or a domestic level, I don’t believe it serves the interests of the people of Pakistan.”
He said he believes Pakistanis understand their country needs to engage with the United States and all countries to become democratic and progress economically.
U.S. President Joe Biden has strengthened ties with Pakistan’s arch-rival India, but Bhutto Zardari said Pakistan is not “jealous” of their relationship. “We believe the world is big enough for both Pakistan and India,” he said.
Biden will meet Indian Prime Minister Narendra Modi and the leaders of Australia and Japan at a summit in Tokyo on May 24 of the so-called Quad, an Indo-Pacific alliance which China sees as an attempt to contain its economic growth and influence.
Pakistan has a very close economic and military relationship with neighboring China. Bhutto Zardari said he didn’t think the growing relationship with the United States would hurt its ties to Beijing.
Pakistan has abstained on U.N. General Assembly resolutions condemning Russia’s invasion of Ukraine and withdrawal of its troops. Bhutto Zardari said Pakistan used to rely a lot on Ukrainian wheat and fertilizer and has been affected by rising food prices and calls for diplomacy to end the war.
Bhutto Zardari recalled the legacy of his mother and grandfather, Zulfikar Ali Bhutto, who led Pakistan in the 1970s and was overthrown and executed by the military. He called them “towering figures on the world stage,” and said he feels “the burden of history.”
“What motivates and drives me is the pursuit of their unfulfilled mission,” he said. “I hope that we live up to the expectations of the people of Pakistan” who have longed for true democracy and struggled for their economic, political and human rights.
“These are the ideals that we hold dear and we work towards every day,” Bhutto Zardari said. | https://cw33.com/news/international/ap-international/the-ap-interview-new-pakistani-fm-seeks-better-ties-with-us/ | 2022-05-20T17:08:16Z |
TEL-AVIV, Israel, April 12, 2022 /PRNewswire/ -- Surance.io has recently completed a round of financing from Tech Mahindra that acquired 25% equity of the start-up with an option to invest in additional 20%. The initial investment is at the amount of US$ 4 million which will support the global expansion of the strong player in the InsurTech industry.
Surance.io is an innovative InsurTech startup changing the landscape of the cyber safety market by focusing its solutions on a triangled unique combination of personalized cyber protection, 24/7 AI & human response in case of attack and cyber insurance coverage. This comprehensive, end-to-end solution is tailored for cyber home and individual safety.
Surance.io one-stop-shop that presents the new generation of proactive & preventive cyber-safety insurance policy. The interaction is made simple with a dedicated mobile cyber App, providing users with ad hoc services such as security plans, safety alerts, 3-tier support for claim management and 24/7 AI & human support. The App may also include loyalty programs and incentives to encourage users for a safe cyber behaviour.
Surance.io offers a white labelled full stack solution allowing insurer carriers, telcos, and other partners to launch a frictionless product of cyber protection service backed by insurance within few weeks.
By adding this innovative product to their portfolio partners gain boost in customer retention, increase customer cross-buying intentions, enhance trust and affective commitment resulting in higher renewal rates.
Surance.io operates tens of thousands of personal cyber insurance policies for 3 leading insurance companies in Israel, operates its technology solution in Singapore for AIG and started operating its solution for insurance carriers in the US and Canada last year. Following the investment Surance.io intends to keep on focusing on global expansion with insurance carriers alongside with introduction of solution to be backed by insurance in partnership with telcos and other retail channels.
Eyal Paltin, CEO at Surance.io, said: "Surance.io sees this investment as a vote of confidence by a leading technology company, and a head-start to leveraging Tech Mahindra's customer relations to expand cyber products distribution with insurance carriers globally. Surance.io is looking forward to a fruitful collaboration with Tech Mahindra that would significantly increase new sales as well as grow existing accounts"
Vivek Agarwal, President – BFSI, HLS and Corporate Development, Tech Mahindra, said, "The Insurance industry is going through a significant transformation and in this evolving threat landscape, it's imperative to go beyond stand-alone personal cyber insurances and invest in comprehensive risk solutions for the home. Through this investment, Tech Mahindra will leverage Surance.io to expand into untapped markets with new functionality enhancements and features."
Tech Mahindra believes in DigitALL philosophy for comprehensive business transformation. Digital technologies catalyze the transformations – they humanize businesses by helping them think, sense, connect, communicate, secure, and act better than before. As part of NXT.NOWTM framework, which aims to enhance 'Human Centric Experience', Tech Mahindra focuses on investing in emerging technologies and solutions that enable digital transformation and meet the evolving needs of the customer.
Tech Mahindra's focus on leveraging next generation technologies to deliver disruptive solutions along with Surance.io's comprehensive platform, will boost Surance.io sales and market share distribution in the personal cyber InsurTech industry.
Contact: pr@surance.io
View original content:
SOURCE Surance.io | https://www.mysuncoast.com/prnewswire/2022/04/12/suranceio-closes-us-4million-series-round-accelerate-growth-proactive-amp-preventive-personal-cyber-insurtech-solutions/ | 2022-04-12T14:50:30Z |
Technology strengthens decarbonization portfolio and builds on recent success
HOUSTON, Sept. 7, 2022 /PRNewswire/ -- Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced major advancements to the Lummus External Air Preheater (LEAP) technology. The latest innovations can significantly reduce CO2 emissions from cracking heaters at ethylene plants as well as other fired heaters.
"Lummus is committed to decarbonizing our entire technology portfolio, and these advancements underscore the continued progress we are making in meeting our commitments," said Leon de Bruyn, President and Chief Executive Officer of Lummus Technology. "This announcement builds on Lummus' recent launch of the industry's first net zero ethane cracker, plus other innovations, that will help operators and producers lower emissions from their investments."
Now available for commercial use, the LEAP technology can be applied to both new and existing heaters to help decarbonize some of the most carbon intensive petrochemical manufacturing processes. Some of the technology's enhanced features include:
- lower fuel firing
- much higher thermal efficiency
- implementation in existing heaters with minimal mechanical changes
- ability to combine with selective catalytic reduction systems to minimize nitrogen oxides emission
For more than half a century, Lummus has designed and supplied a wide range of fired heaters and heat exchangers for the petrochemical and refining industries, which include refinery heaters, steam superheaters, heaters for delayed coking units and steam reformers, and SRT® (short residence time) pyrolysis heaters for ethylene production.
Lummus Technology is the global leader in developing process technologies that make modern life possible and focus on a more sustainable, low carbon future. Lummus is a master licensor of clean energy, petrochemical, refining, gas processing and renewable technologies, and a supplier of catalysts, proprietary equipment, digitalization and related lifecycle services to customers worldwide. To learn more about Lummus, visit www.LummusTechnology.com.
View original content to download multimedia:
SOURCE Lummus Technology, LLC | https://www.wibw.com/prnewswire/2022/09/07/lummus-accelerates-co2-reduction-goals-through-air-preheater-innovation/ | 2022-09-07T15:17:42Z |
US Mint releasing coin to honor Cherokee leader Wilma Mankiller
(CNN) – Start taking a closer look at your quarters.
This year, the U.S. mint is releasing a collection of quarters featuring trailblazing American women.
The latest one is Wilma Mankiller, the first woman elected principal chief of the Cherokee nation and the first woman to lead a major Native American nation in the U.S.
During her three-year run, she tripled the tribe’s enrollment, doubled employment and was integral in launching new housing, health centers and children’s programs in Oklahoma.
On the coin, she is seen wrapped in a traditional shawl with the Cherokee nation seven-pointed star.
The U.S. Mint has already started shipping the quarters out for circulation.
Mankiller is the third of the “American Women Quarters.”
She joins poet, writer and activist Maya Angelou and astronaut Sally Ride, the first American woman in space.
Copyright 2022 CNN Newsource. All rights reserved. | https://www.mysuncoast.com/2022/06/07/us-mint-releasing-coin-honor-cherokee-leader-wilma-mankiller/ | 2022-06-07T17:44:08Z |
Deaths of 3 women in early heat wave raise questions, fears
By DON BABWIN
Associated Press
CHICAGO (AP) — Temperatures barely climbed into the 90s and only for a couple of days. But the discovery of the bodies of three women inside a Chicago senior housing facility this month left the city looking for answers to questions that were supposed to be addressed after a longer and hotter heat wave killed more than 700 people nearly three decades ago.
Now, the city — and the country — is facing the reality that because of climate change, deadly heat waves can strike just about anywhere, don’t only fall in the height of summer and need not last long.
“Hotter and more dangerous heat waves are coming earlier, in May … and the other thing is we are getting older and more people are living alone,” said Eric Klinenberg, a New York University sociologist, who wrote “Heat Wave: A Social Autopsy of Disaster in Chicago.” about the 1995 heat wave. “It’s a formula for disaster.”
The Cook County Medical Examiner’s office has yet to determine the causes of death for the three women whose bodies were found in the James Sneider Apartments on May 14. But the victims’ families have already filed or plan to file wrongful death lawsuits against the companies that own and manage the buildings.
The City Council member whose ward includes the neighborhood where the building is located said she experienced stifling temperatures in the complex when she visited, including in one unit where heat sensors hit 102 degrees.
“These are senior residents, residents with health conditions (and) they should not be in these conditions,” Alderman Maria Hadden said in a Facebook video shot outside the apartments.
Part of the problem, experts say, is that communities nationwide are still learning how deadly heat can be. In Chicago, it took the sight of refrigerated trucks being filled with dead bodies after the 1995 heat wave to drive home the message that the city was woefully unprepared for a silent and invisible disaster that took more than twice as many lives as the Great Chicago Fire of 1871.
That realization led to a system in which city workers start calling the elderly and frail, and turn city buildings into 24-hour cooling centers when temperatures become oppressive.
What happened this month is a reminder that the safeguards in place to make sure people don’t freeze to death because they have not paid their heating bills often do not exist to prevent people from overheating in their homes.
“We have nothing for air conditioning,” Hadden said.
One expert isn’t surprised.
“We recognize people need heating in cold weather and set up programs, financial assistance, to enable that but we don’t do that for cooling,” said Gregory Wellenius, a Boston University professor of environmental health who has studied heat-related deaths. “But subsidies for cooling are really controversial (because) for many people cooling is seen as a luxury item.”
In Chicago, Hadden said the building’s management company believed it was not allowed to turn off the heat and turn on the air conditioning until June 1, because of the city’s heat ordinance. But while she said the ordinance has no such requirement, the explanation may at least be a signal that the ordinance should be amended to better protect vulnerable people from heat.
Wellenius said statistics show that while well over 80% of homes in cities such as Dallas and Phoenix have air conditioning, the percentage is far lower in cities like Boston and New York.
And in the Pacific Northwest, the percentage is even lower, something that came into stark relief in Oregon, Washington and western Canada last June, when temperatures climbed as high as 118 degrees Fahrenheit, killing 600 people or more.
There is encouraging news.
“More people have air conditioning and we are more aware of the health risks of heat waves,” Klinenberg said.
Still, there is evidence that people don’t appreciate or even know just how dangerous the heat can be.
In a study published in 2020, Wellenius and other researchers estimated that nationwide about 5,600 deaths a year could be attributed to high heat — eight times more than the 700 heat-related deaths that are study found were officially reported each year.
Wellenius said the reasons for what he called a “gross miscalculation” begin with the fact that official statistics are simply the result of counting death certificates that list heat as the cause of death.
In the county that includes Chicago, for example, the medical examiner’s office reported two heat-related deaths last year, and seven the year before.
Just how many deaths in the U.S. are heat related today is unclear. Wellenius’ study, published in 2020, is the result of research from 1997 to 2006. And Klinenberg said the issue has been complicated by the pandemic.
“It’s hard to distinguish excess heat deaths from COVID deaths,” he said.
Still, Hadden knows something must be done to deal with heat that can hit earlier and later in the year than it once did.
“We have to plan for this,” she said.
Klinenberg wonders if cities will follow up on such talk.
“Heat never feels like the most important thing in cities and by the time it feels like the most important thing it is too late to do anything about it,” he said. | https://localnews8.com/news/ap-national/2022/05/28/deaths-of-3-women-in-early-heat-wave-raise-questions-fears/ | 2022-05-28T17:06:19Z |
CCFP details practical reforms necessary to address rising antisemitism promulgated by entertainers, entertainment companies and platforms, athletes, and fans.
LOS ANGELES, July 19, 2022 /PRNewswire/ -- Today Creative Community for Peace (CCFP) released the first-ever report focused exclusively on antisemitism within the entertainment industry, documenting how this age-old hatred has festered across film, television, music, professional sports, and on digital platforms.
The report, Fomenting Hate: How The Entertainment and Sports Industries Can Address the Growing Threat of Antisemitism, documents hundreds of examples of antisemitism, outlining how content from studios, influencers, and celebrities filters through the cultural landscape and shapes public perceptions.
The report notes that "there is a feedback loop between the entertainment industry, influencers, and the public. And entertainment leaders are not effectively regulating their products or protecting their Jewish employees and consumers from hate, targeting and discrimination."
CCFP recommends practical reforms that the entertainment industry must take to address this issue. Notably, CCFP encourages studios and digital platforms to adopt the International Holocaust Remembrance Alliance (IHRA) definition of antisemitism, following the U.S. State Department and 37 countries worldwide who have done the same. CCFP also recommends that studios implement a framework for creating more accurate and nuanced representations of Jewish people in media.
For years, CCFP has worked closely with digital platforms to identify and remove antisemitic content. This report outlines the complexity and extent of the challenge that remains in this work today.
"The entertainment industry drives public perception, and thus, has a significant responsibility to avoid perpetuating harmful stereotypes," said CCFP Director Ari Ingel. "This report shows how much work needs to be done within our industry. For instance, usually unaware, streaming platforms, television shows, and films disseminate and promulgate antisemitic tropes. In a society that's increasingly become more sensitive to fair and accurate representation, the impact on Jews often doesn't count."
About CCFP: Founded by entertainment industry executives, Creative Community for Peace (CCFP) is a non-profit entertainment industry organization comprised of prominent members of the entertainment industry to promote the arts as a means to peace, to counter antisemitism within the entertainment industry, and to galvanize support against the cultural boycott of Israel. CCFP is apolitical and does not stand for any government official or party. For more information please visit: creativecommunityforpeace.com.
View original content:
SOURCE Creative Community for Peace | https://www.wibw.com/prnewswire/2022/07/19/antisemitism-is-significant-problem-entertainment-sports-says-new-report-entertainment-industry-group/ | 2022-07-19T21:21:06Z |
- Net earnings of $312.4 million, or $2.54 per diluted share, increased by 140% compared with $130.4 million, or $1.07 per diluted share, in the prior year period
- Core EBITDA of $483.9 million increased 110% year-on-year; a total of $1.4 billion of Core EBITDA achieved over the trailing 12 months
- Margins over scrap in North America and Europe reflect strong market conditions and favorable customer sentiment
- Continued strength in North America downstream pipeline, with record bid activity and backlog levels on both a volume and price basis
- Completed the acquisition of Tensar Corporation, creating a new, attractive strategic growth platform
IRVING, Texas, June 16, 2022 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) today announced financial results for its fiscal third quarter ended May 31, 2022. Net earnings were $312.4 million, or $2.54 per diluted share, on net sales of $2.5 billion, compared to prior year period net earnings of $130.4 million, or $1.07 per diluted share, on net sales of $1.8 billion.
During the third quarter of fiscal 2022, the Company recorded net after-tax costs of $7.8 million related to the acquisition of Tensar Corporation and an asset impairment. Excluding this expense, third quarter adjusted earnings were $320.2 million, or $2.61 per diluted share, compared to adjusted earnings of $127.1 million, or $1.04 per diluted share, in the prior year period. "Adjusted EBITDA," "core EBITDA," "adjusted earnings" and "adjusted earnings per diluted share" are non-GAAP financial measures. Details, including a reconciliation of each such non-GAAP financial measure to the most directly comparable measure prepared and presented in accordance with GAAP, can be found in the financial tables that follow.
Barbara R. Smith, Chairman of the Board, President and Chief Executive Officer, said, "The third quarter was another remarkable financial result for our Company, underpinned by strong operational execution and robust market conditions across our key geographies. I am extremely proud of CMC's financial achievements during the quarter, especially in Europe. CMC employees in Poland have opened their homes and communities in a heartfelt grassroots effort to assist refugees fleeing the war in Ukraine. Amazingly, while responding to dire humanitarian needs, our team produced record quarterly adjusted EBITDA that nearly matched the best annual performance in the history of CMC's Europe segment."
Ms. Smith continued, "In late April, we welcomed Tensar to the CMC organization. Seeing the early results of the teams working together has only further reinforced our confidence in the strategic merits of this transaction and the potential for meaningful commercial synergies. With the onboarding of Tensar, CMC has added a highly attractive new growth platform and is creating a valuable and unique portfolio of solutions for existing and new markets."
The Company's balance sheet and liquidity position remained strong as of May 31, 2022. Cash and cash equivalents ended the quarter with a balance of $410.3 million, following a $550 million payment, net of cash acquired, to complete the purchase of Tensar. In addition, $624.3 million remained available under the Company's credit and accounts receivable facilities. CMC repurchased approximately one million shares of common stock during the quarter, returning $38.6 million of cash to shareholders. As of May 31, 2022, $294.4 million remained under the current share repurchase authorization.
On June 15, 2022, the board of directors declared a quarterly dividend of $0.14 per share of CMC common stock payable to stockholders of record on June 29, 2022. The dividend to be paid on July 13, 2022, marks the 231st consecutive quarterly payment by the Company, and represents a 17% increase from the dividend paid in July 2021.
Business Segments - Fiscal Third Quarter 2022 Review
Demand for CMC's finished steel products in North America was again robust during the quarter, with several key internal and external indicators pointing toward continued strength. Downstream bid volumes, a key indicator of the construction project pipeline, increased meaningfully from a year ago, resulting in the expansion of contract backlog levels. Demand from industrial end markets continued to trend positively, with most end use applications increasing compared to the prior year period.
The North America segment reported adjusted EBITDA of $379.4 million for the third quarter of fiscal 2022, an increase of 83% compared to $207.3 million in the prior year period. This improvement was driven by record margins on sales of both steel products and raw materials. Steel products have experienced five consecutive quarters of year-over-year margin expansion, while margins on raw material sales have grown for nine consecutive quarters. Controllable costs per ton of finished steel shipped were unchanged in comparison to the second fiscal quarter, but were up from the prior year period primarily as a result of higher per unit purchase costs for freight, energy and alloys.
Shipment volumes of finished steel, which include steel products and downstream products, followed typical seasonal patterns, and were essentially unchanged from the prior year period. The average selling price for steel products increased by $316 per ton compared to the third quarter of fiscal 2021, while the cost of scrap utilized rose $103 per ton. The result was a year-over-year increase of $213 per ton in margin over scrap. The average selling price for downstream products increased by $281 per ton from the prior year period and $75 per ton on a sequential basis. Future pricing indicators on new work entering the backlog remain positive, as average price levels for bids and new awards climbed significantly from the prior year period.
The Europe segment reported record adjusted EBITDA of $121.0 million for the third quarter of fiscal 2022, up 142% compared to adjusted EBITDA of $50.0 million for the prior year quarter. The improvement was driven by a significant expansion in both shipment volume and margin over scrap. Similar to North America, underlying demand for steel products remained robust. Volumes of rebar, merchant bar, and wire rod increased on a year-over-year basis, assisted by the addition of a third rolling line, which improved production flexibility and the mill's ability to capitalize on favorable market conditions. During the first 12 months of operating the new rolling line, quarterly shipment volumes of finished products have increased 35% compared to the average of the preceding five years.
As a result of continued strong demand and constrained supply in the wake of trade sanctions against Russia and Belarus, average selling price increased by $303 per ton compared to the prior year quarter, while the cost of scrap utilized rose $154 per ton. The result was a year-over-year increase in margin over scrap of $149 per ton.
The Company's new Tensar business generated EBITDA of $4.9 million during its first five weeks as part of CMC. Excluding a $2.2 million charge to reflect purchasing accounting effect on inventory, EBITDA amounted to $7.1 million on net sales of $28.0 million. EBITDA margin of 25.4% was consistent with Tensar's trailing five-year average. Tensar's financial performance is included within CMC's existing operating segments, with North American results incorporated into CMC's North America segment and all other operations included in the Europe segment.
Outlook
Ms. Smith said, "We anticipate strong financial performance to continue in the fourth quarter. Robust demand for each of CMC's major product lines is expected to persist, augmented by our growing downstream backlog and solid levels of new work entering the project pipeline. Margins over scrap in both North America and Europe should remain at levels near those of the third quarter, driven by favorable market conditions across our geographies."
Ms. Smith added, "Looking into CMC's fiscal 2023, we see several factors that should support continued strength in construction markets. Firstly, as a result of the continued high levels of new bidding activity, we anticipate entering our new fiscal year with historically high levels of contract backlog. In addition, new project bid levels should remain strong based on the benefits of rising activity related to the recently enacted federal infrastructure bill, non-residential construction activity supported by follow-on investment in the wake of historically high new residential community formation in our home markets, and from the continuation of reshoring trends that have already resulted in significant new projects. The expected early calendar 2023 startup of our Arizona 2 micro mill will provide CMC with a greater flexibility to capitalize on these anticipated favorable demand conditions."
Conference Call
CMC invites you to listen to a live broadcast of its third quarter fiscal 2022 conference call today, Thursday, June 16, 2022, at 11:00 a.m. ET. Barbara R. Smith, Chairman of the Board, President and Chief Executive Officer, and Paul Lawrence, Senior Vice President and Chief Financial Officer, will host the call. The call is accessible via our website at www.cmc.com. In the event you are unable to listen to the live broadcast, the call will be archived and available for replay on our website on the next business day. Financial and statistical information presented in the broadcast are located on CMC's website under "Investors."
About Commercial Metals Company
Commercial Metals Company and its subsidiaries manufacture, recycle and fabricate steel and metal products and provide related materials and services through a network of facilities that includes seven electric arc furnace ("EAF") mini mills, two EAF micro mills, one rerolling mill, steel fabrication and processing plants, construction-related product warehouses, and metal recycling facilities in the United States and Poland. Through its Tensar division, CMC is a leading global provider of innovative ground and soil stabilization solutions selling into more than 80 national markets through its two major product lines: Tensar® geogrids and Geopier® foundation systems.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the federal securities laws with respect to general economic conditions, key macro-economic drivers that impact our business, the impact of the Russian invasion of Ukraine, the effects of ongoing trade actions, the effects of continued pressure on the liquidity of our customers, potential synergies and organic growth provided by acquisitions and strategic investments, demand for our products, metal margins, the effect of COVID-19 and related governmental and economic responses thereto, the ability to operate our steel mills at full capacity, future availability and cost of supplies of raw materials and energy for our operations, share repurchases, legal proceedings, the undistributed earnings of our non-U.S. subsidiaries, U.S. non-residential construction activity, international trade, capital expenditures, our liquidity and our ability to satisfy future liquidity requirements, estimated contractual obligations, the expected capabilities and benefits of new facilities, the timeline for execution of our growth plan, and our expectations or beliefs concerning future events. The statements in this release that are not historical statements, are forward-looking statements. These forward-looking statements can generally be identified by phrases such as we or our management "expects," "anticipates," "believes," "estimates," "future," "intends," "may," "plans to," "ought," "could," "will," "should," "likely," "appears," "projects," "forecasts," "outlook" or other similar words or phrases, as well as by discussions of strategy, plans, or intentions.
Our forward-looking statements are based on management's expectations and beliefs as of the time this news release was prepared. Although we believe that our expectations are reasonable, we can give no assurance that these expectations will prove to have been correct, and actual results may vary materially. Except as required by law, we undertake no obligation to update, amend or clarify any forward-looking statements to reflect changed assumptions, the occurrence of anticipated or unanticipated events, new information or circumstances or any other changes. Important factors that could cause actual results to differ materially from our expectations include those described in our filings with the Securities and Exchange Commission, including, but not limited to, in Part I, Item 1A, "Risk Factors" of our annual report on Form 10-K for the fiscal year ended August 31, 2021, and Part II, Item IA, "Risk Factors" of our subsequent quarterly reports on Form 10-Q, as well as the following: changes in economic conditions which affect demand for our products or construction activity generally, and the impact of such changes on the highly cyclical steel industry; rapid and significant changes in the price of metals, potentially impairing our inventory values due to declines in commodity prices or reducing the profitability of our downstream contracts due to rising commodity pricing; impacts from COVID-19 on the economy, demand for our products, global supply chain and on our operations, including the responses of governmental authorities to contain COVID-19 and the impact of various COVID-19 vaccines; excess capacity in our industry, particularly in China, and product availability from competing steel mills and other steel suppliers including import quantities and pricing; the impact of the Russian invasion of Ukraine on the global economy, energy supplies and raw materials, which is uncertain, but may prove to negatively impact our business and operations; compliance with and changes in existing and future laws, regulations and other legal requirements and judicial decisions that govern our business, including increased environmental regulations associated with climate change and greenhouse gas emissions; involvement in various environmental matters that may result in fines, penalties or judgments; evolving remediation technology, changing regulations, possible third-party contributions, the inherent uncertainties of the estimation process and other factors that may impact amounts accrued for environmental liabilities; potential limitations in our or our customers' abilities to access credit and non-compliance of their contractual obligations, including payment obligations; activity in repurchasing shares of our common stock under our repurchase program; financial covenants and restrictions on the operation of our business contained in agreements governing our debt; our ability to successfully identify, consummate and integrate acquisitions, and the effects that acquisitions may have on our financial leverage; risks associated with acquisitions generally, such as the inability to obtain, or delays in obtaining, required approvals under applicable antitrust legislation and other regulatory and third party consents and approvals; operating and startup risks, as well as market risks associated with the commissioning of new projects could prevent us from realizing anticipated benefits and could result in a loss of all or a substantial part of our investments; lower than expected future levels of revenues and higher than expected future costs; failure or inability to implement growth strategies in a timely manner; impact of goodwill impairment charges; impact of long-lived asset impairment charges; currency fluctuations; global factors, such as trade measures, military conflicts and political uncertainties, including changes to current trade regulations, such as Section 232 trade tariffs and quotas, tax legislation and other regulations which might adversely impact our business; availability and pricing of electricity, electrodes and natural gas for mill operations; ability to hire and retain key executives and other employees; competition from other materials or from competitors that have a lower cost structure or access to greater financial resources; information technology interruptions and breaches in security; ability to make necessary capital expenditures; availability and pricing of raw materials and other items over which we exert little influence, including scrap metal, energy and insurance; unexpected equipment failures; losses or limited potential gains due to hedging transactions; litigation claims and settlements, court decisions, regulatory rulings and legal compliance risks; risk of injury or death to employees, customers or other visitors to our operations; and civil unrest, protests and riots.
COMMERCIAL METALS COMPANY
NON-GAAP FINANCIAL MEASURES (UNAUDITED)
This press release contains financial measures not derived in accordance with U.S. generally accepted accounting principles ("GAAP"). Reconciliations to the most comparable GAAP measure are provided below.
Adjusted EBITDA, core EBITDA and adjusted earnings are non-GAAP financial measures. Adjusted earnings per diluted share is defined as adjusted earnings on a diluted per share basis.
Non-GAAP financial measures should be viewed in addition to, and not as alternatives for, the most directly comparable measures derived in accordance with GAAP and may not be comparable to similar measures presented by other companies. However, we believe that the non-GAAP financial measures provide relevant and useful information to management, investors, analysts, creditors and other interested parties in our industry as they allow: (i) comparison of our earnings to those of our competitors; (ii) a supplemental measure of our underlying business operational performance; and (iii) the assessment of period-to-period performance trends. Management uses non-GAAP financial measures to evaluate financial performance and set target benchmarks for annual and long-term cash incentive performance plans.
A reconciliation of net earnings to adjusted EBITDA and core EBITDA is provided below:
A reconciliation of net earnings to adjusted earnings is provided below:
View original content:
SOURCE Commercial Metals Company | https://www.mysuncoast.com/prnewswire/2022/06/16/commercial-metals-company-reports-third-quarter-fiscal-2022-results/ | 2022-06-16T11:02:50Z |
North Korea has criticized an agreement between the United States, South Korea and Japan to strengthen military cooperation -- claiming it is part of a US plan to create a military alliance like NATO in the region.
North Korea's foreign ministry spokesperson said as much to a question put by KCNA, the state news agency reported on Sunday.
"The reality clearly shows that the real purpose of the US spreading the rumor about a 'threat from North Korea' is to provide an excuse for attaining military supremacy over the Asia-Pacific region," said the spokesperson.
"The prevailing situation more urgently calls for building up the country's defenses to actively cope with the rapid aggravation of the security environment," the spokesperson added.
US President Joe Biden, Japanese Prime Minister Fumio Kishida and South Korean President Yoon Suk-yeol met on the sidelines of a NATO summit last week and agreed that the progress of North Korea's nuclear and missile programs posed serious threats to not only the Korean peninsula but also East Asia and the world.
They said they would explore further means to reinforce "extended deterrence" against North Korea.
North Korea has this year been conducting missile tests at an unprecedented pace, and is believed by some to be preparing for another nuclear test.
"The deterrence capabilities of the Japan-US and US-Republic Of Korea alliances need to be upgraded as part of the essential effort to strengthen the trilateral partnership between Japan, the US, and ROK," Kishida said.
Ties between Japan and South Korea have long been strained by memories of Japan's occupation of the Korean Peninsula from 1910 to 1945.
Relations deteriorated to their worst in years under South Korea's previous President Moon Jae-in, with spats over territory and history and the two nations calling off an intelligence sharing pact. Yoon, though, has expressed a desire to repair ties, and Kishida has also seemed to respond favorably.
Rookie fireballer Spencer Strider was overpowering, allowing just one hit and one run in six innings as the visiting Atlanta Braves beat the Cincinnati Reds 4-1 on Saturday, July 2, 2022. Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/news/north-korea-says-us-seeking-an-excuse-for-an-asian-nato-with-south-korea-and/article_d6164d6b-46e5-5947-bd3d-2294f2e8d46d.html | 2022-07-03T04:09:40Z |
RESTON, Va., Aug. 3, 2022 /PRNewswire/ -- NVR, Inc. (NYSE: NVR) announced today that its Board of Directors has authorized the repurchase of $500 million of its outstanding common stock. The purchases will occur from time to time in the open market and/or in privately negotiated transactions as market conditions permit. The Company indicated that the authorization is a continuation of the stock repurchase program that began in 1994 and is consistent with NVR's strategy of maximizing shareholder value. Consistent with prior authorizations, this new authorization prohibits the Company from purchasing shares from the Company's officers, directors, Profit Sharing/401(k) Plan Trust or Employee Stock Ownership Plan Trust. As of August 1, 2022, NVR had 3,282,665 total shares of common stock outstanding.
About NVR
NVR, Inc. operates in two business segments: homebuilding and mortgage banking. The homebuilding segment sells and builds homes under the Ryan Homes, NVHomes and Heartland Homes trade names, and operates in thirty-four metropolitan areas in fourteen states and Washington, D.C. For more information about NVR, Inc. and its brands, see www.nvrinc.com, www.ryanhomes.com, www.nvhomes.com and www.heartlandluxuryhomes.com.
View original content:
SOURCE NVR, Inc. | https://www.mysuncoast.com/prnewswire/2022/08/03/nvr-inc-announces-share-repurchase-authorization/ | 2022-08-03T17:45:05Z |
- If successful, REC-2282 could be the first approved treatment for NF2-mutated meningiomas, which are debilitating lesions that occur in approximately 33,000 patients per year
- REC-2282 has been granted Fast Track and Orphan Drug designations for NF2 meningiomas by the U.S. Food and Drug Administration, as well as Orphan Drug designation for NF2 meningiomas by the European Commission
SALT LAKE CITY, June 20, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced the initiation of its Phase 2/3 POPLAR-NF2 clinical trial during the Children's Tumor Foundation NF Conference. The trial will evaluate REC-2282: a potentially first-in-disease, orally bioavailable, central nervous system (CNS) penetrant small molecule histone deacetylase (HDAC) inhibitor, for the treatment of progressive neurofibromatosis type 2 (NF2)-mutated meningiomas.
The study is actively enrolling patients who meet criteria including the following:
- >12 years of age and weighing at least 40 kg
- Progressive meningioma that is amenable to volumetric analysis
- Has either 1) sporadic meningioma with confirmed NF2 mutation; or, 2) confirmed diagnosis of NF2 disease (revised Manchester criteria); or, 3) at least one NF2-related tumor (with pathogenic germline or proven mosaic NF2 variant)
There are currently no FDA-approved drugs for the treatment of patients with NF2, an inherited genetic syndrome that can cause a variety of benign tumors in the central nervous system, including meningiomas. Recursion discovered REC-2282 as a potential candidate for treatment of disease resulting from mutation in the NF2 gene by leveraging its proprietary AI-powered drug discovery platform, the Recursion OS. We believe this approach, in which machine learning is used to identify relationships between biological contexts and chemical entities, will enable Recursion to accelerate the drug discovery process and expand the scope of potential therapeutic candidates for numerous diseases.
"We are currently crying out for a therapy for inoperable meningiomas and in particular the multiple meningiomas that we see in neurofibromatosis type 2 that cause so much morbidity and ultimately mortality," said Professor Gareth Evans, Manchester University NHS Foundation Trust, St. Mary's Hospital. "An efficacious drug that reduces meningioma size or at least stabilizes tumor growth would be highly impactful for neurofibromatosis type 2 patients, with 60% of even isolated meningiomas in these patients being associated with loss of NF2 gene function."
"Initiating patient enrollment in our Phase 2/3 POPLAR-NF2 clinical trial marks a significant moment for patients with neurofibromatosis type 2 and sporadic meningiomas driven by mutations in the NF2 gene," said Glenn Morrison, M.Sc., Ph.D., Vice President of Clinical Development at Recursion.
The Phase 2/3 trial is designed as a randomized, multi-center, double-blind, placebo-controlled study to investigate the safety, efficacy and pharmacokinetics of REC-2282. The study is expected to enroll approximately 90 participants.
For more information about enrollment, please visit this link or reach out to clinicaltrials@recursion.com.
About REC-2282
REC-2282 is a CNS-penetrant, orally bioavailable, small molecule pan-HDAC inhibitor being developed for the treatment of NF2-mutated meningiomas. This molecule appears to be well tolerated, including in patients dosed for multiple years, and potentially has reduced cardiac toxicity that would differentiate it from other HDAC inhibitors. Its oral bioavailability and CNS penetrance distinguish it from currently-approved HDAC inhibitors. REC-2282 has been granted Fast Track and Orphan Drug designations for NF2-mutated meningiomas by the U.S. Food and Drug Administration, as well as Orphan Drug designation for NF2-mutated meningiomas by the European Commission.
About Neurofibromatosis Type 2
NF2 is an autosomal dominant, inherited, rare tumor syndrome caused by loss-of-function mutations in the NF2 tumor suppressor gene, which encodes the cell signaling regulator protein 'merlin.' Loss of NF2 function results in growth of the hallmark tumors that characterize this disease: vestibular schwannomas (VS) and meningiomas. The VS and meningioma tumor types seen in NF2 are among the most common in neuro-oncology. In addition, NF2 mutations give rise to mesotheliomas and underlie subsets of additional tumor types. NF2-mutated meningiomas occur in approximately 33,000 patients per year. The large numbers of these lesions that frequently occur in NF2 patients lead to significant morbidity, including hearing, vision, and mobility impairment, and mortality.
About Recursion
Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
The Company is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.
Media Contact
Media@Recursion.com
Investor Contact
Investor@Recursion.com
Forward-Looking Statements
This document contains information that includes or is based upon "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding early and late stage discovery, preclinical, and clinical programs; licenses and collaborations; prospective products and their potential future indications and market opportunities; Recursion OS and other technologies; business and financial plans and performance; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as "plan," "will," "expect," "anticipate," "intend," "believe," "potential," "continue," and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; the impact of the COVID-19 pandemic and force majeure events; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; and other risks and uncertainties such as those described under the heading "Risk Factors" in our filings with the U.S. Securities and Exchange Commission, including our most recent Quarterly Report on Form 10-Q and our Annual Report on Form 10-K. All forward-looking statements are based on management's current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.
View original content to download multimedia:
SOURCE Recursion | https://www.mysuncoast.com/prnewswire/2022/06/20/recursion-announces-initiation-phase-23-trial-treatment-nf2-mutated-meningiomas-childrens-tumor-foundation-nf-conference/ | 2022-06-20T12:43:27Z |
BELLINZONA, Switzerland (AP) — Sepp Blatter and Michel Platini strongly reiterated their innocence as the two former soccer leaders were questioned on day two of their criminal trial on charges of defrauding FIFA.
Blatter was due to testify on the opening day on Wednesday but the former FIFA president said he was bothered by chest pains and asked to respond the following morning.
“I feel much better, thank you,” the 86-year-old Blatter said at the start of Thursday’s session at the Federal Criminal Court of Switzerland in Bellinzona.
Blatter’s 17-year reign as president came to an end in June 2015, when he resigned amid a corruption scandal. A few months later, federal prosecutors in Switzerland revealed their investigation into a $2 million payment from FIFA to Platini from four years earlier.
The fallout from the case also ended Platini’s campaign to succeed his former mentor and removed the France soccer great as president of UEFA.
Both have always denied wrongdoing and have also long questioned how the disputed payment came to light, airing unproven claims of prosecutors meeting a whistleblower on a park bench.
That was firmly refuted by Thursday’s final witness, former federal prosecutor Olivier Thormann, as he gave testimony that was widely anticipated.
Blatter and Platini claim they had a verbal deal in 1998 for the latter to be paid 1 million Swiss francs ($1.02 million) to serve as advisor to Blatter if he was elected as FIFA president. That defense first failed with judges at the FIFA ethics committee, which banned them from soccer, and later in separate appeals at the Court of Arbitration for Sport.
Platini’s contract with FIFA, signed in August 1999, was for 300,000 Swiss francs ($312,000) annually and backdated to January. It is claimed Blatter said he would pay only the same as FIFA’s then-secretary general, and promised the balance later.
“In the verbal contract we didn’t determine the date he would get it, it was a contract between men, and we started work immediately. I didn’t give him a precise time when he would get it,” Blatter said.
“When I was elected FIFA president, we had a bad balance … at the time I had no idea (when the payment would be made), I simply had this man with me and he was worth this million but I didn’t know when and how he would get it.”
Platini backed up Blatter’s comments in his testimony and claimed he should have been paid more, but had miscalculated the discrepancy in the amount he had been promised and his salary during his four years in the advisory role.
“I made a mistake. I was convinced the salary was 500,000 (Swiss francs) and I realised when the prosecutor showed me the contract. But FIFA knew they cheated me,” Platini said.
The 66-year-old Platini was asked why he waited until 2011 to send FIFA an invoice for the money allegedly owed. The bill came not long after FIFA paid a seven-figure severance to Jerome Champagne, a French former diplomat who was ousted as a Blatter aide.
“I trusted the president and I knew that one day or the other he would pay me. I wouldn’t get into a deal with the president without trusting him,” Platini said. “It wasn’t vital for me that money. What was vital was the word of the president of FIFA.
“I have principles. I’m not going to ask for money from someone who owes me. Just that, one day, I knew that FIFA had given two big payments to employees who left and at that point I told myself it would be good that they remember they owe me money.”
The trial is set to last 11 days and the three federal judges hearing the case are scheduled to deliver their verdict on July 8. Blatter and Platini each face up to five years in prison, but suspended sentences are a likely option.
“I was in shock (when we were first questioned) and that shock has lasted seven years. It’s still here,” Blatter said. “I have already been punished for seven years. It has seemed like an eternity.
“That’s why I’m happy we’re in court now, to learn the truth about what happened. I’m happy we’re here and this will finally end.”
Blatter and Platini refused to answer questions from FIFA lawyer Catherine Hohl-Chirazi.
“What FIFA did to the president of FIFA and me is scandalous, they made us out to be cheaters, fraudsters, money launderers,” Platini said. “Just so that I wouldn’t become president.
“It’s not easy when you’re known worldwide to be criticised worldwide, especially when you have children and grandchildren … I hope there will be justice one day.”
Criminal proceedings were opened against Blatter in September 2015 and it was years later, after Thormann left the prosecution team, that Platini was targeted.
Platini’s lawyer, Dominic Nellen, attempted to show in court the prosecution office had colluded with soccer officials, and that this helped Gianni Infantino become FIFA president in 2016. A FIFA ethics investigation into the $2 million payment led to Platini being banned in 2015 and barred from the election race to succeed Blatter.
However, Thormann said information about the Platini payment was obtained in May 2015 from FIFA’s then-chief financial officer Markus Kattner. Swiss authorities had seized documents and data at FIFA offices in Zurich as part of their wider investigation at the same time as United States federal agents led their own investigation of corruption in international soccer.
The documents detailed FIFA payments to all members of its executive committee, including Platini.
“We received an alert and we opened up a dossier,” Thormann said in court, dismissing any notion of intrigue or conspiracy.
___
More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports | https://cw33.com/sports/ap-sports/blatter-platini-reiterate-innocence-in-testimony-to-court/ | 2022-06-10T14:28:30Z |
Leading employee experience platform receives the highest vendor Net Emotional Footprint score in the "Champion" category and is noted for its trustworthiness and unique features
AUSTIN, Texas, Aug. 3, 2022 /PRNewswire/ -- LumApps, a leading Employee Experience Platform, today announced that it has been named a Champion in the 2022 Digital Workplace Emotional Footprint Award from SoftwareReviews, a division of IT research and advisory firm Info-Tech Research Group.
LumApps took home first place, earning a score of 98 out of 100, with "trustworthy" and "unique features" receiving perfect marks from reviewers.
"This recognition highlights our ongoing commitment to meeting or exceeding our customers' expectations," said Josue Moens, VP of Customer Success at LumApps. "The importance of employee experience platforms continues to increase with the shift to remote and hybrid work. Comms, HR and IT leaders need innovative solutions to ensure their employees have the resources and information they need to be engaged and productive. This feedback validates our technology is making an impact on many important levels."
The Emotional Footprint report illustrates customers' experience with software vendors. The Net Emotional Footprint of a vendor is a result of aggregated emotional response ratings in the areas of service, negotiation, product impact, conflict resolution as well as strategy and innovation, creating a powerful indicator of overall user feeling toward a vendor and its product from the software users' point of view. Emotional Footprint Champions are selected based exclusively on feedback provided by their users via SoftwareReviews' comprehensive online survey. The survey measures user satisfaction across 27 elements of the provider relationship, resulting in the Net Emotional Footprint score. This score represents the overall user sentiment, a powerful indicator of the user feeling toward the provider and the product.
Visit SoftwareReviews to learn more about the Digital Workplace Emotional Footprint Awards. The full report can be found here.
For more on LumApps, visit: www.lumapps.com.
SoftwareReviews is the most in-depth source of buyer data and insights for the enterprise software market. By collecting customer experience data from IT and business professionals, the SoftwareReviews methodology produces detailed and authentic insights into the experience of evaluating and purchasing enterprise software.
LumApps is a cloud-native Employee Experience Platform launched in 2015. Integrated with Google Workspace and Microsoft 365 collaborative suites, LumApps intelligently connects employees to the information and business applications they need to be productive, engaged, and empowered. Whether in the office or in the field, on desktop or mobile app and in any language, LumApps enables knowledge management and best practices sharing across communities. LumApps also automates HR processes and orchestrates personalized journeys for key phases in the employee life cycle, such as onboarding, interviews with managers and more.
With over 300 employees in 7 offices on 3 continents, LumApps serves some of the biggest companies in the world, such as Airbus, Air Liquide, Electronic Arts, Galeries Lafayette, Japan Airlines, Publicis Sapient, Stellantis, The Economist, Valeo, and Veolia, and has over 4 million users worldwide.
Andrea LePain
eMedia Junction
andrea@emediajunction.com
617-275-8112
View original content to download multimedia:
SOURCE LumApps | https://www.kxii.com/prnewswire/2022/08/03/lumapps-lands-1st-place-softwarereviews-2022-digital-workplace-emotional-footprint-awards/ | 2022-08-03T16:51:47Z |
Arizona death-row prisoner won’t be executed in gas chamber
Published: Apr. 29, 2022 at 3:24 PM EDT|Updated: 1 hours ago
PHOENIX (AP) — A prisoner scheduled to be executed in what would be Arizona’s first use of the death penalty in nearly eight years won’t be put to death in the gas chamber.
Clarence Dixon declined to pick a method of execution when officials asked if he wanted to die by lethal injection or the gas chamber.
That means he will be executed by lethal injection, the default execution method.
Dixon is scheduled to be executed May 11 for the 1978 murder of college student Deana Bowdoin.
The last lethal gas execution in the U.S. was carried out in Arizona in 1999. Arizona refurbished its gas chamber in 2020.
Arizona has 113 prisoners on death row.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/04/29/arizona-death-row-prisoner-wont-be-executed-gas-chamber/ | 2022-04-29T21:10:11Z |
CHICAGO, July 29, 2022 /PRNewswire/ -- The American Board of Medical Specialties (ABMS) strongly disagrees with the persistent and misleading assertions that the National Board of Physicians and Surgeons (NBPAS) recertification process provides a means of continuing ABMS board certification or is equivalent to ABMS board certification. Claims of equivalence to ABMS certification or that NBPAS is a means to maintain ABMS Member Board certification are misleading to the profession, and most importantly, to the public who depend upon the strength of ABMS board certification.
Unlike the ABMS Member Boards, NBPAS does not have a process for defining specialty specific standards for knowledge. It does not offer an external assessment of knowledge and skills, which the Institute for Credentialing Excellence defines as the essence of a certification program's ability to validate competence, nor is the NBPAS certificate consistent with established American Medical Association policy on certification.
NBPAS does not have a requirement for improving medical practice, nor does it appear to have a means to address unprofessional conduct by its members. Lastly, it does not engage in research to provide the evidence base supporting the value of its program and informing its continued quality improvement.
ABMS and its Member Boards recently completed a comprehensive, transparent and collaborative process to review and enhance the Member Boards' continuing certification programs, ensuring they are both relevant and supportive of diplomates' learning and improvement needs while providing the public with a reliable and dependable credential. These program revisions address concerns that had been expressed by diplomates about continuing certification: they offer an alternative to the high-stakes exams, provide feedback to support learning, and include processes to allow diplomates to meet requirements prior to certificate loss.
All of these changes serve to reduce diplomate costs, and diplomates like them: Ninety-eight percent of surveyed diplomates prefer longitudinal assessment models over the previous high-stakes exam. At the same time, ABMS continuing certification continues to honor its obligation to the public to verify that ABMS Board Certified physicians have demonstrated the knowledge, skills, and professionalism to provide high quality specialty care.
The value of board certification should not be understated. Patients deserve access to highly skilled specialty care. They expect their physicians to be up to date with the most recent medical advances in their specialties and to demonstrate their proficiency through a rigorous Board certification process. Recognizing NBPAS as a certifying body equivalent to ABMS Member Boards will confuse the public and the profession regarding the meaning and purpose of board certification and may undermine the public trust in board certification and professional self-regulation.
View original content to download multimedia:
SOURCE American Board of Medical Specialties | https://www.kxii.com/prnewswire/2022/07/29/american-board-medical-specialties-response-national-board-physicians-surgeons-assertion-certifying-body-equivalency/ | 2022-07-30T00:00:10Z |
NASHVILLE, Tenn., Aug. 16, 2022 /PRNewswire/ -- Endeavor Business Media has been ranked #1784 of the top 5,000 fastest-growing private companies in the U.S. by the Inc. 5000 Awards. Ranked according to percentage revenue growth from 2018 to 2021, this award recognizes the dynamic expansion of Endeavor in becoming one of the largest B2B media companies in North America.
"We are honored to be ranked among some of nation's most successful private companies and take great pride in the acknowledgment of our significant growth in the four years since our founding. We look forward to our continued expansion, enhancing our ability to provide innovative resources and solutions to our highly-valued audiences and customers," said Chris Ferrell, CEO, Endeavor Business Media.
The Inc. 5000 Awards were introduced in 1982 with the Inc. 500 list of the fastest-growing privately held companies in the United States. Since then, this prestigious list of the nation's most successful private companies has become a symbol of entrepreneurial success.
Headquartered in Nashville, Tennessee, Endeavor Business Media was formed in 2017 to acquire and operate business media brands, events and marketing solutions. Today the company is one of the largest B2B Media companies in the US with more than 700 employees, 9,000 customers and a database of over 10 million business professionals. The company serves business professionals and marketers in key business sectors such as aviation, buildings, construction, dental, electronics, energy, healthcare, manufacturing, networking systems, public safety, transportation, and water. The company has offices in Nashville, TN; Tulsa, OK; Nashua, NH; Birmingham, AL; Sarasota, FL; Skokie, IL; Fort Atkinson, WI; Houston, TX; Independence, OH; Fort Collins, CO, and Overland Park, KS. To learn more, visit www.endeavorbusinessmedia.com.
MEDIA CONTACT: Anna Wackenhuth, awackenhuth@endeavorb2b.com
View original content to download multimedia:
SOURCE Endeavor Business Media | https://www.mysuncoast.com/prnewswire/2022/08/16/endeavor-business-media-ranked-1784-top-5000-fastest-growing-private-companies-us/ | 2022-08-16T19:32:37Z |
Memberful, the best option for video creators to monetize their audience, announces its sponsorship at VidCon.
SAN FRANCISCO , June 22, 2022 /PRNewswire/ -- Memberful, a membership software that helps creators, entrepreneurs, podcasters, and educators create sustainable businesses, today announced its Sponsorship at VidCon for the first time. Memberful will host a takeover at the Hyatt Regency Bar from June 22 to June 25, 2022.
Memberful is the best-in-class, no code required membership software for independent creators, publishers, educators, podcasters, and more. Memberful provides creators with the tools and support to monetize their content through flexible and customizable software that integrates directly into WordPress websites or existing technology to retain complete control of branding, content, and membership.
The creator economy is exploding, yet traditional social platforms still have control over a creator's future. In addition, they bring many challenges, including algorithm instability, shadow bans, platform outages, and limited community interaction outside of likes and comments. Memberful allows creators to take back control of their audience and content with easy-to-use white-label software.
"Creators face so many challenges these days. Our goal is to make it easy for video creators to quickly launch a membership business where they remain in control and can create a beautifully branded member experience while monetizing their audience," said Tiffany Perko, Head of Marketing at Memberful. "We are excited to meet with the many video creators attending VidCon this week and share why Memberful is the best option for their membership needs."
Membership is a great way to diversify a creator's revenue stream, and Memberful makes it easy. With customized subscription plans, easy member management, automatic transactional emails, optimized checkouts, dashboard analytics, and more, creators can focus on what they do best and begin driving revenue immediately.
Memberful has been featured on Tech Crunch, JumpStart Magazine, The Verge, Vimeo, and more.
About Memberful:
Memberful is a membership software that helps creators, entrepreneurs, podcasters, and educators create sustainable businesses. Through tools that empower customers to reach a larger audience and make a living out of what interests them most, Memberful makes running a successful membership-based business easy.
Press Inquiries
Tribe Builder Media
Kristen Shea
929-367-8993
press@tribebuildermedia.com
View original content:
SOURCE Memberful | https://www.mysuncoast.com/prnewswire/2022/06/22/memberful-announces-hyatt-regency-bar-takeover-with-patreon-vidcon/ | 2022-06-22T10:48:04Z |
$48.0 million in cash and cash equivalents as of June 30, 2022 to support ongoing programs through August 2023
International sites for Mino-Lok® Phase 3 trial engaged as recruitment accelerates
I/ONTAK Biologics License Application (BLA) on track for 2H 2022 submission
CRANFORD, N.J., Aug. 11, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today reported business and financial results for the third fiscal quarter of 2022 ended June 30, 2022.
Fiscal Q3 2022 Business Highlights and Subsequent Developments
- Mino-Lok® Phase 3 trial recruitment approached pre-Covid-19 pace; international trial sites engaged to accelerate trial enrollment; Company reiterates 92 failure events required for trial completion;
- Halo-Lido Phase 2b trial initiated; enrollment completion anticipated by end of 2022;
- I/ONTAK (denileukin diftitox) topline results show no new safety signals and are consistent with prior formulation (ONTAK);
- Pre-BLA meeting held with the FDA for I/ONTAK; biologics license application (BLA) remains on track for submission in the second half of 2022; and,
- Announced intention to spinoff I/ONTAK into standalone oncology-focused publicly traded company.
Financial Highlights
- Cash and cash equivalents of $48.0 million as of June 30, 2022;
- R&D expenses were $4.9 million and $13.8 million for the three and nine months ended June 30, 2022, respectively, compared to $2.2 million and $9.9 million for the three and nine months ended June 30, 2021, respectively;
- G&A expenses were $3.0 million and $9.0 million for the three and nine months ended June 30, 2022, respectively, compared to $3.4 million and $ 7.4 million for the three and nine months ended June 30, 2021, respectively;
- Stock-based compensation expense was $1.0 million and $2.9 million for the three and nine months ended June 30, 2022, respectively, compared to $0.4 million and $1.0 million for the three and nine months ended June 30, 2021, respectively; and,
- Net loss was $8.9 million and $25.6 million, or ($0.06) and ($0.18) per share for the three and nine months ended June 30, 2022, respectively, compared to a net loss of $7.3 million and $19.5 million, or ($0.05) and ($0.20) per share for the three and nine months ended June 30, 2021, respectively.
"Citius made solid progress during the quarter to advance our multiple programs. We expanded the Phase 3 Mino-Lok trial to include international sites with the intention of increasing and accelerating enrollment. Our efforts remain focused on driving patient recruitment, which we believe will hasten trial completion. Based on the current the pace of enrollment and the ramp up of our international sites, we expect to enroll the last patient, to complete the trial by the end of 2022, subsequently with the required number of events," stated Leonard Mazur, Chairman and CEO of Citius.
"Our I/ONTAK program remains on track with an anticipated BLA submission later this year. Topline results for the Phase 3 trial of I/ONTAK were consistent with the prior FDA-approved formulation (ONTAK) and we believe there remains a significant unmet medical need in the market for CTCL patients. We recently completed a pre-BLA meeting with the U.S. Food and Drug Administration (FDA) and appreciate their continued guidance. Additionally, the Halo-Lido Phase 2b trial for the treatment of hemorrhoids was initiated during the quarter and we remain encouraged that we may complete enrollment in this trial by the end of the year," added Mazur.
"Our balance sheet remains strong with $48 million in cash available and no debt, providing us with greater strategic and financing flexibility than many of our peers. We believe these funds are sufficient to allow us to execute our activities through August 2023. To support our value-creating clinical, regulatory and commercial efforts, and to further unlock the value of I/ONTAK and Citius, we announced our intent to explore a tax-free non-dilutive spin-off to create a separate publicly traded oncology company. We believe this remains a viable option, notwithstanding recent market volatility, and will continue to monitor market conditions as we proceed. In addition to a potential spin-off, there are multiple other non-dilutive options available to Citius including out-licensing agreements, asset sales or other strategic arrangements, as well as debt financing. Consequently, we remain encouraged in the progress of our pipeline and confident in our ability to advance each of our key programs," concluded Mazur.
THIRD QUARTER ENDED JUNE 30, 2022 Financial Results:
Liquidity
As of June 30, 2022, the Company had $48.0 million in cash and cash equivalents, no debt, and 146,129,630 common shares issued and outstanding.
The Company estimates that its available cash resources will be sufficient to fund its operations through August 2023.
Research and Development (R&D) Expenses
R&D expenses were $4.9 million and $13.8 million for the three and nine months ended June 30, 2022, respectively, compared to $2.2 million and $9.9 million for the comparable periods ended June 30, 2021. The increase during the quarter is primarily due to additional R&D expenses related to the expansion of the Mino-Lok® trial to include sites outside the United States, start-up costs associated with the Halo-Lido Phase 2b trial which enrolled its first patient in April, 2022, and R&D expenses related to I/ONTAK for which a BLA submission to the FDA is being prepared.
During the nine months ended June 30, 2022, ARDS-related R&D expenses decreased by $4.7 million compared to $5.3 million during the prior year period. R&D expense for the nine months ended June 30, 2021 reflected a $5.0 million license fee paid to Novellus.
We expect that research and development expenses will increase in fiscal 2022 as we continue to focus on our Phase 3 trials for Mino-Lok® and I/ONTAK, progress the Halo-Lido product candidate, and continue our research and development efforts related to ARDS and Mino-Wrap.
General and Administrative (G&A) Expenses
G&A expenses were $3.1 million and $9.0 million for the three and nine months ended June 30, 2022, respectively, compared to $3.4 million and $7.4 million for the comparable periods ended June 30, 2021. The decrease during the quarter is primarily due to reduced costs for performance bonuses. The primary reasons for the increase over the nine-month period were additional compensation costs for new employees, increased investor relations costs and additional insurance expense. General and administrative expenses consist primarily of compensation costs, professional fees for legal, regulatory, accounting, and corporate development services, and investor relations expenses.
Stock-based Compensation Expense
For the fiscal quarter ended June 30, 2022, stock-based compensation expense was $1.0 million as compared to $0.4 million for the prior year period. For the nine months ended June 30, 2022, stock-based compensation expense was $2.9 million as compared to $1.0 million for the nine months ended June 30, 2021. The increase primarily reflects expenses related to new grants made by Citius to employees (including new hires), directors and consultants.
Net loss
Net loss was $8.9 million, or ($0.06) per share for the three months ended June 30, 2022, compared to a net loss of $5.8 million, or ($0.05) per share for the three months ended June 30, 2021.
Net loss was $25.6 million, or ($0.18) per share for the nine months ended June 30, 2022, compared to a net loss of $18.1 million, or ($0.20) for the nine months ended June 30, 2021.
The increase in net loss is primarily due to an increase in research and development expenses, general and administrative expenses and stock-based compensation.
Citius is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapies. The Company has two late-stage product candidates, Mino-Lok®, an antibiotic lock solution for the treatment of patients with catheter-related bloodstream infections (CRBSIs), which is currently enrolling patients in a Phase 3 Pivotal superiority trial, and I/ONTAK (E7777), a novel IL-2R immunotherapy for an initial indication in cutaneous T-cell lymphoma (CTCL), for which a BLA submission is being prepared for the second half of 2022. Mino-Lok® was granted Fast Track designation by the U.S. Food and Drug Administration (FDA). I/ONTAK has received orphan drug designation by the FDA for the treatment of CTCL and peripheral T-cell lymphoma (PTCL). For more information, please visit www.citiuspharma.com.
Safe Harbor
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius. You can identify these statements by the fact that they use words such as "believe," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: our ability to successfully undertake and complete clinical trials and the results from those trials for our product candidates; our decision whether to proceed with the planned spinoff, if at all, our ability to successfully complete the planned spinoff if undertaken, and the benefits achieved by the planned spinoff; our need for substantial additional funds; our ability to commercialize our products if approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; risks relating to the results of research and development activities, including those from existing and new pipeline assets; uncertainties relating to preclinical and clinical testing; the early stage of products under development; our ability to attract, integrate, and retain key personnel; our dependence on third-party suppliers; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; our ability to procure cGMP commercial-scale supply; government regulation; competition; as well as other risks described in our SEC filings. These risks have been and may be further impacted by Covid-19. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our Securities and Exchange Commission ("SEC") filings which are available on the SEC's website at www.sec.gov, including in our Annual Report on Form 10-K for the year ended September 30, 2021, filed with the SEC on December 15, 2021 and updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.
Investor Relations for Citius Pharmaceuticals:
Ilanit Allen
Vice President, Corporate Communications and Investor Relations
T: 908-967-6677 x113
E: ir@citiuspharma.com
-- Financial Tables Follow –
View original content to download multimedia:
SOURCE Citius Pharmaceuticals, Inc. | https://www.kxii.com/prnewswire/2022/08/11/citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2022-financial-results-provides-business-update/ | 2022-08-11T21:21:35Z |
Gov. orders flags at half-staff for Peace Officers Memorial Day
TOPEKA, Kan. (WIBW) - Flags have been ordered to be flown at half-staff over the weekend in honor of Peace Officers Memorial Day.
Kansas Governor Laura Kelly says on Thursday, May 12, she ordered flags to be lowered to half-staff throughout the state effective from sunrise to sundown on Sunday, May 15, to honor Peace Officers Memorial Day.
Gov. Kelly noted that Peace Officers Memorial Day honors local, state and federal peace officers who have died or been disabled in the line of duty.
“Kansas peace officers risk their lives daily to protect their communities,” Kelly said. “Their dedication and sacrifices to keep us safe do not go unnoticed. On May 15th, and every day, we honor their service.”
For more information about flags at half-staff, click HERE.
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/05/12/gov-orders-flags-half-staff-peace-officers-memorial-day/ | 2022-05-12T19:03:36Z |
Targeting positive cash from operations to start during H2/22[1]
Focus on earlier achievement of operational profitability thanks to a recently implemented comprehensive cost reduction plan, with expected operational cost savings of approximately $50 million over the next 18 months
Continuous implementation of disciplined cost controls reduced Q1/22 cash used in operating activities by more than 70% to approximately $4 million, compared to approximately $15 million in Q4/21
Net revenues of $18.2 million in Q1/22; Cash balance[2] of $45 million as of March 31, 2022
Talicia® TRx up 12.8% over Q4/21 and Movantik® continues strong Q4/21 prescription performance
Amendment improves key covenants in the HCR Credit Agreement
Given encouraging data to date, opaganib and RHB-107 COVID-19 Phase 3-stage programs expected to be funded via external sources; Global and U.S. regulatory interactions ongoing
Management to host webcast today, at 08:30 a.m. EDT
TEL AVIV, Israel and RALEIGH, N.C., June 23, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its first quarter 2022 financial results and operational highlights, targeting positive cash from operations1 to start during H2/22 and recent implementation of a comprehensive cost reduction plan, expected to generate operational cost savings of approximately $50 million over the next 18 months.
Dror Ben-Asher, RedHill's Chief Executive Officer, said: "To address the current market realities and operating landscape, RedHill is being decisive about controlling its own destiny and is highly focused on achieving earlier profitability, targeting positive cash from operations to start during H2/221. Our comprehensive cost reduction plan is expected to generate operational cost savings of approximately $50 million over the next 18 months. The majority of these savings result from an approximately one-third reduction of the U.S. commercial team workforce, returning to pre-pandemic levels, streamlined operational expenditure including selling, general and administrative (SG&A) expenses and refining the Company's R&D strategy to rely mostly on external funding sources based on the promising clinical data generated to date. On behalf of RedHill and its Board of Directors, I would like to express my profound and respectful gratitude to the colleagues who are departing RedHill. We value and are extremely grateful for your immense contributions and dedication which enabled RedHill to build a first-class U.S. commercial organization and launch three innovative products that help patients in need. While difficult, the changes we have made as part of our cost reduction plan were necessary given the current realities."
Mr. Ben-Asher continued: "Improved financial stability resulting from cost savings, a commercial basket including three FDA-approved proprietary drugs, continued prescription growth and healthy sales, improved managed care coverage and the amended credit agreement with HCR, positions RedHill for further growth. To that end, RedHill is in non-binding discussions to acquire a synergetic U.S. FDA-approved, patented GI drug currently generating dozens of millions of dollars, which, if materialized, will help expedite and increase cash generation."
Micha Ben Chorin, Chief Financial Officer at RedHill, added: "RedHill's commercial team has further strengthened Movantik®'s share of the growing PAMORA class to approximately 74%, and Talicia®'s approximately 13% quarterly growth further consolidates its position as the leading U.S. brand for H. pylori eradication. The Company's disciplined cost control measures reduced Q1/22 cash used in operating activities by more than 70% to approximately $4 million, compared to approximately $15 million in Q4/21. Despite the challenging market conditions, RedHill is on its way to achieving company-wide positive cash from operations1 this year, and this, along with the envisaged growth drivers from the pipeline and potential acquisitions, could boost cash generation and further improve cash flow. We are confident that RedHill is well positioned for continuing growth."
Mr. Ben-Asher further remarked: "Turning to R&D, in reliance of promising clinical and other data we generated to date, we expect external funding for much of our promising R&D programs, through grants, industry partnerships and participation in platform studies. COVID-19, included in a broader category of 'pandemic preparedness', remains an area of high interest and need for novel oral therapeutics such as RedHill's candidates. Regulatory feedback on opaganib, supportive of a confirmatory study has provided a pathway to potential opaganib submissions for approval in COVID-19. Most recently, opaganib further exhibited its variant-agnostic credentials by demonstrating potent in vitro efficacy against Omicron, while also showing, in a separate study, potent in vitro inhibition of influenza A H1N1, adding to evidence of opaganib's broader antiviral potential and its promising applicability to 'pandemic preparedness'. Meanwhile, RedHill's 2nd COVID-19 therapeutic candidate, RHB-107, successfully met the Part A study primary outcome measure for its Phase 2/3-stage study in non-hospitalized COVID-19, showing, among other promising data, a 100% reduction in hospitalization due to COVID-19. Discussions are ongoing regarding potential external funding through grants, platform studies and other public, private and industry partnerships to support the opaganib and RHB-107 programs, as well as our ongoing Phase 3 study with RHB-204 for NTM disease."
Financial results for the quarter ended March 31, 2022 (Unaudited)[3]
Net Revenues for the first quarter of 2022 were $18.2 million, as compared to $22.1 million in the fourth quarter of 2021, the difference being attributable to typical cyclical trends in Movantik sales and increased gross to net deductions related mainly to increased formulary coverage.
Cost of Revenues for the first quarter of 2022 were $8.0 million, as compared to $19.3 million in the fourth quarter of 2021. The decrease was attributed to recognition of an approximately $9 million impairment related to the intangible asset of Aemcolo® for travelers' diarrhea in the previous quarter.
Gross Profit for the first quarter of 2022 was $10.2 million, as compared to $2.7 million in the fourth quarter of 2021. The increase was attributed to the impairment recognized in the previous quarter, as detailed above.
Research and Development Expenses for the first quarter of 2022 were $3.1 million, as compared to $5.9 million in the fourth quarter of 2021. The decrease was attributed to the ongoing optimization of R&D costs and completion of elements of the opaganib and RHB-107 development programs.
Selling, Marketing and General and Administrative Expenses for the first quarter of 2022 were $20.4 million, as compared to $17.6 million in the fourth quarter of 2021. The increase was mainly attributed to a one-off positive adjustment in quarter four of 2021 and expenses related to professional services and other related expenses in the first quarter of 2022.
Operating Loss for the first quarter of 2022 was $13.2 million, as compared to $20.7 million in the fourth quarter of 2021. The decrease was mainly attributed to the impairment recognized in the previous quarter, as detailed above.
Net Cash Used in Operating Activities for the first quarter of 2022 was $4.2 million, as compared to $14.9 million in the fourth quarter of 2021. The decrease was mainly due to changes in working capital and continued implementation of cost-reduction measures.
Net Cash Used in Financing Activities for the first quarter of 2022 was $4.9 million, as compared to Net Cash Provided by Financing Activities of $17.6 million in the fourth quarter of 2021, comprised mostly from proceeds of equity offerings completed in the fourth quarter of 2021. The additional decrease of $5 million was due to a reduction of Movantik acquisition liabilities.
Liquidity and Capital Resources
Cash Balance1 as of March 31, 2022, was $45.0 million, as compared to $54.2 million as of December 31, 2021.
On June 17, 2022, RedHill Biopharma Inc. signed an amendment to the HCR Credit Agreement reducing the revenue covenant to $75.0 million for the next two quarters, with a 0.5% increase in interest.
The license of opaganib[4] for COVID-19 by Kukbo for South Korea is expected to yield a $1.5 million upfront payment to RedHill and, in addition, up to $5.6 million in milestone payments plus royalties on net sales.
The license of Talicia for H. pylori by Gaelan Medical for the United Arab Emirates, with $2.0 million upfront payment received, is anticipated to yield additional milestones and royalties on net sales.
Discussions with additional potential partners, for both in- and out-licensing partnerships, are ongoing including for potential acquisitions of additional synergetic commercial products with strong cash generation potential.
Commercial Highlights
Movantik® (naloxegol)[5]
The Company's focus and determination to drive both Movantik and the PAMORA class as a whole have delivered important results, with Movantik's Q1/22 performance matching the record pace set in Q4/21. This represents an 8.6% increase in new prescriptions compared to Q1/21, more than doubling the already strong growth of the overall PAMORA class in the same period and contributing to a further increase in market share for Movantik, now up to almost 74% of the PAMORA class.
Nearly 92% of insurance plans provide access for Movantik – best-in-class coverage – and as of January 1, 2022, Movantik® has been approved for inclusion as a preferred and unrestricted brand on a major National Medicare Part D formulary serving more than 10 million Americans. Movantik's total commercial coverage now extends to 151 million American patients' lives and has grown to 46 million Medicare lives, with over 93% coverage of Medicare Part D lives.
With best-in-class payer coverage, focused execution in the pain segment and continuing the PAMORA class market development, Movantik is well-positioned for continued growth in 2022 and beyond.
Talicia® (omeprazole magnesium, amoxicillin and rifabutin)[6]
Talicia reached new TRx heights in Q1/22, growing a further 12.8% compared to the previous record levels set in Q4/21. This growth represents an 80% increase in new prescriptions from Q1/21, further cementing Talicia's position as the most prescribed branded H. pylori therapy in the U.S. Significant increase in prescription volume in March of this year, coupled with a growing prescriber base, improving payor coverage and continuing promotional focus is expected to result in further growth acceleration.
Medi-Cal, California's Medicaid Health Care program, which added Talicia last year to its Contract Drug List (CDL) for H. pylori treatment, with no prior authorization required, expanded coverage to 14 million beneficiaries on January 1, 2022. Florida Medicaid coverage started in April and another large Part D plan coverage became effective earlier this quarter. The Company also expects a major new coverage win to initiate July 1, 2022. As of May 2022, total Talicia coverage stood at nearly 200 million American lives, equating to seven out of ten lives.
Outside of the U.S., in January 2022, the Company announced that it had entered into an exclusive license agreement with Gaelan Medical Trade LLC, a wholly owned subsidiary of the Ghassan Aboud Group (GAG), for Talicia in the United Arab Emirates (UAE). Under the terms of the agreement, RedHill received an upfront payment of $2 million and is eligible for additional milestone payments as well as tiered royalties up to mid-teens on net sales of Talicia in the UAE if marketing authorization is received and Talicia is commercialized. Gaelan Medical received the exclusive rights to Talicia in the UAE, as well as a right of first refusal in relation to Talicia in the Gulf Cooperation Council region (Saudi Arabia, Kuwait, Qatar, Bahrain and Oman) for a pre-determined period.
Aemcolo® (rifamycin)[7]
The Company continues to be ready for post-COVID-19 returning travel opportunities for Americans.
R&D Highlights
Opaganib (ABC294640)
COVID-19:
COVID-19, included in a broader category of 'pandemic preparedness', remains an area of high interest and need for novel oral therapeutics. Data from prespecified analyses of opaganib's Phase 2/3 study (NCT04467840), announced in January and February 2022, demonstrated that opaganib improved viral RNA clearance, achieved faster time to recovery and reduced mortality in key subpopulations of moderate to severe hospitalized patients with COVID-19. Additionally, a post-hoc analysis identified a biomarker, the fraction of inspired oxygen (FiO2), to select patients that showed superior outcomes with opaganib vs. placebo. Opaganib also demonstrated potent in vitro efficacy against the Omicron SARS-CoV-2 variant and is expected to remain effective against sub-variants BA.2, XE and other emerging and future variants. Based on regulatory guidance, a positive confirmatory study constitutes the likely pathway to potential opaganib submissions for approval in the U.S., EU, and multiple other territories.
Data from the global Phase 2/3 study has now been published on MedRxiv and will also be the subject of a "Late-Breaker" oral presentation at the joint CDC / Task Force for Global Health-organized International Conference on Emerging Infectious Diseases, to be held in August.
On June 21, 2022, and adding to opaganib's expanding patent suite, RedHill was granted an additional U.S. patent directed to a method for the treatment of COVID-19 in patients with moderate to severe COVID-19 related pneumonia using opaganib.
RedHill is pursuing multiple public and private external funding sources for our programs including grants in the U.S., UK and EU, government sponsored platform studies and industry partnerships. In March 2022, the Company announced that it had entered into an exclusive license agreement with Kukbo Co. Ltd., a South Korean corporation, for the exclusive rights to commercialize opaganib for the treatment of COVID-19 in South Korea. Under the terms of the agreement, RedHill is entitled to receive an upfront payment of $1.5 million and is eligible for $5.6 million in additional milestone payments, as well as low double-digit royalties on net sales of opaganib if marketing authorization is received and opaganib is commercialized.
Other indications under investigation:
Influenza A H1N1: Opaganib demonstrated potent in vitro inhibition of influenza A H1N1, at low concentrations and with no evidence of toxicity at these levels. The results were obtained in Normal Human Bronchial Epithelial Cells (NHBE) assay, the natural human target of the virus, making it a realistic model. These results add to previous data demonstrating antiviral activity in several in vitro and in vivo viral infection models including SARS-CoV-2, influenza and Ebola, providing further evidence of opaganib's potential broad-spectrum antiviral effect. Discussions with NIH are ongoing regarding next steps for investigating opaganib's broader antiviral potential and its promising applicability to 'pandemic preparedness'.
Oncology:
The Company continues to advance opaganib's development program in oncology with the cholangiocarcinoma (CCA) Phase 2 study analysis expected in Q3/2022
RHB-107 (upamostat)[8]
COVID-19:
In March 2022, the Company announced positive top-line results from Part A of the two- stage Phase 2/3 study of novel, once-daily, orally-administered, antiviral drug candidate, RHB-107. The study, evaluating RHB-107 for the treatment of non-hospitalized patients with symptomatic COVID-19 in the early course of the disease (NCT04723537), who do not require supplemental oxygen (the vast majority of COVID-19 patients) was predominantly conducted in the U.S. (60/61 patients) as well as South Africa.
Results showed that RHB-107 met the primary outcome measure, demonstrating a favorable safety and tolerability profile and showed a 100% reduction in hospitalization due to COVID-19, with zero patients (0/41) on the RHB-107 arms versus 15% (3/20) hospitalized due to COVID-19 on the placebo-controlled arm (nominal p-value=0.0317). The study also showed an approximately 88% reduction in reported new severe COVID-19 symptoms after treatment initiation, with only one patient in the RHB-107 treated group 2.4%, (1/41) versus 20% (4/20) of patients in the placebo-controlled arm. Further analysis of study data also showed a faster recovery from severe COVID-19 symptoms for patients in the RHB-107 arm, with a median of 3 days to recovery with RHB-107 vs. 8 days with placebo.
RHB 107's unique human host-targeted, suggested antiviral mechanism is expected to act independently of viral spike protein mutations and remain effective against Omicron and sub-variants BA.2, XE and other emerging and future variants.
Next steps for the study are expected following ongoing discussions with regulators.
RHB-204 - Pulmonary Nontuberculous Mycobacteria (NTM) Disease[9]
A U.S. Phase 3 study is ongoing in the U.S. to evaluate the efficacy and safety of RHB-204 in adults with pulmonary NTM disease caused by Mycobacterium avium Complex (MAC) infection (NCT04616924). The waning of COVID-19 is expected to accelerate the advancement of the program
The study protocol provides for 6 months co-primary endpoint of sputum culture conversion (SCC) and clinical outcome (patient-reported outcomes - PRO) in a randomized placebo-controlled design, followed by open label active treatment with RHB-204 for 12 months from conversion.
RHB-204 has been granted Orphan Drug designation and QIDP status – providing for Fast Track and Priority Review and resulting in eligibility for 12 years post-approval market exclusivity.
Conference Call and Webcast Information:
The Company will host a conference call and webcast today, Thursday, June 23, 2022, at 8:30 a.m. EDT, during which it will present key highlights for the first quarter of 2022.
The webcast including slides will be broadcast live on the Company's website, https://ir.redhillbio.com/events, and will be available for replay for 30 days.
To participate in the conference call, please dial one of the following numbers up to 30 minutes before the scheduled start time: United States: +1-855-979-6654; International: +1-646-664-1960; and Israel: +972-72-258-7959; the access code for the call is: 647114.
To pre-register for the conference call, click here.
About RedHill Biopharma
RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults7, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults8, and Aemcolo® for the treatment of travelers' diarrhea in adults9. RedHill's key clinical late-stage development programs include: (i) RHB-204, with an ongoing Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) disease; (ii) opaganib (ABC294640), a first-in-class oral SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for hospitalized COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; (iii) RHB-107 (upamostat), an oral serine protease inhibitor in a Phase 3-stage study as treatment for non-hospitalized symptomatic COVID-19, and targeting multiple other cancer and inflammatory gastrointestinal diseases; (iv) RHB-104, with positive results from a first Phase 3 study for Crohn's disease; (v) RHB-102 , with positive results from a Phase 3 study for acute gastroenteritis and gastritis and positive results from a Phase 2 study for IBS-D; and (vi) RHB-106, an encapsulated bowel preparation. More information about the Company is available at www.redhillbio.com/ twitter.com/RedHillBio.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words and include statements regarding anticipated positive cash from operations before interest expected in 2022, the expected operational cost savings from the cost reduction plan and discussions regarding the acquisition of a synergetic U.S. FDA-approved GI drug. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified, and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, the risk that the anticipated positive cash from operations before interest will not be positive in 2022, that the expected operational cost savings from the cost reduction plan will be lower than anticipated, that the acquisition of a synergetic U.S. FDA-approved GI drug will not materialize, that the obligations of the term loan are unable to be met, that we will not be successful in increasing sales of our commercial products, including due to market conditions, that the Phase 2/3 COVID-19 study for RHB-107 may not be successful and, even if successful, such studies and results may not be sufficient for regulatory applications, including emergency use or marketing applications, and that additional COVID-19 studies for opaganib and RHB-107 are likely to be required, as well as risks and uncertainties associated with the risk that the Company will not successfully commercialize its products; as well as risks and uncertainties associated with (i) the initiation, timing, progress and results of the Company's research, manufacturing, pre-clinical studies, clinical trials, and other therapeutic candidate development efforts, and the timing of the commercial launch of its commercial products and ones it may acquire or develop in the future; (ii) the Company's ability to advance its therapeutic candidates into clinical trials or to successfully complete its pre-clinical studies or clinical trials or the development of a commercial companion diagnostic for the detection of MAP; (iii) the extent and number and type of additional studies that the Company may be required to conduct and the Company's receipt of regulatory approvals for its therapeutic candidates, and the timing of other regulatory filings, approvals and feedback; (iv) the manufacturing, clinical development, commercialization, and market acceptance of the Company's therapeutic candidates and Talicia®; (v) the Company's ability to successfully commercialize and promote Talicia®, and Aemcolo® and Movantik®; (vi) the Company's ability to establish and maintain corporate collaborations; (vii) the Company's ability to acquire products approved for marketing in the U.S. that achieve commercial success and build its own marketing and commercialization capabilities; (viii) the interpretation of the properties and characteristics of the Company's therapeutic candidates and the results obtained with its therapeutic candidates in research, pre-clinical studies or clinical trials; (ix) the implementation of the Company's business model, strategic plans for its business and therapeutic candidates; (x) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its therapeutic candidates and its ability to operate its business without infringing the intellectual property rights of others; (xi) parties from whom the Company licenses its intellectual property defaulting in their obligations to the Company; (xii) estimates of the Company's expenses, future revenues, capital requirements and needs for additional financing; (xiii) the effect of patients suffering adverse experiences using investigative drugs under the Company's Expanded Access Program; (xiv) competition from other companies and technologies within the Company's industry; and (xv) the hiring and employment commencement date of executive managers. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 20-F filed with the SEC on March 17, 2022. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement, whether as a result of new information, future events or otherwise unless required by law.
[1] Positive cash from operations before interest payments.
[2] Including cash, cash equivalents, short-term bank deposits and restricted cash.
[3] All financial highlights are approximate and are rounded to the nearest hundreds of thousands.
[4] Opaganib is an investigational new drug, not available for commercial distribution.
[5] Movantik® (naloxegol) is indicated for opioid-induced constipation (OIC). Full prescribing information see: www.movantik.com.
[6] Talicia® (omeprazole magnesium, amoxicillin and rifabutin) is indicated for the treatment of H. pylori infection in adults. For full prescribing information see: www.Talicia.com.
[7] Aemcolo® (rifamycin) is indicated for the treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in adults. For full prescribing information see: www.aemcolo.com.
[8] RHB-107 (upamostat) is an investigational new drug, not available for commercial distribution.
[9] RHB-204 is an investigational new drug, not available for commercial distribution.
View original content:
SOURCE RedHill Biopharma Ltd. | https://www.kxii.com/prnewswire/2022/06/23/redhill-biopharma-announces-q122-highlights-track-positive-cash-operations-h222/ | 2022-06-23T11:38:08Z |
Finding niches, uncovering new revenue streams, and driving the art of the possible across the entire digital banking value chain
MIAMI, Aug. 10, 2022 /PRNewswire/ -- Technisys, the company behind Cyberbank, the cloud-native, next-gen digital banking platform, continues to redefine the digital transformation journey and customer experience for financial institutions (FIs) with its latest release of Cyberbank Core. The solution signifies the next evolution of the core banking platform that enables retail and commercial banks to accelerate their digital banking efforts and future-proof their businesses. With Cyberbank Core, banks and financial institutions can create innovative products and services based on powerful parameterization tools and a library of ready-to-use capabilities.
Today, it's more strategically important than ever to empower FIs with a next-gen digital core that supports agility, innovation, and new modes of working that fuel endless digital potential. Innovations in digital core banking are supporting more cost-neutral and agile ways of optimizing in the cloud. The array of leading-edge technologies—including low-code/no-code, more intelligent business rule discovery, and core mapping—offer new ways to bolster valuable core assets.
Cyberbank Core makes it easy to add capabilities, define behaviors and change product functionality quickly and easily by using business-oriented tools to notably accelerate launching new products to market at massive scale.
"Today, FIs will focus less on enhancing existing financial products and services and more on delivering novel, tailored experiences in real time that meet the ever-evolving needs of consumers," says Mike Santos, Founder and CEO of Technisys. "Enabling FIs with smarter ways to deliver value - through tailored financial products - and forming a clear view where operations and offerings will matter most."
Cyberbank Core 4.0 offers key benefits that justify the power of modernizing to a next-gen core banking platform:
- Economic benefit. Reduce the production costs of your core processing system by taking advantage of the neo-core's small footprint, unique customer-centric pricing model, and the "on-demand" processing power and utility pricing of the cloud.
- Business benefit. Create services that truly solve customer needs, when the customer needs them. Create and deliver financial offerings in unique ways that solve specific customer pain points (e.g., Early Pay/Early Wage Access, PoS Financing/BNPL). Bring new products to market in weeks vs months and enable "fail fast" program execution.
- Operational benefit. Adopt a real-time operating model with embedded risk controls at the level of granularity that banks need, even at the microservices level, reducing the need for error-prone human-centric controls that erode efficiency. Orchestrate across APIs to further automate controls involving other systems, such as a fraud detection engine.
- Strategic benefit. Embrace customer-centricity, down to the core. Build products and pricing for the specific desired customer segments, geographies, and subsidiaries in a vastly simpler way, eliminating the need for the legacy ancillary systems driving today's "lasagna" and "spaghetti" architecture.
Cyberbank Core 4.0 offers a unique customer-centric model (not based on accounts or transactions like legacy cores), while enabling faster time to market and personalization with a pre-integrated digital self-service customer engagement platform for internet and mobile banking. The architecture allows for integration with third-party ecosystems to use best-of-breed solutions with ease of switching in the future, resulting in lower run cost, automation and resilience - the only next-gen core to support true cloud choice on five clouds (i.e., Microsoft Azure, Amazon AWS, Google Cloud Platform, IBM RedHat OpenShift, IBM LinuxOne).
"The work of enhancing legacy core assets is not a one-time task—it's an ongoing opportunity," says Ricardo Zuasti, Chief Product Officer of Technisys. "Core application scope is decomposing across platform ecosystems. It is becoming a decentralized, cloud-enabled, API-orchestrated collection of capabilities made cohesive by a simplified and tailored user experience. By driving innovative change that will continue to disrupt the status quo, forward-leaning FIs that are modernizing their core system will have a road map not only for adapting valuable core assets to new technological realities, but also for opening up ways for endless digital possibilities."
Technisys' platform is a leading next-gen digital and core banking platform that redefines the customer experience. As a best-in-class technology platform, Technisys uniquely delivers differentiation in two key ways. By empowering financial institutions to dynamically create tailored financial products at the speed of commerce. And, by allowing them to offer meaningful recommendations to customers at point of need. How are we different? Technisys' platform uses data-driven insights and integrates them with its unique technology that enables structural flexibility. A flexibility that allows financial institutions to create and tailor any financial product - in real time - to deliver a seamless digital experience at every customer touchpoint whether online, on the phone, or at a branch. Giving banks and fintechs the agility to tailor offerings that become integral to a customer's lifestyle in new and profound ways, down to the segment of one.
Ryan Lannon, on behalf of Technisys
Phone: 1.905.449.3123
Email: technisys@fullyvested.com
View original content to download multimedia:
SOURCE Technisys | https://www.wibw.com/prnewswire/2022/08/10/technisys-redefines-banking-core-modernization-enabling-financial-institutions-embrace-digital-innovation-remarkable-speed-scale/ | 2022-08-10T16:20:08Z |
Antique vampire-slaying kit sparks bidding war
Published: Jul. 4, 2022 at 7:29 AM CDT|Updated: 10 minutes ago
(CNN) - There is an eerie auction for some gothic goods.
An antique vampire-slaying kit has sold in the United Kingdom for almost $16,000. That is more than six times the asking price.
The 19th century box has everything you would need to ward off vampires including crucifixes, holy water, a wooden stake and more.
The auction house says the kit once belonged to Lord William Hailey, a British aristocrat with a place in the House of Lords.
Copyright 2022 CNN Newsource. All rights reserved. | https://www.kxii.com/2022/07/04/antique-vampire-slaying-kit-sparks-bidding-war/ | 2022-07-04T12:40:20Z |
- World's first open web3 carbon credit marketplace launches
- Voluntary carbon offsetting made as easy as ordering from Amazon
- Web3 infrastructure enables traceability and verifiability of carbon credits
FRANKFURT, Germany, Sept. 15, 2022 /PRNewswire/ -- It's all about shaking up the status quo: To date, the voluntary carbon market is anything but transparent and structured. Nevertheless, many companies that have voluntarily committed to climate targets consider investments in offset projects an essential part of their decarbonization strategies. As a result, demand for certificates is increasing, which is leading to a rise in prices. At the same time, global standards are evolving to define appropriate quality levels for carbon credits and carbon offsetting. To help navigate this challenging market, Senken has developed an easy-to-use trading platform where anyone can compare, buy, trade, and retire carbon credits in a straightforward, climate-smart way.
Coordinating the Voluntary Carbon Market and its emerging players
"We see ourselves as a market orchestrator," says René Schäfer, founder of Senken. On senken.io, companies and investors can buy and trade tokenized carbon credits from climate projects in a transparent and traceable way. The certificates are stored in a distributed database in a decentralized and immutable manner. They contain all necessary and available information along the climate project value chain—from information that determines project quality and performance, to information on co-benefits (for example, information on Sustainable Development Goals), trade and market data, and additional information such as ratings.
"We offer about 20 million certificates. Another 18 million credits are currently being onboarded," explains Adrian Wons, founder of Senken. To this end, the company partners with leading regenerative finance and tech startups such as Toucan Protocol, Flowcarbon, Celo, and Polygon, but also with carbon rating agencies such as BeZero Carbon and project developers like Allcot, who are all tackling the lack of transparency and quality by leveraging new standards and technological breakthroughs like blockchain or sensor data.
Senken's mission is to solve the credibility and transparency problem of the voluntary carbon market
"We believe that the Voluntary Carbon Market is a meaningful and effective mechanism in the fight against climate change. We want to give it a new digital guise and help companies and investors to participate in the market in a qualitative and trustworthy way. At the same time, this allows the market to grow quickly and sustainably," says Schäfer.
Founder Adrian Wons built up the blockchain unit at Ernst & Young (EY) Germany and led the department for two years. He has a background in Mechanical Engineering and wrote two books about blockchain technology for SpringerGabler. René Schäfer was previously responsible for digital platform business models and digital strategies at hy - the Axel Springer Consulting Group. He advised over 50 clients in the areas of marketplaces and digital transformation. Djamel Mekibes held various European management roles for TJX Europe and led international teams, most recently as Head of Central Operations Germany TK Maxx.
About Senken
Senken has built the world's first climate finance platform for the trade of on-chain carbon credits. The goal: to democratize purchases, sales, and retirements of carbon credits which were previously only available to privileged investors or over-the-counter insiders. The Senken Marketplace enables transparent investments in tokenized carbon credits from verified climate projects. The projects underlying the credits can be effortlessly queried and compared. The corresponding project credits can be bought, traded, and used to offset carbon emissions. Credibility and trust are guaranteed by a decentralized on-chain infrastructure that stores all accruing information along the value chain of climate projects. Senken was founded in 2022 by Adrian Wons and René Schäfer, co-founder is Djamel Mekibes. https://senken.io/
Press Contact:
Kirsten Hedinger, Hedinger Communications GmbH
+49 40/421011-12, E-Mail: Hedinger@Hedinger-PR.de
View original content:
SOURCE Senken | https://www.kxii.com/prnewswire/2022/09/15/senken-democratizes-market-carbon-credits-bringing-global-climate-economy-on-chain/ | 2022-09-15T15:01:51Z |
(The Hill) – The man who was accused of raping and impregnating a 10-year-old girl in Ohio was indicted on two felony counts of rape on Thursday.
A grand jury in Columbus charged Gerson Fuentes, 27, issued the indictment on the two felony counts. Fuentes was charged with the rape earlier this month after police said that he confessed to raping the girl twice.
After becoming pregnant, the girl was forced to travel to Indiana for an abortion due to an Ohio law which bans the procedure after fetal cardiac activity is detected, usually about six weeks into a pregnancy.
The case sparked national attention and incited further outrage among Democrats and pro-choice advocates following the Supreme Court’s overturning of Roe v. Wade last month.
Critics say that the court’s ruling, which leaves abortion rights up to the states, could result in a large number of “deserts” in which people seeking abortions are forced to travel hundreds of miles to other states to receive the procedure.
President Biden highlighted the case during an address announcing an executive order aiming at safeguarding abortion rights.
“Raped, six weeks pregnant. Already traumatized. Was forced to travel to another state. Imagine being that little girl,” the president said.
The grand jury’s indictment comes days after the doctor who provided the abortion to the 10-year-old girl moved to sue Indiana Attorney General Todd Rokita (R) for “false and misleading statements about alleged misconduct.”
Fuentes’ arraignment is set for Monday. | https://cw33.com/news/nexstar-media-wire/ohio-grand-jury-indicts-man-accused-in-rape-of-10-year-old-at-center-of-indiana-abortion-controversy/ | 2022-07-22T18:20:08Z |
Constance N. Hadley and Mark Mortensen win award for best MIT SMR article on planned change and organizational development
CAMBRIDGE, Mass., Sept. 13, 2022 /PRNewswire/ -- Today the editors of MIT Sloan Management Review announced that Constance N. Hadley and Mark Mortensen are the winners of the 2022 Richard Beckhard Memorial Prize. The prize is awarded to the authors of the most outstanding MIT SMR article on planned change and organizational development published in the winter 2021 through fall 2021 issues.
MIT SMR awarded the prize for the article "Are Your Team Members Lonely?" from the winter 2021 issue. Hadley is an organizational psychologist and lecturer at Boston University's Questrom School of Business. Mortensen is an associate professor of organizational behavior at INSEAD.
The prize-winning article results from two studies involving nearly 500 global executives, along with informal interviews with other managers. The authors found that workplace teams are changing in today's organizations, and they are now less likely to be relatively stable, with long-lasting group member roles underpinned by close working relationships. Teams have not only become ever present in our work lives but have also grown in number and scope and become more flexible, less stable, and more time-pressed. The result is that we are often "alone together" in the organization.
The authors assert that loneliness or the lack of social connections is often thought of as an individual issue, but in organizations, it is also a structural one that can emerge from the composition, duration, and staffing of teams. Four features of current team design foster such disconnection: fluid membership, with rapid turnover in team composition; modularized roles, with members chosen for discrete skills the team requires; part-time commitment such that members can serve on many teams simultaneously; and short duration, with teams forming for short periods before disbanding. Such scenarios tend to promote transactional, limited, and shallow relationships among members.
"The authors' call for managers to exercise more responsibility for the well-being of employees and their social interconnections would resonate with Dick Beckhard," the judges say. "He was a strong advocate for the use of diverse teams in organizations and was keenly aware of the features that encourage and discourage positive intrateam dynamics."
The authors advise monitoring feelings of loneliness among employees. Leaders might create what the authors call core teams, with longer durations, stable membership, low turnover, common affinities or interests, and a shared work location.
This year's panel of judges consisted of distinguished members of the MIT Sloan School of Management faculty: Kate Kellogg, the David J. McGrath Jr. Professor of Management and Innovation; John Van Maanen, the Erwin H. Schell Professor of Management, Emeritus; and David Robertson, a senior lecturer in operations management.
One of the founders and architects of the field of organizational development, Professor Richard Beckhard was a member of the MIT Sloan School of Management faculty for more than 20 years. A longtime friend of MIT Sloan Management Review, Beckhard was known for his efforts to help organizations function in a more humane and high-performing manner and to empower people to be agents of change.
At MIT Sloan Management Review (MIT SMR), we explore how leadership and management are transforming in a disruptive world. We help thoughtful leaders capture the exciting opportunities — and face down the challenges — created as technological, societal, and environmental forces reshape how organizations operate, compete, and create value.
Tess Woods
tess@tesswoodspr.com
View original content to download multimedia:
SOURCE MIT Sloan Management Review | https://www.wibw.com/prnewswire/2022/09/13/are-your-team-members-lonely-winner-mit-sloan-management-review-2022-beckhard-prize/ | 2022-09-13T16:05:23Z |
PALO ALTO, Calif., Aug. 17, 2022 /PRNewswire/ -- Zendure, one of the fastest growing start-ups in the energy tech sector, is on a mission to ensure everyone has access to reliable, affordable energy, and they've brought a new weapon ally into the fight: semi-solid state battery technology.
Semi-solid state batteries boast a higher energy density and greater damage resistance than lithium-ion phosphate (LiFePO4) batteries, providing homes and businesses with more energy storage and enhanced product safety.
"Recent natural disasters, grid failures, and the rising cost of energy are becoming a critical concern for communities around the world. When people and communities are without power, even for a day, it's not just the comforts and conveniences of modern life that are lost, rather energy is about survival and connection. Zendure is offering a solution that delivers energy security and long-term cost savings," said Bryan Liu, CEO & Founder of Zendure.
Since the Industrial Revolution, the global annual temperature has increased in total by a little more than 1 degree Celsius according to NRDC, leading to a worsening global warming problem. This in turn contributes to heat waves and other adverse weather conditions and causes serious problems for people in vulnerable regions.
Recently, the U.S. Government passed a transformative bill that takes action on global warming and provides "the most spending to fight climate change by any one nation ever in a single push," according to the Associated Press.
Texas, whose population is growing rapidly, has struggled to meet the needs of the nearly 30 million people who already live there. Natural gas is a major source of energy for the state, and particularly during periods of high demand. Last year's winter storm left millions of Texans without heat and electricity, causing significant financial damage and a humanitarian crisis.
According to a natural gas analyst for S&P Global Platts Parker Fawcett, gathering lines freeze, wells grow extremely cold, and pumps lose power. As a result, gas and liquid fuel cannot reach the communities that need them, cutting off millions from access to medicine, medical care, and communication, and emergency services.
Zendure plans to tackle blackouts and other infrastructure failures with SuperBase V, the company's new portable, high-performance power station featuring semi-solid state batteries for the first time. SuperBase V is suited to a variety of applications–including household backup power, mobile living, and portable EV charging–and boasts several industry-leading features:
- The first system with semi-solid state batteries for enhanced capacity and safety
- 120V/240V dual voltage from one unit
- 6.4kWh to 64kWh expandable capacity
- Up to 6.6kW dual-recharge
- Up to 3,000W solar input
- Independent RV output from Satellite Expansion Batteries
- Support for public charging stations and Level 2 charging for electric vehicles
About Zendure
Zendure is one of the fastest growing Clean EnergyTech start-ups based in the technology hubs of Silicon Valley and the Greater Bay Area in China's Silicon Valley. Zendure's goal is to make energy accessible anywhere, anytime, and to democratize the latest energy technology to power on-grid and off-grid lifestyles alike in a clean and affordable way. To learn more visit Zendure.com and follow us on Facebook, Instagram, Twitter and LinkedIn.
View original content to download multimedia:
SOURCE Zendure USA Inc. | https://www.kxii.com/prnewswire/2022/08/17/zendure-addresses-energy-insecurity-with-semi-solid-state-battery-technology/ | 2022-08-17T16:05:38Z |
Ford recalls 737K vehicles to fix oil leaks, trailer brakes
Published: Apr. 1, 2022 at 8:39 AM EDT|Updated: 1 hour ago
DETROIT (AP) — Ford is issuing two recalls covering over 737,000 vehicles to fix oil leaks and trailer braking systems that won’t work.
The oil leak recall includes the 2020 through 2022 Ford Escape SUV and the 2021 and 2022 Bronco Sport SUV with 1.5-Liter engines.
A housing can crack and oil can leak onto engine parts, possibly causing fires.
The trailer brake recall includes F-150 pickups from 2021 and 2022, as well as the 2022 F-250, 350, 450 and 550.
Also covered are the 2022 Maverick pickup, Ford Expedition and Lincoln Navigator SUVs.
A software error can stop trailers from braking.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/04/01/ford-recalls-737k-vehicles-fix-oil-leaks-trailer-brakes/ | 2022-04-01T13:51:42Z |
Influenza is always unpredictable. Infectious disease experts like to hedge their forecasts with a caution: When you've seen one flu season, you've seen one flu season.
But when forecasters try to get a bead on what influenza might have in store for North America in any given winter, they look to countries like Australia and New Zealand, where the season typically runs from April to October -- winter months in the Southern Hemisphere.
This year, Australia had its worst flu season in five years. Cases peaked about three times higher than the average for that period, and they topped out about two months earlier than they normally do, according to official government surveillance reports.
Rates of influenza-like illness have also been higher in New Zealand this year than they have been for the past two years.
The US should take heed, Dr. Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, told Bloomberg News.
"The Southern Hemisphere has had a pretty bad flu season, and it came on early," Fauci said. "Influenza -- as we all have experienced over many years -- can be a serious disease, particularly when you have a bad season."
He said that means the US could see flu make a comeback while Covid-19 is still circulating at higher levels.
Recent government modeling predicts that Covid-19 will peak again in early December.
If that happens, it would be the first winter in which the US has had to contend with those two respiratory viruses circulating together at high levels, something infectious disease experts have cautioned about since the beginning of the pandemic.
Lower immunity and maskless kids
When Americans began isolating, social distancing and masking to slow Covid in early 2020, flu all but disappeared.
As people have returned to their normal routines, flu has staggered back, but cases haven't approached pre-pandemic levels, which means most of us haven't been exposed to the flu for a few years, said Dr. Jennifer Nayak, a pediatric infectious disease specialist at the University of Rochester Medical Center.
"With these few mild flu seasons back-to-back, I think immunity in the population is probably lower than what it is entering an average flu season," Nayak said.
On top of that, most kids are no longer wearing masks at schools.
"We know that kids are an important source of influenza infections. They get it at school or day care, and they bring it home to the household," Nayak says. Many adults also aren't wearing masks or avoiding crowded spaces, "so there's a potential for more transmission of influenza" this year.
All of that underscores the need for Americans to get vaccinated. But typically, about half do not. Just 45% of Americans got their flu shots last season, according to the US Centers for Disease Control and Prevention. Flu vaccination rates fell for several at-risk groups, including pregnant women and children.
The US government will launch a campaign this fall to urge people to get their flu shots and updated Covid-19 boosters at the same time.
Nayak wonders how those public health messages -- urging people to get more vaccines to stave off more infections -- may sound to pandemic-weary Americans.
"I think we have to still see how this plays out with what our influenza vaccination rates are going to do," she said.
Flu's burden on society
All of this is still hypothetical. We won't really know for another eight weeks or so what the winter may have in store.
"I think we've got to keep an eye -- if we're going to have something analogous to Australia -- to what goes on in November," said Jeffrey Shaman, a modeling expert at Columbia University's Mailman School of Public Health. "Do we start to see flu a little earlier than we typically do? And it may take off. And of course, on top of that, we've got to worry about how that compiles with the Covid circulating."
Two co-circulating respiratory viruses could spell trouble for hospitals, which are still strained and struggling.
It could also mean people getting viral illnesses that might leave them vulnerable to ongoing health issues, serious disease and death.
"Flu has not become an afterthought," Shaman said. "Seasonal flu has and continues to impose a very heavy burden on society, one we would like to get a handle on."
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/features/health/australias-tough-flu-season-could-spell-trouble-for-the-us-this-winter-especially-with-covid/article_aa4373af-8e58-5e0a-ac14-7590a2a6057e.html | 2022-09-06T12:37:46Z |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.